Distribution and nucleocytoplasmic transport of the thyroid hormone receptor and variants by Bunn, Caroline F.
Distribution and Nucleocytoplasmic 
Transport of the Thyroid Hormone Receptor 
and Variants 
A thesis submitted in partial fulfilment 
of the requirements for the degree of 
Doctor of Philosophy 
III 
Cellular and Molecular Biology 
at the 
University of Canterbury 
Caroline Bunn 
1999 
1 5 SEP 1999 
In memory of my mother, 
Robyn Louise Bunn. 
You remain my inspiration. 
UTo understand the utterances that emanate from the world's secret internal sanctuaries 
takes a lifetime of dedication, study and patience. There are those who would say that it 
takes more than one lifetime to acquire such skills. After all, anyone can hear the Raven 
calling on a grey day in the fields, but how many will ever learn the skill of listening to 
what the bird has said?" 
CaisealMor 
Table of Contents 
ABSTRA CT ............................. 0.0 ••••••••••••••••••••••••• D ••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••• vii 
ABBREVIATI ONS ........................................................................................................... viii 
CHAPTER 1 GENERAL INTRODUCTION ................................................................ 1 
1.1 
1.1.1 
1.1.2 
1.1.3 
1.1.4 
1.2 
1.2.1 
1.2.2 
1.2.3 
1.2.4 
1.2.5 
1.3 
1.3.1 
1.3.2 
1.3.3 
1.3.4 
1.3.5 
1.4 
1'he nuclear hormone receptor superfamily ........................................................ 1 
An introduction to members of the superfamily ................................................... 2 
The thyroid hormone receptor. .............................................................................. 3 
v-ErbA oncoprotein .............................................................................................. 5 
A DNA-binding mutant of TR .............................................................................. 6 
Nucleocytoplasmic transport ................................................................................. 8 
The basis of nucleocytoplasmic transport.. ........................................................... 8 
Mechanisms of protein transport .......................................................................... 9 
Protein import ..................................................................................................... 12 
Nuclear localisation signals ................................................................................ 15 
Nuclear export and nucleocytoplasmic shuttling ................................................ 17 
Aims of investigation and methodological approaches ..................................... 19 
Comparison of cellular TR isoforms with variant receptors ............................... 19 
Use of oncogenes as research tools ..................................................................... 20 
Xenopus oocytes as a model system ................................................................... 21 
Cultured mammalian cells as an expression system ........................................... 22 
Green fluorescent protein tags ............................................................................ 24 
Organisation of thesis ........................................................................................... 25 
CHAPTER 2 SUBCELLULAR DISTRIBUTION OF THE THYROID 
2.1 
2.1.1 
2.1.2 
2.1.3 
2.1.4 
2.1.5 
2.2 
2.2.1 
2.2.2 
2.2.3 
2.2.4 
HORMONE RECEPTOR AND VARIANTS ................................................ 27 
Introduction .......................................................................................................... 27 
Distribution of nuclear hormone receptors ......................................................... 27 
Distribution of TR and v-ErbA ........................................................................... 28 
Association of nuclear hormone receptors with the nuclear matrix ................... 32 
Association of nuclear hormone receptors with hsp90 ....................................... 33 
Summary of results ............................................................................................. 35 
Materials and Methods ........................................................................................ 37 
Plasmids and Antibodies ..................................................................................... 37 
In vitro synthesis of proteins ............................................................................... 39 
Surgical removal and microinjection of Xenopus oocytes .................................. 39 
Analysis of subcellular distribution in Xenopus oocytes .................................... 40 
22.5 
2.2.6 
2.2.7 
2.2.8 
2.2.9 
2.2.10 
2.2.11 
2.2.12 
2.3 
2.3.1 
2.3.2 
2.3.3 
2.3.4 
2.3.5 
2.3:6 
2.3.7 
2.4 
2.4.1 
2.4.2 
2.4.3 
2.4.4 
2.4.5 
11 
Xenopus oocyte incubations in thyroid hormone ............................................... .42 
Immunoprecipitation and detection of v-ErbAlhsp90 complexes ...................... 42 
Mammalian cell culture ...................................................................................... 44 
Transfection of NllI 3T3 cells ..... ' ...................................................................... .44 
Visualisation of EGFP labelled proteins in cultured mammalian cells .............. 45 
T3 addition and absence in cultured mammalian cells ..................................... 45 
Isolation of nuclear fractions and nuclear matrix intermediate filaments ....... 46 
Western analysis of differentially extracted proteins ...................................... 47 
Results ................................................................................................................. II 48 
Microinjected [35S]-labelled TR and variants accumulate in Xenopus 
oocyte nuclei ....................................................................................................... 48 
Subcellular distribution of TRa, TR~, C122A, and v-ErbA in Xenopus 
oocytes ................................................................................................................ 50 
Distribution of EGFP-tagged TRa and C122A in cultured mammalian cells .... 52 
T 3 hormone increases nuclear accumulation of TR in Xenopus oocytes ............ 54 
Hormone does not affect localisation ofEGFP-tagged TRa or C122A 
in cultured cells ................................................................................................... 60 
v-ErbA binds hsp90 from rabbit reticulocyte lysate ........................................... 60 
Subnuc1ear distribution of wild type and EGFP fusion receptors ....................... 65 
Discussion .............................................................................................................. 70 
Localisation of receptor is dependent on cell type .............................................. 70 
Localisation of TR is not solely dependent upon DNA binding in 
Xenopus_oocytes ................................................. ................................................. 74 
Influence of T 3 hormone binding on receptor localisation ................................. 77 
Subnuclear distribution of receptors in cultured mammalian cells ..................... 78 
v-ErbA associates with hsp90 ............................................................................. 79 
CHAPTER 3 NUCLEOCYTOPLASMIC TRANSPORT OF THE 
3.1 
3.1.1 
3.1.2 
3.1.3 
3.1.4 
3.1.5 
3.1.6 
3.1.7 
3.1.8 
3.2 
3.2.1 
3.2.2 
THYROID HORMONE RECEPTOR AND VARIANTS ............................ 81 
Introduction .......................................................................................................... 81 
Nucleocytoplasmic transport .............................................................................. 82 
Nucleocytoplasmic transport of nuclear hormone receptors ............................... 82 
Differentiating facilitated transport from diffusion ............................................ 84 
Energy requirements for transport ...................................................................... 85 
Temperature dependence .................................................................................... 86 
Competition assays ............................................................................................. 87 
Inhibition oftransport by wheat germ agglutinin ............................................... 87 
Summary of results ............................................................................................. 88 
Materials and Methods ..... "." .................................................................... " ................... 90 
Plasmids .............................................................................................................. 90 
Characterisation of receptor transpOlt in Xenopus oocytes ................................. 90 
3.2.3 
3.2.4 
3.2.5 
3.2.6 
3.3 
3.3.1 
3.3.2 
3.3.3 
3.3.4 
3.3.5 
3.3.6 
3.3.7 
3.4 
3.4.1 
3.4.2 
3.4.3 
3.4.4 
iii 
Chilling assays in Xenopus oocytes .................................................................... 91 
ATP depletion and WGA assays in oocytes ....................................................... 91 
Histone HI and ribosomal protein L5 competition assays in Xenopus oocytes .92 
Chilling and ATP depletion assays in cultured mammalian cells ....................... 93 
Results .............................................................................................. 0 •••••••••••••••••••• 95 
Import of TRa, TR~, and C122A in Xenopus oocytes is temperature 
independent ........................................................................................................ 95 
Chilling inhibits TRa export in Xenopus oocytes ............................................... 96 
Histone HI does not inhibit TRa, TR~, or C122A import in Xenopus 
oocytes .............................................................................................................. 102 
Competition with ribosomal protein L5 does not affect TRa, TR~, or 
C 122A import in Xenopus oocytes ................................................................... 103 
WGA and apyrase do not inhibit TR import in Xenopus oocytes ..................... 109 
Chilling does not affect EGFP-tagged TRa or C 122A nuclear localisation 
in cultured NIH 3T3 cells ................................................................................. 112 
ATP depletion does not affect EGFP-tagged TRa and C122A nuclear 
localisation in cultured Nllf 3T3 cells .............................................................. 115 
Discussion ............................................................................................................ 119 
Nuclear import of TRa, TR~, and C122A in Xenopus oocytes occurs 
by a passive process .......................................................................................... 119 
Role of the TR NLS in nuclear localisation ...................................................... 121 
Export ofTR isoforms, C122A, and v-ErbA is temperature dependent 
in Xenopus oocytes ........................................................................................... 122 
No effect of chilling or ATP depletion on localisation of EGFP-tagged 
TRa or C122A is observed in cultured cells .................................................... 123 
CHAPTER 4 CONCLUSION ...................................................................................... 126 
4.1 Comparison of TR with other members of the NHR superfamily ................. 127 
4.2 Nuclear localisation of TR ................................................................................. 130 
4.3 Regulatory mechanisms of TR activity ............................................................ 133 
4.4 Prospects and conclusions ................................................................................. 136 
ACKNOWLEDGEMENTS ............................................................................................ 138 
RE}"'ERENCES ...................................................................................................................... 139 
A.PPENDIX I .......................................................................................................................... 160 
APPENDIX II .................................................................................................................. 162 
APPENDIX III .................................................................................................................................. 163 
APPENDIX IV .......................................................................................... e ••••••••••••• e ........... 164 
IV 
List of Figures 
Figure 1.1 - Schematic of a generalised nuclear hormone receptor.. ................................... 3 
Figure 1.2 - Zinc finger domain of TR ................................................................................ 7 
Figure 1.3 - Modular structures of the receptors TRa, TR~, C122A, and v-ErbA ............. 8 
Figure 1.4 - The three mechanisms of nucleocytoplasmic transport ................................. 11 
Figure 1.5 - Importin a/~ mediated protein import pathway ............................................. 13 
Figure 2.1 - The nuclear accumulation of microinjected TR and variants in 
Xenopus oocytes ............................................................................................................ 49 
Figure 2.2 - The distribution of cytoplasmically-injected TR and variants in 
Xenopus oocytes ............................................................................................................ 51 
Figure 2.3 - The distribution of nuclear-injected TR and variants in Xenopus 
oocytes .......................................................................................................................... 53 
Figure 2.4 - The subcellular distribution of EGFP-tagged TRa and C122A in 
cultured mammalian cells ............................................................................................. 55 
Figure 2.5 - The effect of T3 incubation on TRa distribution in Xenopus oocytes ............ 57 
Figure 2.6 - The effect of T 3 incubation on v-ErbA distribution in Xenopus oocytes ........ 58 
Figure 2.7 - The effect of T3 incubation on TR~, C122A, and L5 distribution 
in Xenopus oocytes ................ : ........... : .......................................................................... 59 
Figure 2.8 - The effect of T3 incubation on TRa::EGFP, C122A::EGFP, and 
EGFP distribution in cultured mammalian cells ............................................... 61 and 62 
Figure 2.9 - Hsp90 associates with v-ErbA in rabbit reticulocyte lysate ........................... 64 
Figure 2.10 - Distribution of TRa, TRa::EGFP, C122A, C122A::EGFP, and 
EGFP in fractionated NIH 3T3 cells ............................................................................. 66 
Figure 3.1 - The effect of chilling on the nuclear impOlt of TRa in Xerwpus 
oocytes .......................................................................................................................... 97 
Figure 3.2 - The effect of chilling on the nuclear import of TR~ in Xenopus 
oocytes .......................................................................................................................... 98 
Figure 3.3 - The effect of chilling on the nuclear import of C122A in Xenopus 
oocytes .......................................................................................................................... 99 
Figure 3.4 - The effect of chilling on the nuclear import of v-ErbA in Xenopus 
oocytes ........................................................................................................................ 100 
Figure 3.5 - The effect of chilling on the nuclear import of L5 in Xenopus oocytes ........ 101 
Figure 3.6 - The effect of competing proteins on the nuclear import of L5 in 
Xenopus oocytes .......................................................................................................... 104 
Figure 3.7 - The effect of competing proteins on the nuclear import of TRa in 
Xenopus oocytes .......................................................................................................... 105 
Figure 3.8 - The effect of competing proteins on the nuclear import of TR~ in 
Xenopus oocytes .......................................................................................................... 106 
Figure 3.9 - The effect of competing proteins on the nuclear import of C122A in 
Xenopus oocytes .......................................................................................................... 107 
Figure 3.10 - The effect of competing proteins on the nuclear import of v-ErbA in 
Xenopus oocytes .......................................................................................................... 108 
Figure 3.11 - The effect of ATP depletion on the nuclear import of TRa, 
v-ErbA, and L5 in Xenopus oocytes ........................................................................... 110 
v 
Figure 3.12 - The effect of WGA on the nuclear import of TRa, v-ErbA, and L5 
in Xenopus oocytes ............................................................................... " ...................... 111 
Figure 3.13 - The effect of chilling on TRa::EGFP and C122A::EGFP localisation 
in transfected mammalian cells ................................................................................... 114 
Figure 3.14 - The effect of ATP depletion on TRa::EGFP and C122A::EGFP 
localisation in transfected mammalian cells ............................................................... 116 
Figure 4.1 - Localisation of nuclear hormone receptors ................................................... 128 
Figure 4.2 - Model for interactions of TR with cellular components ............................... 132 
VI 
List of Tables 
Table 1 A Terminology of nucleocytoplasmic transport factors ......................................... 14 
Table 2· Nuclear localisation sequences present in nuclear hormone receptors ............... 16 
Table 3 - Distribution of nuclear hormone receptors ......................................................... 30 
Table 4 - Receptor association with heat shock protein 90 ................................................ 35 
Table 5 - Properties of TR and variants ............................................................................ 36 
TabJe 6 - Summary of receptor distribution studies in Xenopus oocytes ........................... 68 
Table 7 - Summary of EGFP-tagged receptor distribution studies in NIH 3T3 cells ........ 69 
Table 8· Distribution of receptors in cell fractions ........................................................... 69 
Table 9 - Transport of nuclear hormone receptors ............................................................. 83 
Table 10 - Transport inhibition treatments in Xenopus oocytes ........................................ 93 
Table 11 - Transport assays in cultured NIH/3T3 cells ..................................................... 94 
Table 12 - Predicted outcomes for low temperature incubations and ATP 
depletion studies .......................................................................................................... 113 
Table 13 - Summary of nUcleocytoplasmic transport studies in Xenopus oocytes .......... 117 
Table 14 - Summary of nucleocytoplasmic transport studies in NIH 3T3 cells .............. 118 
vii 
Abstract 
The thyroid hormone receptor (TR) is a member of the nuclear hormone receptor (NHR) 
superfamily. Members of this superfamily exhibit diverse subcellular distributions and 
nucleocytoplasmic transport mechanisms. TR exhibits a dual role as a repressor (or 
activator) in the absence of thyroid hormone (T3), and an activator (or repressor) of 
transcription in the presence of T3, thus implying constitutive nuclear localisation and 
persistent contact of TR with DNA. To investigate the complexity of the cellular response 
to T3, the nucleocytoplasmic distribution of TR, its viral oncogenic variant (v-ErbA), and a 
DNA-binding mutant (CI22A) were studied, using SDS-PAGE and fluorography to detect 
radiolabelled proteins extracted from microinjected Xenopus oocytes, and green 
fluorescent protein (GFP) fusions to study trafficking in transfected NIH/3T3 cells. 
Surprisingly, after cytoplasmic injection only 39-40% of TRa, TR~, and C122A was 
localised to the oocyte nucleus, increasing to 45-51 % in response to T3. After nuclear 
injection, 62% of TRa was retained in the nucleus in the absence of T3 and 85% in the 
presence, suggesting that more intranuclear binding sites are available for interaction with 
T3-bound receptor. Only 10% of v-ErbA was localised to oocyte nuclei after cytoplasmic 
injection, due to assocIation of v-ErbA with hsp90. A similar cytoplasmic sUbpopulation of 
v-ErbA/hsp90 in mammalian cells has been previously reported. The distribution of 
v-ErbA was unaffected by T3. Nuclear accumulation in oocytes is not due to DNA binding 
alone, since C122A distribution was similar to TR. Interestingly, import of TR and C122A, 
but not v-ErbA, in oocytes was energy and temperature independent and not inhibited by 
wheat germ agglutinin. However, export of TRa, TR~, and C122A was temperature 
dependent. In contrast to Xenopus oocytes, EGFP-tagged TRa localised entirely to the 
nuclei in transfected mouse cells, even in energy-depleted and chilled cells, and 
EGFP-tagged C122A remained extranuclear. Both TRa and EGFP-tagged TRa were 
shown to be associated with the nuclear matrix in biochemically fractionated NIH 3T3 
cells. C122A and EGFP-tagged C122A were not found in the nuclear fractions, confirming 
the observations in living cells. A universal model for TR localisation is proposed to 
account for the observations made in the two cell systems. Since nuclear localisation of 
TR, v-ErbA, and C122A is not constitutive in Xenopus oocytes, this provides a model 
system for reconstituting regulatory networks affecting nuclear or cytoplasmic retention of 
TR and its variants in vivo. 
a.a. 
Ab 
AEV 
AR 
ATP 
BSA 
DBD 
DNA 
D-PBS 
EGFP 
ER 
GFP 
GIcNAc 
GR 
GTP 
HBD 
HIV-l 
hnRNP 
HRE 
hsp 
kDa 
MR 
mRNA 
NES 
NHR 
NLS 
NM (-IF) 
NPC 
NuMA 
PBS 
PR 
RAR 
RNP 
rRNA 
RXR 
snRNA/RNP 
SV40 
T3 
TFIIlA 
TR 
VDR 
WGA 
Amino Acid 
Antibody 
AbbreviatiollS 
Avian Erythroblastosis Virus 
Androgen Receptor 
Adenosine Triphosphate 
Bovine Serum Albumin 
DNA Binding Domain 
Deoxyribonucleic Acid 
Dulbecco's Modified Phosphate Buffered Saline 
Enhanced Green Fluorescent Protein 
Oestrogen Receptor 
Green Fluorescent Protein 
N-Acetylglucosamine 
Glucocorticoid Receptor 
Guanosine Triphosphate 
Hormone Binding Domain 
Human Immunodeficiency Virus Type-l 
Heterogeneous nuclear RNP 
Hormone Responsive Element 
Heat Shock Protein 
Kilo Daltons 
Mineralocorticoid Receptor 
Messenger Ribonucleic Acid 
Nuclear Export Signal 
Nuclear Hormone Receptor 
Nuclear Localisation Signal 
Nuclear Matrix (- Intermediate Filaments) 
Nuclear Pore Complex 
Nuclear Mitotic Apparatus Protein 
Phosphate Buffered Saline 
Progesterone Receptor 
Retinoic Acid Receptor 
Ribonucleoprotein 
Ribosomal Ribonucleic Acid 
Retinoid X Receptor 
Small Nuclear Ribonucleic Acid/Ribonucleoprotein Particle 
Simian Virus 40 
3,3' ,5-triiodo-L-thyronine 
Transcription Factor IlIA 
Thyroid Hormone Receptor 
Thyroid Hormone Responsive Element 
Vitamin D Receptor 
Wheat Germ Agglutinin 
Vlll 
1 
Chapter 1 
General Introduction 
1.1 The nuclear hormone receptor superfamily 
The recognition of an increasing number of genetic diseases has focused the attention 
of researchers on the dismption of cell growth and development. However, it is difficult to 
envisage curative agents being developed without a substantial increase in the understanding 
of how cells function normally. Nuclear hormone receptors (NHRs) are involved in many 
aspects of cellular development at the level of gene expression. They act as highly abbreviated 
signal transduction pathways and upon binding specific sites in the genome, regulate 
transcription of adjacent genes (Evans, 1988). 
The members of this superfamily, including the thyroid hormone receptor (TR), 
display a diversity of distributions within the cell and variation in transport mechanisms 
between the cytoplasmic and nuclear compartments. The exact cellular distributions of these 
receptors, in the absence or presence of hormone, are still an issue due to variations in results 
obtained with a variety of techniques in different cell types. Recently it has been recognised 
that the transport of receptors does not appear to be a static, unidirectional process, but also 
seems to reflect shuttling of receptor molecules between the nucleus and cytoplasm. The 
refinement and development of techniques to determine receptor distribution and transport 
has lead to a reassessment of previously accepted studies. 
This thesis focuses on the distribution and transport of TR between the cytoplasmic 
and nuclear compattments of two model systems; Xenopus oocytes and cultured NllI 3T3 
cells. Distribution and transport of two variants of TR are characterised: the viral oncogenic 
protein (v-ErbA), and a DNA-binding mutant (C122A). 
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1.1.1 An introduction to members of the superfamily 
In addition to TR, the members of the NHR superfamily include receptors for 
progesterones, oestrogens, androgens, glucocorticoids, mineralocorticoids, vitamin D, and 
retinoids (reviewed in Tsai and O'Malley, 1994). The receptors that comprise this supelfamily 
are transcription factors that bind to specific cis-acting DNA sequence elements in the 
genome or hormone respo~sive elements (HREs). Cis-acting sequence elements are found 
adjacent to the genes they are involved in regulating. Subsequent to HRE binding, NHRs 
regulate transcription of these adjacent target genes in response to ligand binding (Evans, 
1988). For example, TR binds thyroid responsive elements (TREs). It activates or represses 
gene transcription in both the absence and presence of thyroid honnone. The products of these 
target genes form a network of proteins inv91ved in control of cell growth and differentiation, 
and therefore morphogenesis of the animal. 
Nuclear hormone receptors contain several domains that are differentially conserved 
between members. Figure 1.1 displays the domains of a generalised member of the NHR 
supelfamily and highlights the specific regions involved in nuclear transport, receptor 
dimerisation, and heat shock protein 90 (hsp90) binding. Domains A and B are involved in 
modulating the trans-activation function of the receptor; domain C contains the DNA binding 
domain (DBD) which includes two zinc finger motifs (Figure 1.2); domain D is a 'hinge' 
region; whilst domain E is required for honnone binding (HBD) , dimerisation of receptor 
molecules, and regulation of transcliption (Laudet et al., 1992; Nelson et al., 1993). 
The N-terminal regions of NHRs are variable amongst members of the superfamily. A 
portion of this domain, together with the DBD and part of the HBD, is responsible for 
trans-activation (Guiguere et al., 1986; Kumar et al., 1987; Godowski et al., 1988; Webstcr et 
al., 1988). Nuclear localisation and hormone binding may also be involved in trans-activation 
functions providing further mcans of regulating NHR activity (Kumar et ai., 1987; Picard and 
Yamamoto, 1987). The sholt, cysteine-rich central region is well conserved and the 
C-terminal half is relatively well conserved. The cysteine residues in the central region of the 
receptor form two zinc fingers, each with a zinc atom tetrahedrally co-ordinated to four of the 
3 
cysteine residues (Miller et al., 1985). Separately the zinc fingers are unable to associate with 
DNA, but together they are responsible for DNA binding (Evans and Hollenberg, 1988; 
Freedman et al., 1988). Overlapping this region and extended into the C-tenninal region are 
the generalised nuclear localisation signals (NLSs) for receptor impOli, shown in Figure 1.1. 
These sequences are elaborated on in Section 1.2.4. The short region responsible for 
association with hsp90, indicated below, is discussed in Section 2.1.4. TR functions as dimers 
in association with TREs (Section 1.1.2); that is, the receptor dimerises with another molecule 
of itself (homodimer) or another NHR (heterodimer). The dimerisation domain is shown in 
Figure 1.1. 
N AlB E c 
.......................................... ,.. Nuclear transport 
" .... , .. "'........ , .......... " ... "''''''''''''''''''''''''''', .. "''''',, .. ,,'''''''' Dimerisation 
hsp90 
DNA recognition 
"" .......... " .............. ,,, .... '" , .. " , Transcriptional activation 
Figure 1.1 - Schematic of a generalised nuclear hormone receptor. Domains are 
designated by letters A to E. A and B are variable regions involved in trans-activation of 
the receptor, C contains the DBD, D is a hinge region, and E contains the HBD, 
dimerisation, and transcriptional regulation regions (as described in Section 1.1.1). The 
amino and carboxyl termini are represented by Nand C, respectively. Hashed lines 
indicate the regions associated with the displayed receptor functions. 
1.1.2 The thyroid hormone receptor1 
The TR gene was initially identified due to its homology to a viral oncogene, v-erbA 
(Weinberger et al., 1986). The similarity of v-ErbA protein to another NHR, the 
glucocOliicoid receptor (GR), led to this investigation. A second group of researchers 
simultaneously reported finding two genes encoding the cellular thyroid hormone receptor 
(Sap et al., 1986). These two TR genes (or c-erbA genes) were isolated from chicken embryo 
and human placental tissue, respectively. Several isoforms of the c-erbA gene have been 
1 c-erbA and v-erbA refer specifically to the genes encoding the proteins c-ErbA and v-ErbA, 
respectively. Additionally, c-ErbA is referred to as TR. 
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identified in a variety of animals, including Xenopus Iaevis (Damm et al., 1989; Yaoita et al., 
1990). The isofonns range in size from 45 to 55 kDa, including the two most common c-ErbA 
isofOlIDS, designated TRa and TR~. The TR~ gene can be differentially spliced to produce a 
number of proteins. Analysis of the two distinct isoforms isolated by Yaoita and colleagues 
identified 97% homology shared by the a-is OfOlIDS , whilst the ~-isofOlms were seen to be 
produced by alternative splicing of transcripts, transcribed from up to eight exons (Yaoita et 
al., 1990). A comparison between the two most common receptor isoforms (TRa and TR~) is 
displayed in Figure 1.3. 
Two thyroid hormones, 3,5,3'-triiodo-L-thyronine (T3) and L-thyroxine (T4) , are 
critical for development, differentiation, and morphogenesis in animals (Graupner et ai., 
1989, Ribeiro et aI., 1995), although TR only associates with T3. Molecules of TR bind as 
homodimers or heterodimers formed with .r:'JHR partners, most commonly retinoid X receptor 
(RXR) but also retinoic acid receptor (RAR), to TREs in target genes. In contrast to other 
members of the NHR superfamily, a cytoplasmic popUlation of TR has not been 
demonstrated, although some TR-related proteins have been shown to have an extranuclear 
localisation (discussed in Section 2.1.2). Therefore, all of the classical proposed modes of 
action were based on constitutive contact of TR with TREs. Indeed, it has been shown that in 
the absence of hormone, TR can bind to its response elements and repress or activate 
transcription (Damm et al., 1989; Graupner et al., 1989). 
Four trans-activation regions have been identified in TR that control transcriptional 
activation of genes containing a TRE. A constitutive trans-activation domain is situated in the 
N-terminal region (Hadzic et ai., 1995; Hollenberg et al., 1995), whilst three honnone 
inducible domains are located in the C-terminal region (Baniahmad et al., 1995). In 
mammalian cells, TR acts as an activator in the presence of hormone through the hormone 
inducible C-terminal domains. In addition, TR acts a repressor of gene transcription in the 
absence of hormone (Damm et al., 1989; Sap et al., 1989; Baniahmad et al., 1990; 1992; 
Zenke et at., 1990). Hormone independent activation has also been observed (FOlIDan et al., 
1988; Forman and Samuels, 1990; Privalsky et al., 1990; Saatcioglu et al., 1993). The 
repressor action of TR has been isolated to the hinge region of the receptor and is distinct 
from the activation domains (Damm and Evans, 1993). At a further level of regulation, 
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release of a TR-bound corepressor (N-CoR), after ligand binding, and subsequent binding of 
co-activators are responsible for T3-induced trans-activation (reviewed in Shibata et ai., 
1997). A second co-repressor (SMRT: silencing mediator for RAR and TR) associates with 
unliganded receptor in solution, as well as unliganded receptor bound to DNA (Chen and 
Evans, 1995; Chen et at., 1996; Sande and Privalsky, 1996), which is also the case for 
N-CoR. 
1.1.3 v-ErbA oncoprotein 
The v-erbA gene is one of two oncogenes carried by the avian erythroblastosis virus 
(AEV) that induces erythroleukemias in chickens (Graf and Beug, 1983). It is found on a 3 kb 
cell-derived insert, flanked by remnants of the retroviral structural genes, gag and env (Graf 
and Beug, 1983). The two proteins encoded by the cell-derived genes of AEV, v-ErbA and 
v-ErbB, appear to act cooperatively to induce transformation of cultured chicken erythroblasts 
and to cause acute erthryoleukemia in chickens (Beug et at., 1982; Sealy et al., 1983). The 
v-erbB gene is a truncated fOlm of chicken epidermal growth factor and v-ErbA is derived 
from the cellular c-erbA gene. The v-ErbA protein is not required for oncogenic 
transformation of cells. It does, however, enhance v-ErbB action by modifying growth in the 
infected fibroblasts and by blocking differentiation of infected erythroid cells, so they remain 
in an immature and highly proliferative state (Graf and Beug, 1983; Gandrillon et al., 1989). 
Deregulation of the control of cell division leads to the development of leukaemia, which is a 
form of cancer of progenitor cells that produce the circulating cells in the blood and lymphatic 
system (reviewed in Watson et aI., 1987). 
The v-erbA gene produces a 75 kDa gag/v-erbA fusion protein that binds to TREs 
(Sap et al., 1986; Damm et al., 1989). However, v-ErbA, unlike its cellular homologue, is 
unable to bind thyroid hormone at physiological concentrations. The inability of the receptor 
to bind hormone is due to multiple mutations in the carboxyl-terminal domain (Sap et at., 
1986; Munoz et al., 1988). Twelve amino-tenninal amino acids ofTR are replaced by the gag 
gene product in v-ErbA (Damm et at., 1989). The structure of v-ErbA is compared with TR in 
Figure 1.3. 
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As v-ErbA retains its DNA binding activity, it is able to prevent TR from binding to 
TRE sequences in the DNA. At high levels, therefore, v-ErbA can repress the activation of 
specific genes involved in cell differentiation. Examples of genes repressed by the over 
expression of v-ErbA include CAll, encoding carbonic anhydrase II, the erythrocyte anion 
transporter gene in chickens (Schroeder et ai., 1990; Disela et ai., 1991), and the interstitial 
collagenase gene found in chicken embryo fibroblast cells (Desbois et al., 1991). Due to 
stlUctural changes, relative to TR, v-ErbA protein appears to act as a dominant negative 
repressor that interferes with the actions of its cellular homologue during transformation of 
normal cells to cancerous cells (Damm et al., 1989). 
However, this action of v-ErbA depends on the cellular context. In Xenopus oocytes, 
v-ErbA has been repOlted to act as a constitutive activator, and does not affect TR regulation 
of a tripartite rat growth hOlIDone gene TRE (Nagl et al., 1995). In the presence of v-ErbA, 
retinoic acid and thyroid hormone do not induce the expected induction of apoptosis in 
erythrocytic progenitor cells (Gandrillon et al., 1994). Activated RXR is repressed by both 
TRa and v-ErbA, although the repression is distinct and dependent on both cell type and the 
HRE to which RXR binds (Wahlstrom and Vennstrom, 1998). Only TR represses efficiently 
in HeLa cells, whilst both TRa and v-ErbA were equally effective in JEG cells. Interestingly, 
in Xenopus oocytes, ultrastructural changes induced by v-ErbA were not mimicked by an in 
vitro generated dominant negative mutant of TR (Nagl et ai., 1997). Suppression of another 
steroid hom10ne receptor, RAR, may also be an important element in the mechanism of 
v-ErbA action (Chen and Privalsky, 1993). 
1.1.4 A DNA-binding mutant ofTR 
As introduced in Section 1.1.1, the members of the NHR superfamily contain a highly 
conserved DNA binding domain. Within this domain are two zinc finger motifs (as displayed 
in Figure 1.2), and immediately C-terminal to each finger is an a-helix, which is involved in 
folding of the zinc fingers into a compact globular structure (Hard et ai., 1990a; 1990b; 
Schwabe et al., 1990; Remerowski et ai., 1991). Each a-helix has a specific function. The 
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helix adjacent to the first finger is responsible for sequence specific DNA recognition, whilst 
the second contacts the DNA backbone (Danielsen et ai., 1989). 
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Figure 1.2 M Zinc finger domain of TR. The zinc finger motif present in the DBD is 
displayed. The hexagonally outlined cysteine is replaced by an alanine in TR/3 
DNAMbinding mutant C122A. 
At amino acid position 122 of TR~, a cysteine residue is one of the four involved in 
the tetrahedral co-ordination of a zinc atom (as shown in Figure 1.2). An in vitro-generated 
cysteine to alanine transition at this position in TR~ produces a receptor defective in DNA 
binding, simply designated C122A (Nelson et al., 1993). A comparison of the four TR 
variants used in the investigations described in this thesis, including TR~ and C122A, is 
displayed in Figure 1.3. As C122A represses TR-mediated gene transcription, it has been 
suggested that the DNA-binding mutant acts by forming inactive heterodimers with TR, 
although this has not been demonstrated (Nelson et at., 1993). In addition, the subcellular 
distribution of C122A was not analysed. Therefore, C122A provides an essential tool for 
investigating whether localisation of TR is due entirely to its ability to bind DNA, or whether 
there are other sites available for receptor interactions within the nucleus of a cell. 
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rTRa N E100% C (46.8 kDa) 
hTR~ N (52 kDa) AlB ES6% C 
C122A N AlB ES6% C (52 kDa) 
* * 
v~ErbA N Ess% C (75 kDa) gag 
AlB 
Figure 1.3 - Modular structures of the receptors TRa, TRB, C122A, and v-ErbA. 
Receptor domains are designated as in Figure 1.1. Percentage homology of receptor 
domains C and E are shown with respect to rTR a The transition at position 122 from C 
(in TRfJ) to A (in C122A) is shown; details are presented in Figure 1.2. Asterisks show 
the position of mutations in v-ErbA in comparison to rTRa (rTRa: rat TRa; hTRfJ: 
human TRfJ). Protein sequences are compared in Appendix 1. 
1.2 Nucleocytoplasmic transport 
1.2.1 The basis of nucleocytoplasmic transport 
Eucaryotic cells can be thought of as divided into two compartments, dependent upon 
function. The nuclear membrane forms a selective barrier between the genetic material of the 
nucleus and the site of protein synthesis in the cytoplasm. The movement of macromolecules 
and complexes between these two compartments is a regulated process that occurs through 
the nuclear pore complexes (NPCs) situated on the nuclear membrane. The NPCs are large 
proteinaceous stmctures embedded within the nuclear membrane. The component proteins are 
ananged to fonn a central channel approximately 9 nm in diameter that allows diffusion of 
macromolecules and complexes up to 40 to 60 kDa in size. Transport of larger karyophilic 
molecules requires expansion of the central channel though an energy dependent process 
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(Akey, 1990; 1992; Forbes, 1992; Hurt, 1993; Pante and Aebi, 1993; 1994; Agutter and 
Prochnow, 1994; Hinshaw, 1994; reviewed in Davis, 1995; reviewed in Nigg, 1997; Melchior 
and Gerace, 1998; Cole and Hammell, 1998; Gorlich, 1998). 
This movement between the nucleus and cytoplasm is referred to as 
nucleocytoplasmic transport Nucleocytoplasmic transport can be separated into the influx of 
molecules into the nucleus, or import, and the efflux from the nucleus, or export A variety of 
proteins such as NHRs and other transcription factors must be transported, after synthesis, 
into the nucleus in order to associate with DNA and perform their required functions. 
1.2.2 Mechanisms ojprotein transport 
Nucleocytoplasmic protein transport has been further described according to the 
interaction of the protein cargo with intennediate factors during the transport process 
(reviewed in Nigg, 1990). Two general mechanisms of import have been described. The first 
mechanism requires expansion of the NPC to allow large proteins and molecules to pass 
through the central channel. This process, active transport, is energy and temperature 
dependent, occurs against the concentration gradient, and displays saturation kinetics (Akey, 
1990; 1992; Forbes, 1992; HUlt, 1993; Pante and Aebi, 1993; 1994; Agutter and Prochnow, 
1994; Hinshaw, 1994; reviewed in Davis, 1995; Gorlich and Mattaj, 1996). The second 
mechanism is the passive diffusion of a small protein through the NPC central channel into 
the nucleus, where it is retained by binding to an intranuclear component (Peters, 1984). In 
the case of export, the protein passes through the NPC to the cytoplasm where it may shuttle 
back into the nucleus or interact with other cytoplasmic factors. Nuclear export is discussed in 
more detail in Section 1.2.5. 
Passive diffusion is a relatively slow process that does not include binding of 
transporting proteins to structural components of the cell, such as the cytoskeleton, or to 
receptors aiding in targeting (Peters, 1984). Net accumulation of protein in the nucleus or 
cytoplasm, in the cases of import and export respectively, is dependent upon the availability 
of binding sites to which freely diffusing molecules can bind, maintaining the diffusion 
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gradient. Examples of simple diffusion include import and export of the free catalytic subunit 
of cAMP-dependent protein kinase, after microinjection into cultured cells (Harootunian et 
al., 1993); fusion-construct experiments showed that export may be temperature-independent 
for NLS-bearing proteins (but not for nuclear export signal-, or NES-, bearing proteins) 
(Fischer et al., 1995; Michael et al., 1995); and egress of p-galactosidase, a nonnally 
cytopla..;;mic protein, occurs in an energy independent fashion when it is fused to a classical 
NLS (Guiochon-Mantel et al., 1994). 
Further studies have suggested that transport of some molecules occurs via diffusion 
but in a regulated manner, unlike the mechanisms characterised previously (Bustamante, 
1992; 1994; Cohen and Paine, 1992; Paine, 1992; 1993; Vancurova et al., 1993; Himpens et 
al., 1994a; 1994b; Mazzanti et al., 1994; reviewed in Davis, 1995; Jenldns et al., 1998). 
Facilitated diffusion can be thought of as intennediate between the other two mechanisms, 
requiring interaction of the cargo protein with cellular factors necessary for signal-mediated 
import, but not occurring against the chemical gradient. Although energy is not a requirement, 
and transport proceeds down the chemical activity gradient, transport of some molecules does 
appear to occur by a mediated process, supporting the existence of a facilitated mechanism 
(Cohen and Paine, 1992; Jenkins et al., 1998). Molecules that are transported by this process 
include histone HI (Breeuwer and Goldfarb, 1990), simian virus 40 (SV40) Vp3 (Dean and 
Kasamatsu, 1994), and the Vpr protein of human immunodeficiency virus 1 (RN -1 ; Jenkins 
et al., 1998). Interestingly in the case of histone HI, the protein is within the size limits for 
passive diffusion, at 21 lcDa. The absolute criterion that differentiates facilitated transport 
from active transport is that, in contrast to a facilitated process, active transport occurs against 
the concentration gradient. For the purposes of this thesis, facilitated and active transport 
mechanisms are grouped under the term facilitated to enable clearer comparisons to be made 
between these signal-mediated mechanisms and passive diffusion. 
Figure 1.4 displays the three mechanisms of protein import through the NPC into the 
nuclear compartment, as described in this section. In addition, passive diffusion and 
signal-mediated nuclear export are also presented (refer Section 1.2.5). Characterisation of 
import mechanisms is discussed in Chapter Three. 
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Figure 1.4 - The three mechanisms of nucleocytoplasmic transport. See text for details 
(Sections 1.2.2 and 1.2.3). 
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1.2.3 Protein import 
Several pathways, which have features in common, have been characterised for 
signal-mediated protein import. In all these pathways, protein transport through the NPCs can 
be divided into two steps; firstly, docking of a signal-bearing karyophilic protein complexed 
with a transport receptor at the NPC, and secondly, translocation through the central channel. 
The translocation step requires metabolic energy, which may be required to activate the 
machinery which enlarges the central channel or to move the protein through the channel into 
the nucleus (Newmeyer and Forbes, 1988; Richardson et al., 1988). Once in the nucleus, a 
transport receptor dissociates from the transported protein and is recycled to the cytoplasm 
(reviewed in Nigg, 1997; Ohno et al., 1998). 
The best characterised pathway for nuclear import is for those proteins bearing an 
NLS tich in basic residues, such as the large tumour antigen of SV 40 (SV 40 T; Lanford et al., 
1986) and the RNA-binding protein La (SS-B: Rosenblum et al., 1998). Nuclear localisation 
signals are discussed in Section 1.2.4. A heterodimeric receptor complex has been isolated for 
this pathway that is responsible for targeting NLS-bearing proteins to the NPC (see Figure 
1.5). Irnportin a is the component of the receptor complex responsible for NLS binding 
(Gorlich et al., 1994; Weis et al., 1995). Irnportin ~ binds importin a and mediates the 
binding of the transport complex to the NPC (Chi et al., 1995; Gorlich et al., 1995a; 1995b; 
Radu et al., 1995a; 1995b). A small GTP-binding protein related to the Ras family, Ran, was 
first identified as being responsible for the translocation step in Xenopus oocytes (Moore and 
Blobel, 1993; 1994a; 1994b). The active form of Ran (GTP-bound) is essential for transport 
of proteins in digitonin permeabilised cells (Melchior et al., 1993; Moroianu and Blobel, 
1995). GTP hydrolysis and a Ran activating protein, Rna1p, are required for protein import in 
yeast cells (Corbett et al., 1995; Schlenstedt et al., 1995). It has been suggested that the 
metabolic energy requirement for translocation may be supplied by Ran-mediated GTP 
hydrolysis instead of ATP hydrolysis (Melchior et al., 1993; Cheng et al., 1995; Moroianu 
and Blobel, 1995; Sclenstedt et al., 1995). Further factors implicated in the importin transport 
pathway include plO (Moore and Blobel, 1994b; Paschal and Gerace, 1995), cytoplasmic 
GTPase activating protein RanGAP, a nuclear localised nucleotide exchange factor RCCI 
(Gorlich et al., 1996; Izauraude et al., 1997), and the chaperone protein hsp70 (Yang and 
DeFranco, 1994). Functions and alternative terminologies for the factors involved in this and 
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other import pathways are detailed in Table I. Members of the Ran GTP-binding protein 
superfamily have been implicated in the nuclear import of ribosomal proteins (Rout et aI., 
1997; Schlenstedt et aI., 1997) and proteins involved in RNA processing (Pemberton et aI. , 
1997; Rosenblum et ai., 1998), as well as the nuclear export of importin a (Kutay et aI., 
1997). 
Cytoplasm 
Nuclear 
membrane 
Nucleus 
e Protein cargo 
Importin a 
~ Importin ~ e Ran 
• GDP 
• GTP 
Figure 1.5 - Importin aJ~ mediated protein import pathway. The proposed 
mechanism for signal-mediated import via the importin aI fJ complex is modified from 
Cole and Hammell (1998). Question marks indicate undefined mechanisms. Activation 
of Ran (by phosphorylation) is shown by interaction with GTP to form RanGDP. 
Subsequently, GDP is recycled to give GTP by phosphorylation in the nuclear 
compartment. 
A second unique nuclear import pathway has been described for the RNA-binding 
protein hnRNP AI. The hnRNP Al NLS (or M9 sequence) mediates both import and export 
of the protein (Siomi and Dreyfuss, 1995; Michael et aI., 1995). Transportin, a receptor that is 
distantly related to importin ~, has been identified as being responsible for the in vitro import 
of hnRNP A I (Aitchison et aI., 1996; Pollard et al.. 1996; Fridell et al.. 1997). Transportin 
mediated transport is also dependent on the presence of Ran (N akielny and Dreyfuss., 1996). 
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In contrast to these two pathways, in vitro nuclear import assays have shown that 
although HIV -1 protein Vpr directly engages the NPC, neither transportin nor the 
impOltin alimportin P complex are necessary for nuclear import. Further, this process is 
independent of Ran-mediated GTP hydrolysis (Jenkins et al., 1998). 
Table 1 ~ Terminology of nUcleocytoplasmic transport factors. 
Term used in Function Localisation Alternative terminology 
this thesis 
Irnportin a NLS binding Cytoplasmic and karyopherin a 
NPC associated SRPla 
(shuttles) NLS receptor 
Importin ~ NPC docking of NLS Cytoplasmic and karyopherin P 
proteins (binds NPC associated p97 
importin a) (shuttles) 
Transportin NPC docking of Cytoplasmic and Kap 104 
hnRl\TP Al NPC associated 
protein-M9 signal (shuttles) 
Ran Translocation (? Role Cytoplasmic, nuclear, Ran GTPase 
still unclear) and NPC associated RantrC4 
Complex dissociation 
plO Translocation (? Role Cytoplasmic, nuclear, pp15 
still unclear) and NPC associated Ranip (Ran interacting 
Binds to RanGDP protein) 
andNPC NTF2 
B-2 
hsp70 Chaperone Cytoplasmic and hsc70 (cytosolic 
nuclear (shuttles) counterpart of hsp70) 
RCCI Guanine nucleotide Nuclear (chromatin PRP20 
exchange factor associated) SRMI 
MTRI 
hRipl Binds to Rev NES Nucleoplasm and RABI 
(function unknown) NPC or NPC only YRipl (homologue?) 
(unclear) 
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1.2.4 Nuclear localisation signals 
In the case of import, both facilitated diffusion and active transport pathways require 
the presence of a karyophilic 'targeting signal' or NLS. Several types of NLSs have been 
identified. Typically, the NLS is fOlmed from a short stretch of amino acids, approximately 
eight to ten, which are predominantly the basic residues, lysine or arginine. The most simple 
NLS is composed of a single stretch of basic amino acids, as in the case of the SV 40 T 
antigen (Kalderon et al., 1984; Lanford et al., 1986). 
More complex signals involve several amino acid sequences. A bipartite structure of 
basic amino acids separated by a stretch of non-basic amino acids forms a second type of 
NLS, as in the case of nucleoplasmin (Dingwall et aI., 1988; Robbins et al., 1991). Two 
further classes of NLS have been identified that do not confOlm to the more common stretch 
of basic amino acids. Dispersal of the amino acids comprising NLSs throughout a large 
segment of protein suggests a role for secondary and tertiary structures of the protein. Folding 
of the protein may bring the residues into a more compact form, sometimes referred to as a 
'patch signal'. This class of signal has been identified for the U1 small nuclear 
ribonucleoprotein (RNP)-specific U1A protein (Kambach and Mattaj, 1992), the U2 
snRNP-specific U2B protein (Kambach and Mattaj, 1994), and for the Gal4 protein in 
Saccharomyces cerevisiae (Silver et aI., 1988). A novel C-terminal glycine-rich domain, 
referred to as M9, has been implicated in the import of the pre-mRNAlrnRNA binding protein 
hnRNP A1 protein (Siomi and Dreyfuss, 1995). Regardless of its sequence or structural 
arrangement, a functional NLS is required for the docking step in facilitated and active 
transport. 
Members of the NHR supelfamily contain two general types of NLS, constitutive or 
inducible. Constitutive NLSs are active in all cellular environments, whereas hormone is 
required for the activation of inducible sequences. This suggests that hormone binding results 
in an alteration of protein structure allowing NLSs to be presented in an 'open conformation'. 
Characteristically, NLSs are found in or bordering the DNA binding domain (DBD), the 
hOlmone binding domain (HBD), or the hinge region of the receptor. Therefore, it may be 
difficult to separate out NLS function from other functions of the region, such as DNA 
binding, which may also be involved in receptor localisation. Steroid hormone receptor NLSs 
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are complex signals, and in the case of PR and ER, none of the signals for nuclear targeting 
are sufficient on their own. Table 2 displays the NLSs identified for TR as well as GR, 
androgen receptor (AR), oestrogen receptor (ER: for the American spe1ling), and 
progesterone receptor (PR). 
Table 2 - Nuclear localisation sequences present in nuclear hormone receptors. 
Receptor Number Position (a.a) I Observations References 
ofNLSs Designation a 
OR (rat) Two 497-524 I NLl (hinge) Picard and Yamamoto, 1987 
540-795 (main NLS) I NL2 (HBD) 
OR (human) Two 478-505 I NLl (hinge) Picard and Yamamoto, 1987 
521-777 (main NLS) I NL2 (HBD) Reviewed in LaCasse and 
Lefebrvre, 1995 
AR(human) Two 608-625 NLI (hinge) Simcntalefa/" 1991 
(910 a.a.) 628-634 I NL2 (HBD) Jenster et al., 1993 
AR (human) Two 580-661 Overlapping signals in the Reviewed in LaCasse and 
(919 a.a.) hinge and HBD Lefubrvre, 1995 
ER (human) Three 256-260 Hinge and HBD (none are Picard et al., 1990 
266-271 sufficient NLS singly) Ylikomi el al., 1992 
299-303 
PR (rabbit) Three 638-642/645 (main) C NLSs are in hinge and HBD Guiochon-Mantel et al., J 989 
614-618 (NL2- Blocked by ATP Guiochon-Mantel el al., 1991 
624-627 depletion) 
(NL3- Weak NLS) 
PR (chicken) Four 490-506 C (NL2- overlaps DBD) Ylikomi et aI., 1992 477-487 C 
second zinc finger C (NL3- weak NLS) 
HBDI 
TR (chicken) One 127-135 Stretch of a.a flanking DBD Dang and Lee, 1989 
TR(TRa]; One 134-136 Hinge region Lee and Mabdavi, 1993 
rat) identified in 
study 
TR(TR~l; One 184-190 Hinge region Zhu et al., 1998 
human) identified in Lys184_Arg185 functionally 
study more important than 
Lys l88 _ArgI89_LysI90 
v-ErbA One 370-376 Hinge region Boucher and Privalsky, 1990 
(AEV) Boucher et al .. 1988 
a The type of NLS is given where known (I: hormone inducible NLS; C: constitutive NLS). 
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Cloning of NHRs followed by in vitro mutagenesis studies enabled the 
characterisation of NLSs for GR (Picard and Yamamoto, 1987), PR (Guiochon-Mantel et al., 
1989; Ylikomi et al., 1992), ER (Picard et al., 1990), and AR (Simental et al., 1991; Jenster et 
al., 1993). When NHRs are aligned at the DBDs and a comparison is made, it is observed that 
sequences homologous to the constitutive PR NLS (a. a. 638-642) are found at the same 
position (10 amino acids after the last conserved cysteine). The only exception is ER, in 
which case the signal is located 11 amino acids after the cysteine residue. Four successive 
clusters of basic amino acids forming an NLS have been identified for chicken PR (Ylikomi 
et al., 1992). Three constitutive NLSs are located in the zinc finger regions of chicken PR 
whilst a fourth NLS in the HBD is weakly hormone inducible. In contrast, the two NLSs 
identified for GR are inducible (picard and Yamamoto, 1987). Whilst the main NLS was 
localised to the HBD, the second NLS was inducible and less important in determining 
receptor localisation. A 20 amino acid signal similar to GR NLI (in both rat and human) was 
identified in human AR (Simental et al., 1991). The NLS was located in the hinge region and 
had the same properties as a bipmtite signal, while the second NLS was hormone inducible 
(Jenster et al., 1993). The three NLSs chm'acterised for ER were not sufficient to act on their 
own (Picm'd et al., 1990). The first two NLSs are almost perfectly conserved among species 
whereas the third is conserved only in charge. Lee and Mahdavi (1993) demonstrated that 
mutation of the Lys-Arg-Lys residues (134-136 in the hinge region of the receptor) of rat 
TRa1 was sufficient to disrupt nuclear localisation, suggesting the presence of an NLS at this 
position. Likewise, a sequence was identified at the same position relative to the DBD in 
chicken TRa (Dang and Lee, 1989) and in the v-ErbA hinge region (Boucher and Privalsky, 
1990; Boucher et al., 1988). 
1.2.5 Nuclear export and nucleocytoplasmic shuttling 
As nucleocytoplasmic transport can be a bi-directional process, it is important to 
determine whether both impOlt and export of a particular protein occur. In this situation, the 
question of whether import and export occur by the same mechanism must also be addressed. 
Several studies indicate that transport of a range of small proteins is bi-directional; that is, 
nucleocytoplasmic shuttling occurs. Shuttling proteins identified to date include heat shock 
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protein 70 (hsp70) (Mandell and Feldherr, 1990), steroid hormone receptors 
(Guiochon-Mantel et al., 1991), nucleolar proteins (Borer et ai., 1989; Meier and Blobel, 
1992), heterogeneous nuclear RNP (hnRNP) Al (Pinol-Roma and Dreyfuss, 1992), and HIV 
Rev protein (Meyer and Malim, 1994). 
Whilst many studies have addressed the process of import, nuclear export has been 
characterised to a lesser extent. It has been suggested that protein export may be restricted 
primarily by retention within specific nuclear compartments. In these cases, export may not 
require a specific signal sequence, but merely proceed via a default pathway which released 
nuclear proteins are channelled through (Schmidt-Zachmann et ai., 1993). EXpOlt of the 
cytoplasmic protein p-galactosidase, which has been artificially introduced by microinjection 
into the cell nucleus, does require a functional NLS (Guiochon-Mantel et ai., 1994), whilst 
nucleolin export only appears to be temperature dependent (Schmidt-Zachmann et ai., 1993). 
Although PR import is an energy-dependent process, export of receptor continues in the 
presence of sodium azide (an energy inhibitor) or at low temperatures, suggesting that export 
occurs via diffusion (Guiochon-Mantel et ai., 1991; 1994). Whilst shuttling of some nuclear 
proteins has been observed, when non-nuclear proteins are microinjected into the nucleus they 
are unable to be exported (Dingwall et ai., 1982; Lanford et at., 1986; Mandell and Feldherr, 
1990; Guiochon-Mantel et al., 1991). Although the subject of some controversy, these results 
suggest that a specific signal (NES) may be required for export of specific proteins (Laskey 
and Dingwall, 1993; Schmidt-Zachmann et at., 1993). Specific NESs have been identified for 
protein kinase inhibitor (Wen et al., 1995), hnRNP Al (m9-NES, Michael et ai., 1995), HIV 
Rev protein (Fischer et al., 1995), and p53 for which export is mediated by a highly 
conserved leucine-rich NES located in the tetramerisation domain (Stommel et al., 1999). It is 
unclear whether factors and mechanisms similar to those utilised in import are also used in 
expOlt: for example, whether NLSs and nuclear export signals are the same. When NLSs of 
SV40 T antigen and PR are grafted to p-galactosidase, they have the ability to induce 
shuttling of this normally cytoplasmic protein (Guiochon-Mantel et al., 1994). The presence 
of a nuclear retention sequence (NRS), that localises the protein to a retention site in the 
nucleus, has been repOlted in hnRNP C proteins (Nakielny and Dreyfuss, 1996). The NRS has 
the ability to override an NES, thereby restricting the protein to the nuclear compartment. 
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1.3 Aims of investigation and methodological approaches 
The aim of the research described in this thesis was to investigate differences in the 
propelties of two TR isoforms, TRa and TR~, and two variants, v-ErbA and DNA-binding 
mutant C122A, with respect to subcellular distribution and nucleocytoplasmic transport in 
two model cell systems, cultured mammalian NIH 3T3 cells and Xenopus oocytes. Aspects of 
the use of these two systems are discussed in Section 1.3.3 (Xenopus oocytes) and Section 
1.3.4 (cultured somatic cells). Microinjection was used to introduce protein into oocytes and 
transfection for the introduction of DNA into cultured NIH 3T3 cells. The use of green 
fluorescent protein tags, utilised in the NIH 3T3 studies, is described in Section 1.3.5. 
.l.3 . .l Comparison of cellular TR isoforms with variant receptors 
Members of the NHR superfamily display diverse subcellular distributions and 
nucleocytoplasmic transport mechanisms. In addition, these distributions and transport 
mechanisms are still under review due to differences in observations made in varying cell 
types with different techniques. It has also been observed that localisation of NHRs is not 
static process and may, rather, be dynamic, involving shuttling of receptor molecules between 
the cytoplasmic and nuclear compartments. 
TR has been reported to be constitutively nuclear in somatic cells (Perlman et ai., 
1982; Kumara-Siri et aI., 1986; Horowitz et al., 1989; Puymirat et al., 1989; Macchia et aI., 
1992; Lee and Mahdavi, 1993). However, with the advances made in the field of NHR 
distribution and transport, it seemed likely that the story may not be so simple for TR. 
As detailed in Section 1.1.2, there are two common isoforms of TR, designated a and 
~. Both isoforms are used in this study along with the TR~ DNA-binding mutant variant, 
C122A, and the viral oncoprotein Valiant, v-ErbA. The DBD of GR has been shown to be 
essential for correct localisation and binding to DNA (Saclcey et al., 1996). Therefore, use of 
C122A allows investigation of the role that the TR DBD plays in determining transport 
characteristics and subcellular distribution of the receptor. Similarly, v-ErbA provides a tool 
to investigate the effects of an increase in size (an increase from 46.8 lilla in the case of TRa 
20 
to 75 IcDa) and also the loss of honnone binding ability on nuclear import and export, as well 
as receptor distribution. Use of oncogenes as tools to investigate cell function is discussed in 
the following section (Section 1.3.2). 
1.3.2 Use of oncogenes as research tools 
It is a disconcerting idea that our own cells contain genes with the potential to cause 
cancer. Nevertheless, some 100 genes, called proto-oncogenes, have been identified in 
vertebrates that can, when activated, induce tumours. Investigations into the action of these 
oncogenes must focus on the genetic alterations that produce the uncontrolled cell division 
and development seen in cancer cells. In normal cells, oncogenes function in conjunction with 
tumour suppressor genes to control cell growth. Defects, which are inherited or induced by 
mutagens (such as, radiation, chemicals, or viruses), can potentiate or activate these genes, 
liberating the cell from its usual regulatory constraints and triggering abnonnal cancerous 
growth (Watson et al., 1987). In addition, activated oncogenes are found widely associated 
with tumours in humans, suggesting common mechanisms govern transformation by 
oncogenic retroviruses and other carcinogenic agents (reviewed in Vannus, 1989). 
Retroviruses, such as AEV, are the most efficient and rapidly acting oncogenic agents 
known (reviewed in Teich et al., 1985). The rate of base substitutions in the retroviral genome 
is approximately one million times that observed in cellular genes (Gojobori and Yokoyama, 
1985). This rapid mutation rate is suggested to be due to the lack of proof-reading by the viral 
polymerase, reverse transcriptase, during reverse transcription of the viral genes (Temin, 
1989). Potentially a retrovirus can undergo a series of these mutations before it is subject to 
selection, and therefore it has been suggested that the evolution of the retroviral oncogene is a 
mutation-driven process, not unlike the process of cellular proto-oncogene activation (Temin, 
1988; reviewed in Weinberg, 1989). Viral oncogenes have proved to be effective tools for 
investigating cell function by observing changes to nOlmal responses and development. 
To date, aberrant expression of thyroid honnone receptors has been implicated in a 
variety of endocrine and neoplastic diseases, such as small cell lung carcinoma, generalised 
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thyroid hOlmone resistance, human colon carcinoma, and hepatocellular carcinoma in mice 
(Dobrovic et al., 1988; Markowitz et al., 1989; Darnm, 1993; Barlow et al., 1994; Yen et al., 
1994; Beug et al., 1996; Lin et al., 1997; Fraichard et al., 1997). Likewise, increased response 
to the steroid hormone, oestrogen, has been linked to the development of breast cancer 
(Marshall, 1993). As abelTant TR expression and function has the potential to induce 
abnOlmal cell growth and development; it is important to define mechanisms induced or 
repressed by T3 binding, accessibility to factors that modify the structure and/or activities TR 
within the nucleus, and the proximity of TR to DNA response elements. This thesis elucidates 
differences in the distribution and transport properties of TR and v-ErbA. These differences 
will provide insight into the processes by which vertebrate cells control their differentiation 
and development, and may aid in comprehension of the events that can lead to transformation 
of normal cel1s into tumour cells. 
1.3.3 Xenopus oocytes as a model system 
Oocytes of the South African clawed frog, Xenopus iaevis, provide an excellent model 
system for studying the transport of proteins and other molecules within cells. The use of 
oocytes is advantageous over cell-free systems as they are able to CatTY out post-translational 
modifications and can correctly direct products for protein transport and secretion (Colman, 
1984). Exogenous proteins can be expressed in Xenopus oocytes through the introduction, by 
microinjection, of DNA and mRNA (Dawid and Sargent, 1988), and proteins synthesised in 
vitro may also be introduced in this manner (Murdoch and Allison, 1996). Microinjection of 
oocytes allows direct introduction of cellulat' components and therefore reconstruction of 
cell-specific environments in vivo, unlike transfected cell cultures. Distribution and transport 
mechanisms of the introduced molecules can be determined by appropriate assays after a 
period of incubation. The src kinase (Spivack et al., 1984), insulin receptor (Maller, 1987), 
human epidermal growth factor receptor (Opresko and Wiley, 1990), and ribosomal protein 
L5 (Murdoch and Allison, 1996) have all been introduced into Xenopus oocytes. 
Oogenesis in Xenopus has been divided into six stages (I to VI), dependent on the 
morphology of the developing immature egg, or oocyte (Dumont, 1972). Oocytes have nearly 
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reached their maximum size by stage V (1 to 1.2 nun), when yolk accumulation ceases. Stage 
VI oocytes are characterised by a distinct unpigmented equatorial band and are ready for 
ovulation. Large maternal stores of enzymes, storage proteins, and organelles are accumulated 
during oogenesis (Colman, 1984). The large size of late stage oocytes (V and VI) make 
Xenopus oocytes an attractive option for use in the study of replication, transcliption, 
translation, assembly, and compartmentalisation processes. As proteins, as well as other 
molecules, can be microinjected into the cytoplasm or nucleus, and both subcellular 
compartments can be manually dissected, it is possible to study nuclear transport processes 
quantitatively. The NHRs used in this study were microinjected into either the nuclear or 
cytoplasmic compaltments. After incubation at physiological temperatures, the oocyte nuclei 
were dissected prior to analysis of the cell fractions. 
1.3.4 Cultured mammalian cells as an expression system 
Cultured manrrualian cells offer an alternative to calTying out investigations in intact 
organisms. In the early years of cell culture, only masses of excised tissue could be 
consistently grown on undefined serum or embryonic extracts. Later, groups of individual 
cells dissociated from tissue by the enzyme trypsin could grow at high cell densities; although 
single cells could not be induced to grow into clones. By the early 1940's continuous cell 
lines, established from a single cell, were able to be derived from these cultures as a result of 
improved techniques and identification of some of the inherent problems of cell culture. Cell 
lines may be derived from several sources; such as fibroblast, epithelial, or lymphoid tissues. 
A number of immortal cell lines have been produced from mammalian tumours, as possession 
of a cancerous phenotype often allows easier adaptation to the conditions of cell culture, 
although a few 'normal cell' lines have also been established, such as mouse NIH 3T3 cell 
lines (Copeland and Cooper, 1979). The number of chromosomes in these cell lines is often 
greater than in normal diploid cells; in the case of NIH 3T3 cells (used in this study), there are 
65 chromosomes compared to the nOlmal complement of 40. Mouse NIH 3T3 cells have 
many of the growth properties associated with normal cells and so can be used for in vitro 
studies of transformation to the cancerous state. The frequency of spontaneous transformation 
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in NIH 3T3 cells is significantly lower than the rate induced by carcinogenic agents, at one 
per 10-5 to 10-6. 
Cultured mammalian cells have been used widely as expression systems for a variety 
of proteins; such as the NHRs vitamin D receptor (VDR; Barsony et al., 1997) and GR (Carey 
et al., 1996). Therefore, in this thesis, the results obtained in Xenopus oocytes are compared to 
those in cultured mammalian cells to determine whether the distribution and transport of 
receptor is peculiar to the oocyte cell type. 
Benefits of utilising cultured mammalian cells include the use of completely defined 
media, of which a wide range of quality controlled product is available commercially. 
Consequently, cells can be grown in media lacking specific factors (such as sugars or 
hormones) supplemented with additional agents. Secondly, DNA may also be introduced 
relatively easily into cultured cells by transfection, which is less labour intensive than 
microinjection (the method used in this study for introduction of exogenous material into 
Xenopus oocytes). As a negative however, the rate of transfection efficiency varies, dependent 
upon cell type and transfection reagents and protocols used, whereas microinjection ensures 
reproducible delivery of exogenous material into a cell. It is also possible to monitor 
introduction of molecules by microinjection into specific cellular compartments (for example, 
nuclei) by way of tracking dyes to ensure correctly targeted delivery. Whilst microinjection of 
cultured cell lines is an established technique, the facilities to adopt this protocol were not 
available for use in the research described in this thesis. 
Although establishment of a cell culture may be a lengthy exercise, potentially an 
unlimited resource is then available for experimentation whereas maintenance of Xenopus 
colonies is space dependent, and oocyte production is limited in the adult female. In addition, 
cultures are easily maintained and divided to produce material for experimentation without a 
need for invasive surgery, as is the case for oocyte removal from the frog. 
Lastly, the development of visualisation systems utilising fluorescent tags in living 
cultured mammalian cells ha.l) proved a successful and useful tool, negating a requirement for 
radioactive labelling and intensive manipulation of antibody detection systems. However, a 
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comparison of results from a number of systems is important to eliminate artefacts or bias 
obtained as a result of a particular technique or model system. 
1.3.5 Green fluorescent protein tags 
Green fluorescent protein (GFP) from the pacific jellyfish Aequorea victoria has 
become an important reporter molecule for monitoring real time gene expression, protein 
localisation, and protein transport, both in vivo and in situ. GFP is composed of 238 amino 
acids and contains a chromophore made up of a Ser-Tyr-Gly tripeptide which undergoes 
cyclisation and oxidation reactions to become active (Prasher et ai., 1992; Cody et at., 1993). 
Therefore, as GFP fluorescence does not require a substrate or co-factor, it has an advantage 
over other bioluminescent reporters that do not have an intrinsic chromophore. GFP diffuses 
throughout the cell and emits bright green light (/l.max=509 nm) when excited by blue or UV 
light (A.max=395 nm, with a minor peak at 470 nm) (Chalfie et at., 1994). Mutagenesis of the 
GFP eDNA chromophore region has led to the generation of a range of GFPs with different 
spectral properties or chromophore formation rates (Heim et al., 1994; 1995; Delagrave et al., 
1995), referred to as enhanced GFPs, or EGFPs. 
GFP has been used successfully in a range of protein localisation and transport studies 
(Chalfie et al., 1994; Eguchi et al., ] 997). When forming a constmct with the gene of interest, 
the gene is fused to the amino or carboxy] terminal end of the GFP gene as determined by the 
researcher. The protein, when expressed in a living cell, is visualised by fluorescent 
microscopy. Utilisation of GFP eliminates the need for fixation, cell perrneabilisation, and 
antibody incubation necessary for more traditional techniques. In conjunction with this, GFP 
is also resistant to photobleaching, which means real time imaging of protein localisation and 
trafficking is possible. 
The GFP used in the studies detailed in this thesis, pEGFP-Cl, encodes a red shifted 
variant of wild type GFP which ha.'.; been optimised for brighter fluorescence and higher 
expression in mammalian cells (excitation Amax=488 nm and emission Amax=507 nm). This 
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variant (referred to as EGFP in this thesis) contains the double amino acid substitution of 
Phe64 to Leu and Ser65 to Thr. 
Detection of wild type GFP in cultured mammalian cells has proven difficult due to 
relatively low expression levels. Red shifted mutants of GFP have been used more 
successfully, showing greater than 15-fold increases in fluorescence (Kitt et al., 1995; 
Marshall et al., 1995; Stearns, 1995; Cheng et al., 1996). GFP fluorescence is species 
independent and has been observed in yeast, bacteria, and plants, as well as in a variety of 
cultured mammalian cells: such as COS-l (Ogawa et al., 1995); COS-7, NIH 3T3 (Pines, 
1995); CHO (Gubin et ai., 1997); and HeLa (Pines, 1995; Chatterjee and Stochaj, 1998). GFP 
has also been effectively used to investigate trafficking and localisation of NHRs, including: 
AR (Georget et ai., 1997), GR (Carey et ai., 1996; Htun et al., 1996), and MR (Fejes-T6th et 
ai., 1998). 
1.4 Organisation of thesis 
The research contained in this thesis is presented in two sections: firstly, investigation 
of subcel1ular distribution of receptor molecules and secondly, characterisation of the 
mechanism of nucleocytoplasmic transpOlt. 
Chapter Two describes the distribution of radioactively-labelled NHRs (TRa, TR~, 
v-ErbA, and C122A) between the cytoplasmic and nuclear compartments of Xenopus oocytes, 
after microinjection. In addition, the distributions of TRa and C122A receptors tagged with 
GFP were examined in living NIH 3T3 cells. The effects of hormone addition on subcellular 
distribution were assessed in both Xenopus oocytes and mammalian cells. Association of in 
vitro synthesised v-ErbA with hsp90 is addressed in Chapter Two. As it has been reported 
previously that v-ErbA, but not TR, forms an association with this cytoplasmic complex, 
distribution of v-ErbA may have been influenced by binding to this heat shock protein. 
Evidence for nuclear binding sites other than DNA sequences alone is presented. The 
investigation of the subnuclear distribution of receptors, biochemically fractionated from 
transfected Nlli 3T3 cells, is presented. 
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The processes whereby TR and variants are transported between the subcellular 
compattments of Xenopus oocytes and Nlli 3T3 cells are addressed in Chapter Three. A 
comparison of the mechanisms utilised by the TRa isoform and variants, TRP isofOlID, 
oncoprotein v-ErbA, and DNA-binding mutant C122A, is made in Xenopus oocytes. The 
mechanism of nucleocytoplasmic transport in cultured mammalian cells is presented 111 
Chapter Three and compared with the transport mechanisms defined in Xenopus oocytes. 
A model is proposed in Chapter Four to account for the observations made during the 
course of the investigations detailed in this thesis. The interactions of TR with the nuclear 
machinery and architecture in a variety of cell types are described, placing these results in 
context with previously repOlted observations. 
Chapter 2 
Subcellular Distribution of the Thyroid 
Hormone Receptor and Variants 
2.1 Introduction 
2.1.1 Distribution of nuclear hormone receptors 
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The classical model of steroid hormone action proposes that cytoplasmic pools of 
receptor are translocated to the nucleus after hormone binding. The liganded receptor 
associates with the target DNA HRE prior to activation or repression of discrete gene 
transcription (reviewed in Nigg, 1990). However, by 1986 this model began to be challenged 
after development of polyclonal and monoclonal antibodies to members of the NHR 
superfamily (Greene et al., 1980; Logeat et al., 1983; Okret et al., 1984; Sullivan et al., 1986). 
Antibodies raised against ER, PR, and GR, when used in immunocytochemical studies, 
overcame the potential problem of rotefactual receptor redistribution during cell 
homogenisation and fractionation studies. Both ER and PR were shown to be localised 
exclusively to the nucleus in situ, even in the absence of hormone (King and Greene, 1984; 
Perrot-Applanat et al., 1985; respectively). These results supported biochemical fractionation 
studies, using cytochalasin B-induced enucleation to obtain cytoplast and nucleoplast 
fractions, which showed unliganded receptor almost exclusively localised to the nucleoplast 
(Welsh ons et ai., 1984). 
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The distributions of GR and MR have proven to be somewhat different. It appears that 
GR is mainly cytoplasmic in the absence of hormone, but nuclear in its presence (Fuxe et ai., 
1985; Wikstrom et ai., 1987; Rossini and Malaguti, 1994; Almer et al., 1995). However, a 
subpopulation of GR ha.'l been shown to be nuclear in the absence of hOllllone in 
nucleoplastJcytoplast studies similar to the ER studies described above (Welshons et al., 
1985) and in some immunocytochemical studies (Sanchez et al., 1990; Martins et al., 1991). 
In some studies, in the absence of hormone, MR was found to be cytoplasmic or .both 
cytoplasmic and nuclear (Lombes et ai., 1990; Falman et al., 1991), whilst in the presence of 
honnone, the receptor was concentrated in the nucleus (Fuxe et ai., 1985). More recently, 
unliganded MR has been described as cytoplasmic, whereas liganded receptor is nuclear in 
distribution (Robertson et al., 1993; Lombes et ai., 1994). Contradictory reports have also 
been made with regard to VDR Immunocytochemical studies on chemically-fixed cens 
showed VDR as exclusively nuclear (reviewed in Barsony et al., 1997), in contrast to 
microwave fixation studies which revealed a cytoplasmic form of receptor (Barsony et al., 
1990). Unliganded AR has been described as nuclear (Husmann et at., 1990; Sal' et aI., 1990); 
however, in addition, in cens overexpressing receptor, AR can be cytoplasmic (Simental et 
al., 1991; Jenster et ai., 1993), both cytoplasmic and nuclear (Jenster et ai., 1993), or nuclear 
(Jenster et al., 1993), dependent on cell type. However, in these studies, liganded receptor was 
always localised to the nucleus. 
The distributions of these NHRs as well as TR and v-ErbA, compiled from a variety 
of experimental studies, are summarised in Table 3. The distributions of TR and v-ErbA are 
described in the following section. 
2.1.2 Distribution of TR and v-ErbA 
Although researchers have refocused their attention on the distribution of NHRs, TR 
and v-ErbA appear to have escaped this renewed interest, except for a recent paper describing 
the distribution of GFP-TR~ (Zhu et al., 1998). 
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A significant difference is observed between the subcellular distributions of TR and 
v-ErbA in mammalian cells. Although all endogenous TR and a subpopulation of v-ErbA 
appear to be constitutively nuclear, 30-40% of v-ErbA exists cytoplasmically in stable, high 
molecular weight complexes with heat shock proteins 90 and 56 (Privalsky, 1991; Privalsky, 
1992). Qualitative immunofluorescence analyses suggest that stable nuclear accumulation of 
v-ErbA in cultured mammalian cells requires the integrity of regions of the protein involved 
in DNA binding. A similar requirement has been observed for the c-erbA protein (Boucher 
and Privalsky, 1990; and references therein). These observations suggest a role for the DNA 
binding region of the receptors in stable nuclear accumulation of receptor after nuclear 
impOli. The DNA-binding mutant (CI22A) contains a mutation in one of the two zinc fingers 
of TRP, which are present within this domain. Therefore C122A provides a tool to investigate 
whether DNA provides the sole binding site for TR, or whether alternative sites are available 
for receptor binding. 
It has generally been accepted that TR is constitutively nuclear in the presence or 
absence of honnone; that is, receptor molecules are bound to TREs (Perlman et al., 1982; 
Puymirat et al., 1989; Macchia et al., 1990; 1992; Lee and Mahdavi, 1993; Kim et al., 1996). 
In support of this model, TR molecules are recovered from the nucleus either in tight 
association with DNA or, after high salt extraction, as monomers (Perlman et al., 1982), and 
TR has been observed to function as a transcriptional regulator in both the presence and 
absence of hormone, in mammalian cells (Fonnan et al., 1988; Forman and Samuels, 1990; 
Bigler and Eisenman, 1994). TR acts as a ligand-independent activator of gene transcription 
in yeast cells, Saccharomyces cerevisiae, and this expression is increased in the presence of 
T3 (Privalsky et al., 1990). In mammalian cells, unliganded receptor can suppress the basal 
activity of promotors containing TREs (Damm et al., 1989; Sap et al., 1989; Zenke et al., 
1990; Baniahmad et al., 1990; 1992). The activator function has been separated from the 
repressor function (described in Section 1.1.2) by Damm and Evans (1993). At positively 
regulated TREs, addition of T3 results in transcriptional activation (Allan et al., 1992; Toney 
et al., 1993). In the case of negatively regulated TREs, liganded receptors also repress 
transcription (reviewed in Chatteljee and Tata, 1992). 
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However, as discussed in Section 1.1.2, some TR-related proteins have been shown to 
display an extranuclear localisation (Bigler and Eisenman, 1988; Fukuda et al., 1988; 
Wrutniak et al., 1995; Andersson and Vennstrom, 1997). Several smaller size cellular TRa 
proteins occur in chicken erythroid cells, some of which display an extranuclear distribution 
(Bigler and Eisenman, 1988). A 43 kDa TRa-related protein, with TRE and T3 binding 
activities, was found located in the matrix of rat liver mitochondria (Wrutniak et ai., 1995). In 
addition, a significant amount of chicken TR is found in the cytoplasm when transiently 
expressed at high levels in a rat cell line (Horowitz et al., 1989). This suggests that 
localisation of receptor may also be dependent on the availability of sufficient receptor sites in 
the nucleus. Therefore, these findings suggested that the question of the distributions of TR 
and v-ErbA needed to be revisited. 
Table 3 - Distribution of nuclear hormone receptors. 
NHR Methods Cell type Distribution a , References 
VDR Cell fractionation and Rat ROS 17/2.8 Nuclear Bidwell ef af., 1994 
western analysis osteosarcoma (not matrix associated) 
Immunocytochemistry Osteoblasts Cytoplasmic Barsony ef al., 1990 
nuclear (predominant) 
(both unlliganded) 
OFP-tagged Human skin Cytoplasmicl nuclear Barsony ef af .. 1997 
fibroblasts 
v-ErbA Antiserum raised Chicken embryon' Bigler and Eisenman, 1988 
against: v-ErbA erythroid cells 
. Boucher et af .. 1988 
TR salt extraction, OR] cells Nuclear (DNA associated) Perlman el al .. 1982 
micrococcal nuclease, 
DNase1 
Differential nuclear OC cells 30-50% nuclear matrix Kumara-Sid el af., 1986 
extraction and associated 
e25I]-hormone binding 
Over expression of Rat cell line Significant: in cytoplasm Horowitz el al., 1989 
chicken c-erbA nuclear 
Immunocytochemistry Hypothalamic DA Nuclear Puymirat el af., 1989 
neurons 
Indirect Adult rat liver Nuclear Macchia el al., 1992 
immunofluorescence 
Immunocytochemish'y COS cells Nuclear (unlliganded) Lee and Mahduvi, 1993 
TR~ OFP-tagged Living CV 1 celis 60% nuclear (unliganded) Zhu el al., 1998 
85% nuclear (liganded) 
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PR Immunocytochemisu'y Tissue from Nuclear (unfliganded) Perrot~Applanat et al., 1985 
immature rabbits or 
castrated guinea pigs 
Heterokaryons L cells Nuclear plus small Guiochon~Mantel etal., 
percentage shuttling 1991 
through cytoplasm Kung et al., 1994 
ER Immunocytochemistry Human mammary Nuclear (unlIiganded) King and Greene, 1984 
and endomeu'ial 
tumour cells. 
Biochemical~ Rat OH3 cells Nuclear (unJiganded) Welshons et al., 1984 
cytochalasin-induced Welshons ef al., 1985 
enucleation 
Heterokaryons L cells Nuclear plus small Guiochon·Mantel el al., 
percentage shuttling 1991 
through cytoplasm Kung et al., 1994 
Differential nuclear Female rat liver Nuclear plus 60% in Alexander et aI., 1987 
extraction and antibody nuclear matrix (Iiganded) 
detection 
MR Immunocytochemistry Kidney sections Cytoplasmic Lombes el al., 1990 
( unfJiganded) LombCs el al., 1994 
Immunocytochemistry Rabbit kidney Nuclear (unlliganded) Farman el al., 1991 
Immunocytochemistry Sf9 insect cells Cytoplasmic (unliganded) Robertson ef al" 1 993 
( overexpressing) Nuclear (liganded) 
Mouse macrophages 
(overexpressing) 
OFP-tagged CHO Both cytoplasmic and Fejes·T6th el al., 1998 
nuclear (unliganded) 
100% nuclear (liganded) 
OR Biochemical studies Rat OH3 cells Nuclear (unliganded) Welshons et al., 1985 
Immunocytochemistry CHO Nuclear (un1iganded) Sanchez et al., 1990 
Martinsetal., 1991 
Immunocytochemistry Rat neurons Cytoplasmic (unliganded) Fllxe et al., 1985 
Nuclear (liganded) Wikstrom et al., 1987 
Rossini and Maiuguti, 1994 
Akneretal.,1995 
Immunocytochemistry Human T24 Nuclear mauix associated van Steensel et al., 1995 
(Nuclear) Human HeLa 
RatNRK 
AR Immunocytochemisu'y Rat/human prostate Nuclear (unliganded) Husmann et al., 1990 
Sar et al., 1990 
Immunocytochemistry Transfected Cytoplasmic Simental et aI., 1991 
( overexpressing) Jenster et al., 1993 
Immunocytochemistry Transfected Cytoplasmic! Jenster el al., 1993 
( overexpressing) nuclear 
Immunocytochemistry Transfected Nuclear Jenster el al., 1993 
( overexpressing) 
a Hormone binding status is indicated when known. 
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2.1.3 Association of nuclear hormone receptors with the nuclear matrix 
Several steroid hOlIDone receptors, including ER, GR, and AR, have been found 
associated with the nuclear matrix. The nuclear matrix was first described in 1974 by Berenzy 
and Coffey and has been characterised as the nonchromatin structural protein and 
ribonucleoprotein scaffolding of the nucleus. This scaffolding is an interconnected meshwork 
of filaments (nuclear matrix intermediate filaments: NM-IFs) which remains after nuclease, 
detergent, and high salt extraction of soluble proteins and chromatin (reviewed in Getzenberg, 
1994). It is not clear what the protein and RNP composition of the nuclear matrix is. The 
nuclear matrix includes the lamina proteins, defining the sUliace of the nucleus, as well as 
many low abundance nuclear proteins, heterogeneous nuclear RNPs, and matrix-associated 
DNA regions (Gerace et al., 1978; Kaufman et al., 1983; Fey et al., 1984; 1986; Dworetsky et 
al., 1992). 
More recently, the nuclear matrix has been implicated in regulation of gene 
expression. The structural framework appears to contribute sites for DNA replication, 
preferentially associates with actively transcribed genes, and associates with some, but not all, 
steroid hormone receptors and transcription factors (Berezney, 1991; and references therein). 
RNA synthesis and pre-mRNA splicing have also been localised to the nuclear matrix (Xing 
et al., 1993; and references therein). Tissue specificity of nuclear matrix proteins has also 
been observed (reviewed in Getzenberg, 1994), and two-dimensional electrophoresis methods 
have been used to identify tumour-specific nuclear matrix proteins in breast, prostate, and 
colon cancer (Khanuja et al.} 1993; Keesee et al., 1994; and references therein). Association 
of the AMUCBF-a u'anscription factors with the nuclear matrix is DNA-independent and 
requires a specific nuclear matrix targeting signal that is distinct from an NLS (Zeng et al., 
1997). The presence of nuclear matrix proteins that bind a nuclear matrix targeting sequence 
and localise growth promoting factors has been reported. For example, the retinoblastoma 
protein is localised to subnuc1ear regions associated with RNA processing by nuclear matrix 
factor p84 (DUlt'ee et al., 1994). 
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Several NHRs have been shown to associate with the nuclear matrices of a variety of 
cel1lines (Table 3). ER was detected in the nuclear matrices of biochemically fractionated rat 
liver cells (Alexander et at., 1987). Although OR is predominantly cytoplasmic in the absence 
of ligand (Fuxe et al., 1985; Wikstrom et al., 1987; Rossini and Malaguti, 1994; Akner et at., 
1995), receptor is localised to the cell nucleus in the presence of hormone, and it has further 
been shown that OR localises to the nuclear matrix in discrete clusters (van Steensel et al., 
1995). Up to 50% of TR has been shown to be associated with the nuclear matrices of rat 
pituitary tumour cells (OC cells) by [125I]-Tr binding assays and it has been suggested that this 
provides a further level of regulation of hormone action (Kumara-Siri et ai., 1986). This 
suggests a role for the nuclear matrix in steroid honllone-mediated control of transcription. 
However, there is a need to provide supporting evidence by analysis of additional cell lines. 
All of these findings suggest a role for the nuclear matrix in NHR-mediated control of 
transcription. Nuclear matrix-TRa associations have not been described in NIH 3T3 cells. 
Therefore the potential presence of TRa extrachromosomal binding sites, specifically in the 
nuclear matrix, was investigated during the course of this thesis. 
2.1.4 Association of nuclear hormone receptors with hsp90 
Heat shock proteins are rapidly synthesised by eucaryotic cel1s in response to stress, 
although some members of the heat shock protein family are expressed normally within cells 
and are involved in protein folding, assembly and subsequent transport (reviewed in 
Morimoto et at., 1990). Heat shock protein 90 is a 90 kDa molecular chaperone that has been 
found in a range of organisms from humans to Xenopus to bacteria, predominantly as a 
cytoplasmic dimer (Lindquist and Craig, 1988; Buscher, 1996; reviewed in Meng et at., 
1996). Little is known about the mechanism of hsp90 action although a range of associating 
factors has been identified. 
Unliganded GR, AR, and MR are found associated with hsp90 dimers (reviewed in 
FeldhelT and Alan, 1994; reviewed in Brasch and Ochs, 1995; Dittmar et al., 1996). 
Specifically, hsp90 binds to the HBD of these NHRs (Pratt et al., 1988; Howard et al., 1990; 
Dalman et at., 1991). PR and ER can also be recovered with the predominantly cytoplasmic 
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hsp90 (Guiochon-Mantel et ai., 1991; Kang et al., 1994). It has been demonstrated that during 
in vitro translation of GR, binding to hsp90 occurs at or near the end of the translation process 
(Dalman et ai., 1989). This association with hsp90 maintains GR in a conformation 
appropriate for ligand binding, although this may not be the case for other NHRs (Bresnick et 
ai., 1989; Chambraud et ai., 1990). Cell-free in vitro translation of TR in rabbit reticulocyte 
lysate does not result in an hsp90-bound form of receptor, whilst generation of GR in the 
same system results in tight receptor association with hsp90 dimers (Dalman et al., 1990). In 
this case, TR is translated in a state suitable for DNA binding without transformation by 
hsp90, whereas GR must be transformed to a DNA binding state. However, GR translated in 
hsp90-free wheat germ extract does not require this further transformation step (Dittmar et ai., 
1996). Whilst TR does not associate with hsp90, v-ErbA can be co-immunoprecipitated with 
hsp90 from mammalian cells if the proteins are chemically cross-linked prior to 
immunoprecipitation (Dalman et aI., 1990; 1991). In addition, RAR, RXR, and VDR are not 
associated with hsp90 (Dalman et ai., 1990; 1991). Associations of various members of the 
NHR supelfamily with hsp90 are summarised in Table 4. 
It has been proposed that, although members of the NHR superfamily might differ in 
the stability of interaction with hsp90, high affinity ligand binding and signalling across the 
whole family may nevertheless require these interactions (Holley and Yamamoto, 1995). 
Therefore association with hsp90 may result in repression of DNA binding activity which 
would directly influence cellular localisation of receptor in the absence of hormone (Dalman 
et ai., 1989; 1990). The in vitro transcription/translation rabbit reticulocyte lysate system used 
to synthesise v-ErbA, in the studies contained in this thesis, include hsp90. Therefore, it was 
necessary to assess whether v-ErbA was associating with the cytoplasmic heat shock protein, 
which would prevent nuclear localisation of v-ErbA. 
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Table 4 - Receptor association with heat shock protein 90. 
Receptor Association Observations a References 
GR hsp90 Unliganded GR Dalman etal., 1990 
Reviewed Feldherr and Akin, 1994 
Reviewed Braseh and Oehs, 1995 
Dittmar et al., 1996 
AR hsp90 Unliganded AR Reviewed Feldherr and Akin, 1994 
Reviewed Braseh and Oehs, 1995 
Dittmar et al., 1996 
MR hsp90 Unliganded MR Reviewed Feldherr and Akin, 1994 
Reviewed Braseh and Oehs, 1995 
Dittmar et al., 1996 
ER hsp90 Unliganded ER in both Guioehon-Mantel et al., 1991 
nucleus and cytoplasm 
Kang ef al., 1994 
PR hsp90 Unliganded PR in both Guioehon-Mantel et al., 1991 
nucleus and cytoplasm 
Kang et al., 1994 
VDR None Dalman et al., 1991 
RAR None Dalman ef al., 1991 
TR None Dalman et al., 1990 Dalman et al., 1991 
v-ErbA hsp90 Requires chemical Dalman etal., 1991 
crosslinking (unlike other 
receptors) 
a As some experiments were performed in vitro, association with cell compartments was not possible 
and, therefore, is not indicated. 
2.1.5 Summary of results 
The subcellular distributions of microinjected e5S]-methionine-labelled TRa, TR~, 
oncoprotein v-ErbA, and C122A (DNA-binding mutant) were investigated in Xenopus 
oocytes, by polyacrylamide gel electrophoresis and flu orography of proteins extracted from 
manually dissected oocytes. The properties of TR and variants are summarised in Table 5. 
Contrary to the dogma of constitutive nuclear localisation, with the exception of v-ErbA, TRa 
and variants all displayed a similar distribution with only approximately 40% nuclear 
localisation, following cytoplasmic microinjection. The majority of v-ErbA was sequestered 
in the cytoplasm, apparently due to an association with hsp90, formed during in vitro 
synthesis of the receptor. A greater percentage of all four receptors (from 62-87%) was 
retained within the nuclei of nuclear-injected oocytes. 
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Localisation of EGFP-tagged TRa and C122A was assessed by fluorescent 
microscopy in a second cell type, mouse NIH 3T3 cells. These receptors, whilst being larger 
than the untagged receptor molecules, due to the fusion with GFP protein (27 IcDa), were 
expressed effectively in the mammalian system. EGFP-tagged TRa was localised exclusively 
to the nuclei of cultured NIH 3T3, as reported for native receptors in other cell lines. The 
ability of receptor to bind DNA appears to be directly involved in receptor distribution, as 
reflected in the C122A::EGFP distribution, which was 100% extranuclear in NIH 3T3 cells. 
The subnuclear distributions of TRa (with and without GFP tags for both receptors) were 
investigated in cultured mammalian cells, by sequential cellular extraction of the NM-lFs, 
westem analysis and immunodetection. C122A::EGFP and C122A distributions were also 
examined by this sequential extraction method to further characterise cytoplasmic 
associations and also to determine whether a nuclear population was present that had been 
undetectable by fluorescent microscopy. 
Addition of T 3 induces a shift in TRa, TR~, and C122A distribution to the nuclei, as 
well as increased retention of nuclear-injected receptor in Xenopus oocytes, but not in 
cultured cells (for EGFP-tagged TRaand C122A). The distribution of v-ErbA was not 
significantly affected in oocytes. The implications of the variation between distribution of 
receptors within and between cell types are discussed. 
Table 5 - Properties of TR and variants 
Receptor Source of Gene Size DNA binding Hormone Binding 
TRa Rat 46.81cDa binding binding 
TR~ Human 52lcDa binding binding 
C122A Human TR~ 52lcDa no binding binding 
(modified in vitro) 
v-ErbA Viral (AEV) 75lcDa • binding no binding 
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2.2 Materials and Methods 
Unless otherwise stated, general laboratory reagents used were obtained from BDH 
(Poole, England) and electrophoresis reagents were obtained from Boeluinger Mannheim (NZ 
Ltd., Auckland, New Zealand). All chemicals were of Aualytical or Molecular Biology grade. 
2.2.1 Plasmids and Antibodies 
RS-rTRa and RS-v-erbA were gifts from R. Evans (Salk Institute for Biological 
Studies, La Jolla, CA, USA). hl these constructs, rat TRa1 cDNA and the gag-v-erbA 
oncogene were placed under the transcriptional control of Rous sarcoma virus (RSV) long 
terminal repeats (LTR) (Damm et ai., 1989; Thompson and Evans, 1989). RSh-TRP and 
RSh-TRP C>122A were provided by Dr P. Romaniuk (University of Victoria, Victoria, 
British Colombia, Canada). RSh-TRp contains the human wild type TRPI cDNA and 
RSh-TR~ C> 122A contains an in vitro-generated mutant human TRP 1 cDNA (alanine 
substituted for cysteine at position 122). Both genes are under the control of RSV L TR. 
(Nelson et ai., 1993). Dr P. Romaniuk also provided two constructs containing the same 
cDNAs but in pGEM3 vectors under the control of T7 RNA polymerase. rTRal was a gift 
from Dr M. Lazar (Lazar et ai. 1991, University of Pennsylvania School of Medicine, USA) 
and contains the rat TRal cDNA under the control of the T3 RNA polymerase promoter in 
pBluescript (pBS SK). The construct encoding the gag-v-erbA fusion protein was provided by 
Dr M. Pdvalsky (University of California, Davis, CA, USA) and is constructed from two 
fragments of AEV digested to give the full length gag-v-erbA gene cloned into pGEM-4Z 
under the control of an SP6 RNA polymerase promoter (Nagl et ai., 1997). The ribosomal 
protein cDNA clone, pSP6-L5, was a gift from Dr W. Wormington (University of 
Virginia, Charlottesville, VA, USA) and its transcription is under the control of SP6 RNA 
polymerase (Wormington, 1989). 
Fusion plasmids of pEGFP-Cl (Clontech Laboratories, CA, USA) and TRa or 
C122A were generated by J. MCGrew in the laboratory in which this research was carried out 
(Dr L. A. Allison's laboratory, University of Canterbury, Chdstchurch, NZ). These 
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EGFP-tagged plasmids were used in the localisation and transport studies for TRa and 
C122A in cultured mammalian cells. In brief, the genes of interest were amplified by 
polymerase chain reaction (PCR) using primers containing restriction sites from the plasrnids 
RSV-rTRa and pGEM-C122A. Product digested with suitable restriction enzymes was 
ligated into the multiple cloning site of pEGFP-Cl to produce receptor fused to the 
C-temlinus of EGFP, when expressed in vivo. Constructs were sequenced by PCR sequencing 
to check for correct insertion and amplification errors. Plasmid constructs and plimer 
information are provided in Appendices II and m. EGFP fusion plasnlids for v-ErbA and 
TR~ were not able to be subcloned during the time frame of this thesis, although conventional 
subcloning techniques through restriction digests followed by ligation, as well as PCR 
generation of clones, were attempted. It is not clear why the subcloning was unsuccessful, 
although some of the sequence information provided with the original clones may have 
contained errors. The EGFP clones are designated TRa::EGFP and C122A::EGFP. 
Plasmids were transformed into Escherichia coli strain DH5a cells by the method of 
Brown (Brown, 1991). Plasrnids were purified using Qiagen columns (Qiagen, Hilden, 
Germany), and resuspended in TE, pH 8.0 (10 mM Tris-HCI; 1 ruM ethylene-diarnine-
tetracychc acid, EDT A). Restriction digests were performed to check integrity of the plasrnids 
isolated. 
An antibody, LA038, raised against a synthetic peptide containing residues 58-75 of 
v-ErbA, was used to detect v-ErbA (Quality Biotech, Camden, NJ, USA; characterised in 
Freake, et al., 1988). An affinity-purified rabbit polyclonal antibody raised against a peptide 
corresponding to amino acids 1-408, representing the full length chicken thyroid hormone 
receptor, was used to detect TRa and TR~ protein molecules (designated FL-408; Santa Cruz 
Biotechnology Inc., Santa Cruz, CA, USA). Purified rat monoclonal antibody specific for 
hsp90 was obtained from StessGen Biotechnologies Corporation (clone 16Fl; Victoria, BC, 
Canada). Mouse IgM monoclonal antibody was used to detect Nuclear Mitotic Apparatus 
protein, or NuMA (Transduction Laboratories, Lexington, KY, USA). Horseradish peroxidase 
(POD) conjugated goat anti-rabbit IgG secondary antibodies were used to detect the rabbit 
TRal primary antibody during westem analyses. Detection of NuMA antibodies was 
performed with anti-mouse total Ig secondary antibodies conjugated to POD. 
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2.2.2 In vitro synthesis of proteins 
In vitro synthesised proteins were prepared from 1 ~g circular DNA template 
(pBS-rTRa1, pGEM-TR~l, pGEM-C122A, pGEM-v-erbA, and pSP6-L5) by coupled 
transcription/translation in a rabbit reticulocyte lysate system (Promega, Madison, WI, USA) 
supplemented with SP6, T3, or T7 RNA Polymerase (Epicentre, Madison, WI, USA), as 
described (Murdoch and Allison, 1996; Nagl et al., 1997). Protein synthesis occurred in the 
presence of 40 ~Ci L-esS]-methionine (l 000 Ci/mmole, in vitro labelling grade; Amersham 
Australia Ltd. or DuPont NEN: Life Technologies Ltd., Auckland, New Zealand). 
The approximate amounts of protein synthesised were calculated relative to the 
amount of control firefly luciferase protein produced dming each reaction. The in vitro 
transcription/translation mixture was diluted with sterile ultrafiltered H20 to give a 
microinjection concentration of approximately 0.1 ng per 50 nl delivery. 
2.2.3 Surgical removal and microinjection of Xenopus oocytes 
Xenopus laevis (Xenopus I, Ann Arbor, MI, USA) were maintained in the Zoology 
Depmiment at the University of Canterbury. All surgical procedures were approved by the 
University of Canterbury Animal Ethics Committee. Replicate batches of oocytes were used 
from different frogs, or after at least a six month recovery period from surgery. 
Adult female frogs were anaesthetised by chilling in ice cold water for 30 minutes 
followed by a further 30 minutes on ice. Sections of ovarian tissue lobes were surgically 
removed under sterile conditions according to established laboratory protocols (Allison et al., 
1991). The frogs were retumed to tanks after being sutured with 4/0-coated Vicryl disposable 
sutures (Ethicon, UK). The tissue was rinsed three times in sterile TNE (abbreviated for: 50 
mM Tris-HCI, pH 8.0; 150 mM NaCI; 1 mM EDTA) to remove blood and twice in sterile 
phosphate-buffered saline, PBS (68 mM NaCI; 1.3 mM KCI; 4.0 mM Na2HP04; 0.7 mM 
KH2P04; 0.35 mM CaCh; 0.25 mM MgCh), to remove EDTA, which could intelfere with 
collagenase activity. To sepm'ate the connective tissue from the oocytes, the lobes were 
chopped into small pieces and incubated in a solution of 30 mg collagenase (Type I, Sigma 
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Chemical Co., St Louis, MO, USA) in 30 ml 0.1 M sodium phosphate, pH 7.4, with end-over-
end rotation (33 rpm) for 20 minutes at room temperature. After separation, the oocytes were 
rinsed a further two times in PBS and twice in Oocyte Removal Buffer (0-R2: 82.5 mM 
NaCI; 2.5 mM KCI; 1.0 mM CaCh; 1.0 mM MgCh; 1.0 mM NaZHP04; 5.0 mM Hepes; 3.8 
mM NaOH). The oocytes were incubated at 18-20°C in culture dishes containing 0-R2 until 
use. The 0-R2 was changed daily and any damaged or unhealthy oocytes displaying mottled 
pigmentation were discarded. 
Microinjections were performed according to published methods, with some 
modification (Allison et al., 1991; 1993). One millimetre 0.0. glass capillary tubes (Clark 
Electromedical, England) were drawn out by a Narishge micropipette puller (Japan) and 
ground manually to give a needle tip bore of 20 11m. Microinjections were pelformed using a 
PV830 pneumatic picopump (World Precision Instruments Inc., New Haven, CT, USA) and 
micromanipulator (model M330l). The samples were loaded under vacuum and delivered 
under Nz gas pressure of 35 psi. Calibration of the amount of sample for delivery was 
performed by using the calibrated eyepiece of the microscope and alterations in the time 
(milliseconds) of delivery. Depending on the sample to be injected, a volume of 20 to 50 nl 
was microinjected. Volume was calculated using the equation: 
(where 'v' is drop volume and 'd' is drop diameter) 
Healthy stage V and VI oocytes were selected based on the classification of Dumont 
(1972). Stage V oocytes are defined as being 1000 to 1200 mm in diameter, with a pigmented 
animal pole, whereas Stage VI oocytes are characterised by a distinct unpigmented equatorial 
band. 
2.2.4 Analysis of subcellular distribution in Xenopus oocytes 
Oocytes microinjected with in vitro translated proteins were incubated for six hours in 
0-R2 containing 100 )lg/rnl cycloheximide (Sigma). Whilst cycloheximide inhibits the 
synthesis of eSS]-labelled proteins in vitro from unincorporated eSS]-methionine retained in 
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the lysate mixture, it does not intelfere with protein import in Xenopus oocytes (Kambach and 
Mattaj, 1992). Nuclei were manually removed from the animal hemisphere ofthe oocyte via a 
small tear made in the cell membrane with sterile watchmaker's forceps using the method 
outlined in Colman (1984). To remove any protein adhering to the outside of the nuclear pore 
complex, Nucleus Isolation Buffer (25 mM Tris-HCI, pH 8.0; 5 rnM MgCh; 2 rnM 
dithiothreitol, DTT; 10% glycerol) was used for dissecting oocytes involved in transport 
studies (adapted from ~Knight et al., 1980 by Parnaik and Kennady, 1990). Adherent 
cytoplasmic material was removed from the isolated nuclei by pipetting them in and out of an 
Eppendorf ultramicro-pipette tip. The nuclear fraction was collected separately from the 
cytoplasmic fraction into microfuge tubes placed on ice (six nuclei and six cytoplasms were 
separately pooled per sample). Each sample was homogenised in 70 ~l Homogenization 
Buffer (1 % Triton X-loo; 100 mM NaCl; 20 rnM Tris-HCI, pH 7.6, 0.4 mM Pefabloc™ 
(Boehringer» using a Gilson pipette. 'Ibe cytoplasmic sample was further purified by 
separating the lipid pellicle from each sample by centrifugation at 10 000 x g for 5 minutes at 
4°C, in a Jouan MR 14.11 centrifuge (France), and the cleared supernatant was transferred to 
a new microfuge tube. Five volumes of acetone were added to each sample and protein was 
precipitated overnight at -80°C. After centrifugation for 15 minutes at 10 000 x g, the protein 
pellets were air dried before resuspension by vigorous shaking for two hours at room 
temperature in 20 ~l of SDS PAGE-Sample Buffer (2% sodium dodecyl sulfate, SDS; 10% 
glycerol; 0.6 rnM Tris-HCI, pH 6.8; 0.005% bromophenol blue; 0.1 rnIvI DTT). 
After denaturation, by boiling for two minutes, samples were placed on ice before 
separation by discontinuous polyacrylamide gel electrophoresis (PAGE) on 12% 
polyacrylamide/OJ % SDS gels (SDS-PAGE). Discontinuous polyacrylamide gels consist of a 
resolving (or separating) lower gel and a stacking (upper) gel. The upper stacking gel is of 
lower acrylamide concentration and acts to concentrate large sample volumes, which results 
in better band resolution. Discontinuous gels, 7 cm in length by 8 cm in width, were run in 
SDS-Running Buffer (959 mM Glycine, 124 rnM Tris, 17.3 rnM SDS) at 200 volts for 45 to 
50 minutes and fixed for between one and 24 hours in gel fixative (25% isopropanol: 10% 
acetic acid). Incubation in an aqueous fluorographic agent, AmplifyTM (Amersham Life 
Sciences, Auckland, NZ), for 15 minutes increased the signal from eSS]-methionine. After 
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drying on a BioRad gel drier, under vacuum, for two hours at 80°C, gels were visualised by 
exposure to Hyperfilm-MP autoradiography film (Amersham). 
Films were scanned on a Hewlitt Packard Scanjet rrcx and quantified by NIH Image, 
version alpha 9 (Scion Corporation, Frederick, MD, USA). The densities of the bands in the 
cytoplasmic and nuclear lanes were determined by the Gelplot2 macro. The nuclear density 
was compared to the sum of the cytoplasmic and nuclear densities to quantify the amount of 
nuclear localised protein. Nuclear accumulation was expressed as a percentage. Mean sample 
results from replicate batches of oocytes (n: number of replicate batches presented in figure 
legends) were analysed for significant difference by the two tailed Student's t-test carried out 
using Excel 97 (Microsoft® Corporation, Redmond, W A, USA). 
2.2.5 Xenopus oocyte incubations in thyroid hormone 
Oocytes were microinjected with TRa, TRP, v-ErbA, C122A, or control protein L5, 
as described in Section 2.2.3. Post-injection, oocytes were incubated in O-R2 supplemented 
with 100 mM T3 (Sigma) and 200 )lg/ml cycloheximide for six hours at 18-20°C. Protein was 
isolated from manually dissected oocytes and the distribution of protein in the nuclear and 
cytoplasmic fractions was analysed according to the standard protocol (Section 2.2.4). Results 
were compared with control incubations made in the absence of T3. It has been demonstrated 
previously in the laboratory that no detectable levels of T3 are present in Xenopus oocytes 
(Nag1 et at., 1995). 
2.2.6 Immunoprecipitation and detection oJv-ErbA/hsp90 complexes 
Antibody was bound to pre-swollen protein G-sepharose beads (Pharmacia, Uppsala, 
Sweden) in NET-2 (150 mM NaCI, 50 mM Tris-HCl, pH 8.0, 1 mM EDTA) at room 
temperature for two hours with end-over-end rotation. Resin was pelleted for 5 seconds in a 
microfuge then washed four times in NET-2. The sample for analysis was added to the resin 
up to a final volume of 0.5 ml with NET-2 (containing 0.1 mM phenylmethylsulfonyl 
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fluoride, PMSF) and incubated at 4°C for one hour. The resin was collected by centrifugation 
as before and the supernatant was removed for precipitation in acetone. Prior to addition of 
20 fll of SDS-PAGE sample buffer, pellets were washed four times in NET-2. The 
immunoprecipitates were spun for five seconds in a microfuge, to collect the protein G 
sepharose beads, after denaturation by boiling for two minutes. Samples were separated on 
12% discontinuous polyacrylamide gels, containing SDS, and prepared for exposure to 
Hyperfilm-MP autoradiography film, as detailed more fully in the Section 2.2.4, or visualised 
through silver staining of the polyacrylamide gels. Briefly, gels were fixed for one hour in gel 
fixative prior to detection with the BioRad Rapid Silver Staining protocol (as per the 
manufacturer's instructions). 
The separated protein samples were transferred to Millipore Immobilon PVDF 
membrane by western blotting in a BioRad Mini Trans-Blot Electrophoretic Transfer Cell. 
The was equilibrated in Western Transfer Buffer (25 mM Tris, 192 mM Glycine, 20% 
methanol; pH 8.3) before being placed on buffer-soaked 3MM paper (Whatman, Singapore). 
PVDF membrane was pre-wet briefly in methanol before equilibration in Western Transfer 
Buffer for two to three minutes. The "transfer sandwich" was assembled by placing the 
membrane directly upon the gel, and topping with a second piece of buffer-soaked 3MM 
paper. This sandwich was prepared according to the manufacturer's instructions and transfer 
was perfOlmed overnight in Western Transfer Buffer, at 30 rnA and 4°C. Membranes were 
blotted overnight with shaking in blocking buffer (l % bovine serum albumin and 0.1 % 
Tween 20 in TBS: 10 mM Tris, pH 7.5; 100 mM NaCl). Two washes of 15 second", each 
were made in TBS, followed by one for 15 minutes and two washes for five minutes. 
Subsequently, membranes were incubated at room temperature for one hour in primary 
antibody (detailed in Section 2.2.1) diluted in blocking buffer to 1: 1000 or at the appropriate 
dilution determined by titration. Prior to incubation in secondary antibody, membranes were 
washed, as described above, to remove unbound primary antibody. Membranes were washed 
again, using the same protocol, after a one hour incubation in secondary antibody conjugated 
to horseradish peroxidase (POD), diluted to 1: 10 000. To initiate the detection reaction, 
protein blots were placed for one minute in chemiluminescent substrate solution, containing 
one part ECL Solution I and one part ECL Solution IT (Amersham). Blots were drained 
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bliefly and wrapped in a single layer of plastic wrap plior to exposure to Hyperfilm-MP 
autoradiography film for between 30 seconds and five minutes. 
2.2.7 Mammalian cell culture 
NlliI3T3 cells are derived from NllI Swiss mouse embryo cultures and are highly 
contact-inhibited (American Type Culture Collection, Rockville, MD, USA). A tissue culture 
facility was set up and protocols were prepared for culturing NllI 3T3 cells. Tissue handling 
was performed in a Class n Biological Safety Cabinet (BH2000 series; Clyde Apac, 
Australia) with rigorous aseptic techniques. Cells were maintained at 5% CO2:95% air in a 
humidified Napco 5415 IRC02 system incubator (Precision Scientific, Chicago, IL, USA). 
Cells were cultured in Dulbecco's modified Eagle's Medium (DMEM) containing 10% calf 
serum (CS) and 1 % penicillin-streptomycin stock (Stock: 10 000 units penicillin and 10 000 
Ilg streptomycin/mJ), as required (Life Technologies, Gaithersburg, MD, USA), at 37°C under 
5% CO2:95% air in the humidified incubator. Cells were reseeded by trypsinisation weekly 
with 0.1 % trypsin and media replaced twice weekly, or as required. Cell stocks, in Cell 
Freezing Medium (Life Technologies), were frozen and maintained in liquid nitrogen 
according to the manufacturer's instructions. 
2.2.8 Transfection of NIH 3T3 cells 
NlliI3T3 cells were reseeded into a variety of vessels, dependent upon the 
experiments in which they were to be used. Cell stocks were maintained in Nunc 25 cm2 filter 
top f1asks (Nalge Nunc International, Rochester, NY, USA). For the purpose of GFP 
experiments, cells were seeded onto Lab-Tek two or four well tissue culture chamber slides 
(Nunc). Large quantities of cells were required for the nuclear matrix preparations, therefore, 
cells were seeded in 100 mm culture dishes (Nunc). Twenty four hours after reseeding into 
DMEMlIO% CS, cells at 50-60% confluence were transfected with plasmid DNA and 
lipofectamine reagent, in Opti-MEM I Reduced Serum Medium, according to the 
manufacturer's instructions (Life Technologies). Transfection conditions were optimised for 
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DNA and reagent concentrations, and transfections were peIformed for between 16 and 20 
hours at 37°C and 5% CO2:95% air. Media was replaced 24 hours post transfection. Living 
cells were washed gently in Du1becco-modified PBS (D-PBS: 2.7 mM KCI; 1.5 mM 
KH2P04; 136.9 mM NaCI; 8 mM Na2HP04) and examined 48 hours post transfection to 
visualise EGFP fusion proteins. Cells for nuclear matrix-intermediate filament isolation 
(NM-IF) analysis were prepared as detailed below (Section 2.2.11). 
2.2.9 Visualisation of EGFP labelled proteins in cultured mammalian cells 
The transfected cells on chamber slides were rinsed gently in D-PBS to remove any 
calf serum that might otherwise autofluoresce. Cells being maintained at 4°C were washed in 
ice-cold D-PBS and maintained on ice for all stages except microscopic examination. Cells 
incubated at 37°C were maintained in a portable incubator (TYPE). The slide chambers were 
disassembled according to the manufacturer's instructions and cells were mounted in fresh 
D-PBS under number 1 coverslips. Cells were maintained at the temperature incubations were 
peIformed at, with D-PBS being added as required to prevent dehydration of the preparations. 
Slides were examined on a Leitz Orthoplan fluorescence microscope under both bright field 
and fluorescent conditions (Blau BG38/4mm; Blau BG1212mm; K495; K470/490). 
Observations were also made in combined light conditions to better enable localisation of 
fluorescence to cellular compartments. Photography was peIformed with a Leitz Orthomat 
camera and Fujichrome Provia 400 Daylight slide film, in all light conditions. Replicate slides 
were examined and distributions of EGFP proteins were recorded qualitatively. Distribution 
and the percentage of transfection were calculated for each experiment, prior to compilation 
of the results for each experimental type. 
2.2.10 T3 addition and absence in cultured mammalian cells 
DMEM culture medium was stripped of thyroid hormone (T3) according to the 
protocol of Yen et al. (1994). In brief, DMEM containing 10% calf serum was mixed with 
5% AG1-X8 resin (BioRad) for 12 hours at 4°C. The medium was decanted, before addition 
of fresh resin to 5%, and a second incubation was carried out for 12 hours at 4°C, with 
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stirring. The media was immediately filtered by peristaltic pump into a sterile bottle before 
storage at 4°C. 
Cells were seeded and transfected with EGFP and fusion plasmids in the standard 
manner. Twenty four hours post transfection, the cell medium was replaced with T3-stripped 
DMEM, or supplemented T3-stripped DMEM containing a range of T3 concentrations 
(lO,9M, 10,6 M, 10'3 M). A 100 mM T3 stock was prepared in 100% ethanol, from which 
subsequent dilutions were made into 100% ethano1. Stocks were maintained at -20°C until 
use. Cells were examined for fluorescence after a further 24 hours incubation at 37°C and 
2.2.11 Isolation of nuclear fractions and nuclear matrix intermediate filaments 
NIHI3T3 cells were seeded into 100 mm culture dishes (Nunc) to give 50-60% 
confluence after 24 hours. Cells were transfected with the EGFP fusion vectors specified in 
Section 2.2.1, as detailed in Section 2.2.8. The increased size and possible non-specific 
affinities of the EGFP fusion proteins for cellular compartments could influence the nuclear 
distribution of the tagged receptors. Therefore, the non-EGFP "source plasmids", also 
described in Section 2.2.1, were included as controls for EGFP-tagged receptors. Forty eight 
hours post-transfection, cells were harvested according to an established protocol (He et al., 
1990). Ten plates were placed on ice at once and the cells were harvested. After removal of 
culture medium, cells were rinsed in ice-cold D-PBS. Plates containing ice-cold D-PBS were 
scraped using a disposable cell scraper (Nunc). The detached cells were transferred to a 
conical tube on ice. Cell detachment was completed in ice-cold D-PBS, which was transferred 
between plates prior to scraping. The NIH 3T3 cells were collected by centrifugation at 880 x 
g for five minutes at 4°C, in a Jouan CR412 (M4 swing out rotor) centrifuge, prior to 
separation of individual cell fractions in various buffers. Fractions were collected after each 
centrifugation step described below. Pellets were resuspended in CSK buffer (100 mM NaCl; 
300 mM sucrose; 10mM Pipes, pH 6.8; 3 mMMgCh; 1 mMEGTA; 0.5% Triton X-IOO; 1.2 
mM PMSF), which dissolves phospholipids and soluble proteins whilst leaving the 
cytoskeleton intact. The supernatant containing the phospholipids and soluble proteins was 
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collected by centrifugation as before. The cytoskeleton and polyribosomes were removed 
from the remaining cell fractions by resuspension in RSB-Majik buffer (10 mM Tris, pH 7.4; 
10 rnM NaCI; 3 rnM MgC}z; 1% Tween 40; 0.5% deoxycholate; 1.2 mM PMSF) and 
subsequent centrifugation. Chromatin was digested in digestion buffer (50 rnM NaCl; 300 
mM sucrose; 10 mMPipes, pH 6.8; 3 rnM MgCh; 1 rnMEGTA; 0.5% Triton X-lOO; 1.2 rnM 
PMSF) , containing 400 f.!g/rnl DNase 1 and 50 f.!g/rnl RNase A (Sigma Types II and UIA 
from bovine pancrea'>, respectively) for 20 minutes at room temperature on a tilting shaker. 
One half volume of 0.5 M ammonium sulphate was added to release the digested chromatin 
and associated histones. After 10 minutes centrifugation at 880 x g and 4°C, the isolated 
nuclear matrix intermediate filament (NM-IF) pellet was separated from the chromatin 
fraction and resuspended in digestion buffer without additives. Small aliquots of the NM-IF 
and other collected fractions were snap frozen in liquid nitrogen and stored at -80°C. 
2.2.12 Western analysis of differentially extracted proteins 
One volume of 2xSDSIPAGE-sample buffer was added to 16 f.!l of sample (from 
NM-IF preparations). Samples were denatured, by boiling for two minutes, prior to loading 
on 12% discontinuous polyacrylamide gels, containing SDS. Gels were run at 20 rnA for 
approximately one hour and transferred to PVDF membrane by Western transfer as described 
in Section 2.2.6. 
The quantities of protein loaded on the polyacrylamide gels (contained within the 
16 f.!l sample) were determined by microassays performed with a BioRad Protein Assay Kit 
with a seIUm albumin standard, according to the manufacturer's instIUctions. The reaction 
absorbance was measured at 540 nm on a Ultrospec II spectrophotometer (Pharmacia LKB 
Biochrome Ltd., Cambridge, England). The amount of protein contained in each sample is 
shown in Table 8. 
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2.3 Results 
The results in this chapter are presented according to the cell system used for each 
experiment. Distribution studies carried out in microinjected Xenopus oocytes are described in 
Sections 2.3.1, 2.3.2, and 2.3.4. These sections present the results for the investigation of 
TRa, TR~, C122A, and v-ErbA import kinetics, determination of the subcellular distributions 
of these receptors, and the effect of hormone incubation on receptor distribution, respectively. 
Results of hsp90 and v-ErbA association studies are given in Section 2.3.6. Sections 2.3.3, 
2.3.5, and 2.3.7 present the results obtained in cultured Nlli 3T3 cells. Subcellular 
distributions for EGFP-tagged TRa and C122A are presented in Section 2.3.3, and T3 
incubations in Section 2.3.5. The results for fractionation studies pel formed in TRa, 
TRa::EGFP, C122A, and C122A::EGFP transfected cells are contained in Section 2.3.7. 
Results for both Xenopus oocyte arid cultured Nlli 3T3 cell systems are summarised in Table 
6 and Table 7, respectively. These tables also contain the probability values for Student's 
t-tests carried out between data sets. 
2.3.1 Microinjected t5SJ-labeUed TR and variants accumulate in Xenopus oocyte 
nuclei 
To determine the optimal time at which to perform distribution and transport assays, 
the kinetics of nuclear import for TRa, TR~, C122A, and v-ErbA were assayed over time. 
Steady state was reached at approximately six hours post-injection (Figure 2.1). Further 
analyses of receptor distribution were carried out between five and six hours, after the steady 
state was reached. The difference in receptor levels at each time point (indicated by the error 
bars) is due to variability among batches of oocytes. The amount of protein to be used in each 
injection was determined by titration. The range of protein concentrations assessed included 
50, 100, and 200 picograms per 50 nanolitres injection volume (data not shown). The 
concentration of 100 picograms per injection was selected for future experiments as this 
produced a strong signal, when pooled fractions from six oocytes were extracted and analysed 
by SDS-PAGE and fluorography. No difference was observed in protein distribution between 
100 and 200 picrograms. 
Figure 2.1. The nuclear accumulation of microinjected TR and variants in Xenopus 
oocytes. 
Approximately 100 picograms of in vitro synthesised eSS]-methionine labelled protein were 
cytoplasmically-microinjected per oocyte. Oocytes were incubated at 18-20°C over the time 
intervals indicated on the x-axis of the graph. Nuclei were manually dissected from the 
oocytes and proteins were isolated from six pooled nuclear or cytoplasmic fractions, according 
to the respective microinjections. TRa, TRP, C122A, v-ErbA, or L5 protein was separated 
from oocyte proteins by electrophoresis on 12% discontinuous polyacrylamide gels containing 
SDS, followed by autoradiography. The percentage of nuclear accumulation was determined 
by densitometry of the autoradiograms. Each graphed data point reflects the mean of replicate 
batches (n) of six pooled oocytes (TRa: n=8; TRP: n=4, C122A: n=4; v-ErbA: n=9). 
Standard error of the means is indicated by the bars. 
tn 
;j 
Q) 
-CJ 
;j 
s:::: 
s:::: 
s:::: 
.-Q) 
-0 ~ 
Q. 
"C 
Q) 
Q) 
.c 
co 
-
~ 0 
Time course of protein accumulation 
in oocyte nuclei 
70% ~----------------------------________ ~ 
60% 
50% I r T 40% 
30% 
20% 
10% 
0% +---~~--~--~~----~----~--~ ____ ~ 
o 2 4 6 8 10 12 14 
Time (hours) 
C122A -+- V-ErbAI 
49 
50 
2.3.2 Subcellular distribution of TRa, TRjJ, C122A, and v-ErbA in Xenopus oocytes 
DNA binding is an important determinant in the localisation and tight binding of GR 
in the nucleus (Sackey et ai., 1996). As TR has been reported to be constitutively bound to 
DNA, it follows that integrity of the DBD may playa role in receptor localisation. In addition, 
TR and v-ErbA deletion mutants for the NLS domains, which are located close to the DBD 
(see Table 2), were found to be localised to the cytoplasm (Dang and Lee, 1989; Lee and 
Mahdavi, 1993). TR variant C122A contains a mutation in the first zinc finger of TR~, and is 
therefore unable to bind DNA. Thus, the distribution of DNA-binding mutant C122A was 
compared with wild type TRa, TR~, and v-ErbA to assess whether DNA binding is necessary 
for stable nuclear accumulation of receptor. 
Unexpectedly, the distributions of TRa, TR~, C122A, and v-ErbA observed in 
Xenopus oocytes (Figure 2.2) were distinctly different from previous reported findings made 
in cultured somatic cells for TRa (Perlman et at., 1982; Kumara-Siri et at., 1986; Horowitz et 
at., 1989; Puymirat et ai., 1989; Macchia et al., 1992; Lee and Mahdavi, 1993) and v-ErbA 
(Bigler and Eisenman, 1988; Boucher et aI., 1988). Although some TR-related proteins have 
been observed to have cytoplasmic forms, TR has not previously been shown to have a 
cytoplasmic subpopulation (as discussed in Sections 1.1.2 and 2.1.2). 
Thirty nine percent of cytoplasmically-injected TRa was localised to the nuclei of 
Xenopus oocytes after a five to six hour incubation (Figure 2.2, A and B). Similarly, TR~ and 
C l22A were distributed between the cytoplasm and nucleus, with 39% and 41 % localised to 
the nucleus, respectively (Figure 2.2, A and B), suggesting that DNA binding is not essential 
for nuclear localisation. 
Figure 2.2. The distribution of cytoplasmically-injected TR and variants in Xenopus 
oocytes. 
A. In vitro synthesised eSS]-methionine labelled protein was introduced into either the 
cytoplasmic or nuclear compartment of each oocyte by microinjection, as detailed in 
Figure 2.1. After a five hour incubation at 18-20°C, nuclear accumulation of TRa, 
TR~, C122A, v-ErbA, and L5 was analysed as described in the legend of Figure 2.1. A 
representative autoradiogram is shown. (C: cytoplasmic fraction; N: nuclear fraction). 
B. The graph shows nuclear accumulation results for replicate experiments (n) of 
cytoplasmically injected L5 (n=4), TRa (n=8), TR~ (n=4), C122A (n=4), and v-ErbA 
(n=9). 
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In contrast to the constitutive nuclear localisation of TR reported for somatic cells 
(Perlman et al., 1982; Kumara-Siri et al., 1986; Horowitz et al., 1989; Puymirat et al., 1989; 
Macchia et aI., 1992; Lee and Mahdavi, 1993), 30-40% of v-ErbA has been shown to be 
cytoplasmic in mammalian cells (Privalsky 1991; 1992). The distribution of v-ErbA in 
Xenopus oocytes also varies from that rep011ed previously. In oocytes, 21 % of the receptor 
was distributed to the nucleus and 79% was cytoplasmic (Figure A and B). Ribosomal 
protein L5 was used as a control protein in this study as import kinetics have been well 
characterised in Dr L. A. Allison's laboratory (Murdoch and Allison, 1996). As expected a 
subpopulation of L5 was localised to the nucleus (33%; Figure 2.2A). 
The subcellular distribution of receptor molecules, microinjected into the nuclei of 
Xenopus oocytes, was also determined after five to six hours (Figure 2.3). Nuclear-injected 
TRa was retained in the nucleus to a greater extent than TRa injected into the cytoplasm: 
62% (Figure 2.3, A and B) compared with 39% (Figure 2.2, A and B). A greater proportion of 
nuclear injected TR~, C122A, v-ErbA, and L5 molecules was also retained in oocyte nuclei 
(74%, 72%, 87%, and 68%, respectively; Figure 2.3, A and B) compared with nuclear 
localisation after cytoplasmic injection (39%, 41 %,21 %, and 33%, respectively; Figure 2.2, 
A and B). 
2.3.3 Distribution of EGFP-tagged TRaand C122A in cultured mammalian cells 
GFP has been shown to autofluoresce in a vruiety of cultured mammalian cells: such 
as COS-7, HeLa, and NIH 3T3 (Pines, 1995). GFP has also been effectively used as a tag to 
investigate transport and localisation of a variety of NHRs; including GR (Cru'ey et ai., 1996; 
Htun et al., 1996), AR (Georget et al., 1997), and MR (Fejes-T6th et aI., 1998). 
Figure 2.3. The distribution of nuclear.injected TR and variants in Xenopus oocytes. 
A. eSS]-labelled TRa., TRP, C122A, v-ErbA, or L5 was introduced into oocyte nuclei by 
microinjection. After five to six hours incubation at 18-20°C, protein was isolated from 
oocytes, manually dissected into cytoplasmic (C) and nuclear (N) fractions, and analysed, 
as described in Figure 2.1. A representative autoradiogram is shown. 
B. The percentage of labelled protein in the oocyte nuclei from replicate experiments (n) was 
quantified by densitometry of the autoradiograms produced in the experiments described 
above. (TRa.: n=8; TRP: n=3, C122A: n=3; v-ErbA: n=5; L5: n=4) 
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The a isofOlID of TR has long been described as constitutively bound to DNA in 
cultured mammalian cells (Perlman et al., 1982); that is, no cytoplasmic subpopulation of the 
receptor has been identified (as discussed in Section 2.1.2). This raises the possibility that 
DNA binding may playa key role in nuclear retention of these receptors. However, contrary 
to this notion, no significant difference was seen in oocytes between the distributions of TR 
and the DNA-binding mutant, C122A. To detennine whether these two proteins are similarly 
distributed in living, cultured mammalian cells, red-shifted EGFP fusion proteins were used to 
visualise the localisation ofTRa and C122A in these cells. Wild type EGFP protein was used 
as a control. Transfection efficiencies are recorded in Table 7. 
As expected, EGFP was present throughout the cell, as visualised in Figure 2.4. In 
suppOli of previously reported distributions (Perlman et al., 1982; Puymirat et ai., 1989; 
Macchia et ai., 1992; Lee and Mahdavi, 1993), EGFP-tagged TRa was localised to the cell 
nuclei of NlH 3T3 cells in all observed experiments. A representative example of this 
localisation is presented in Figure 2.4, whilst all data are summarised in Table 7. In contrast to 
EGFP-tagged TRa, and to the results obtained in Xenopus oocytes, EGFP-tagged C122A was 
completely excluded from the nuclear compartment of NIH 3T3 cells (Figure 2.4). 
2.3.4 T3 hormone increases nuclear accumulation of TR in Xenopus oocytes 
This series of experiments aimed to address whether stable nuclear accumulation of 
TR in Xenopus oocytes is dependent upon the HBD. Results are summarised in Table 6. 
Whilst, TRa, TR~, and C122A display the ability to bind hOlIDone, mutations have rendered 
v-ErbA unable to bind T3 at physiological concentrations. 
Addition of T3 to O-R2 incubation buffer altered the distribution of cytoplasmically 
injected TRa. Honnone binding induced a shift of receptor from the cytoplasmic 
compartment to the nucleus. Analysis by Student's t-test indicated a significant increase 
(p<O.OOl) from 39% to 51% nuclear TRa (Figure 2.5, A and B). This shift was also observed 
for nuclear injected TRa, with 85% of TRa retained in the nucleus compared to 62% 
(p<O.OOl; Figure 2.5, A and B). 
Figure 2.4. The subcellular distribution of EGFP-tagged TRa and C122A in cultured 
mammalian cells. 
Plasmid constructs containing TRa or C122A fused to EGFP were transfected into NIH 
3T3 cells, cultured to 50% confluence. Transfection medium was replaced by complete 
medium after 24 hours incubation at 37°C and 5% C02:95% air. Cells were analysed after 
a further 24 hours incubation. Living cells were rinsed with D-PBS prior to visualisation 
with a fluorescent microscope, a combination of bright-field and epifluorescence, as well as 
with epifluorescence only (as shown). Control transfections with EGFP and with no EGFP 
were performed. (TRa: EGFP-tagged TRa; C122A: EGFP-tagged C122A) 
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Conversely, no significant increase (p>O.l) in v-ErbA nuclear localisation was 
observed when oocytes were incubated in T 3 (Figure 2.6). However, as such a small 
percentage of receptor is localised to the nuclei of oocytes incubated at physiological 
conditions, it would be difficult to assess even a one to two fold increase in nuclear receptor 
after incubation in T3. 
As seen for TRa, there was an increase in C122A and TR~ receptor accumulation in 
nuclei of oocytes incubated in T3 (Figure 2.7, A and B). However, this was smaller in 
magnitude and was significant for TR~ at the 95% confidence level (p=0.03). In the case of 
TR~, T3-incubation of oocytes increased nuclear accumulation from 39% to 45%, compared 
with a shift from 41 % to 46% nuclear for C122A. The shift for C122A was only significant at 
the 90% level of confidence (p<O.l). 
In addition to incubations at physiological temperatures, oocytes microinjected with 
either TRa or v-ErbA were incubated at 0-4°C, in the presence or absence of T3 hormone. A 
significant shift (p<O.OOl) of TRa to the nuclei of chilled, T3-incubated oocytes is shown in 
Figure 2.5 (A and B). The observed change is an increase in nuclear protein from 40% to 
48%. Addition of T3 at 0-4°C does not affect v-ErbA distribution (Figure 2.6, A and B), 
although visualisation of such a shift may be difficult, as discussed above. 
A control incubation of ribosomal protein L5 in T 3 did not result in an increase of L5 
in oocyte nuclei (Figure 2.7, A and B). In fact, a slight reduction in nuclear L5 was observed 
which skews the t-test results. As L5 does not bind T3 hOlmone, this confirms that the change 
in TR distribution is attributable to hormone binding, and is not due to a non-specific effect. 
Figure 2.5. The effect ofT3 incubation on TRadistribution in Xenopus oocytes. 
A. Approximately 100 picograms of in vitro synthesised CSS]-methionine labelled TRa. were 
introduced into each oocyte by microinjection. Oocytes were incubated at 18-20°C or 0-4°C 
(as indicated) in O-R2, or in O-R2 supplemented with 100 mM T3 (as indicated), for five to 
six hours prior to manual dissection of the oocytes into cytoplasmic (C) and nuclear (N) 
fractions, Protein was isolated from six pooled nuclear or cytoplasmic fractions and 
separated from oocyte proteins by electrophoresis on 12% discontinuous polyacrylamide gels 
containing SDS, followed by autoradiography. A representative autoradiogram is shown. 
B. The percentages of nuclear accumulation from the experiments described in (A) were 
determined by densitometry of the autoradiograms. Each graphed data point reflects the 
mean of replicate batches (D) of six pooled oocytes. Standard error of the means is 
indicated by the bars. (TRa.[20°CI-T3]: n=8; TRa.[0°CI-T3]: n=4; TRa.[20°CIT3]: n=8; 
TRa.[0°CIT3]: n=4; TRa.[20°CI-T3/nu.]: n=8; TRa.[20°C/nu.1T3]: n=3) (T3: thyroid 
hormone; -T3: minus thyroid hormone; DU.: nuclear injections) 
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Figure 2.6. The effect of T3 incubation on v-ErbA distribution in Xenopus oocytes. 
A. Approximately 100 picograms of in vitro synthesised eSS]-methionine labelled v-ErbA were 
introduced into each oocyte by microinjection. Oocytes were incubated at 18-20°C or 0-4°C 
(as indicated) in O-R2, or in O-R2 supplemented with 100 mM T3 (as indicated), for five to 
six hours prior to manual dissection of the oocytes into cytoplasmic (C) and nuclear (N) 
fractions. Protein was isolated from six pooled nuclear or cytoplasmic fractions and 
separated from oocyte proteins by electrophoresis on 12% discontinuous polyacrylamide gels, 
followed by autoradiography. 
B. The percentages of nuclear accumulation from the experiments described above were 
determined by densitometry of the autoradiograms. Each graphed data point reflects the 
mean of replicate batches (n) of six pooled oocytes. Standard error of the means is 
indicated by the bars. (v-ErbA[20°CI-T3]: n=9; v-ErbA[O°C/-T3]: n=4; v-ErbA[20°CIT3]: 
n=4; v-ErbA[O°CIT3]: n=4; v-ErbA[20°C/-T3/nu.]: n=5; v-ErbA[20°C/nu.1T3]: n=4) (T3: 
thyroid hormone; -T3: minus thyroid hormone; nu.: nuclear injections) 
A 
B 
c: 
Cl) 
-0 ~ 
c. 
"01/) 
Cl)~ 
=Cl) 
Cl)-
.cO C'a~ 
_c: 
~c: o ._ 
Cytoplasmic Nuclear 
Nuclear accumulation or retention of 
v-ErbA following T 3 incubation of oocytes 
100% 
80% 
60% 
40% 
20% 
0% 
OoC 200 C(nu.) 200 C(nu.) 
Treatment 
58 
Figure 2.7. The effect of T3 incubation on TRfi, C122A, and LS distribution in Xenopus 
oocytes. 
A. Approximately 100 picograms of in vitro synthesised eSS]-methionine labelled TR~, C122A, 
or L5 were introduced into each oocyte by microinjection. Oocytes were incubated at 
18-20°C or 0-4°C (as indicated) in O-R2, or in O-R2 supplemented with 100 mM T3 (as 
indicated), for five to six hours prior to manual dissection of the oocytes into cytoplasmic (C) 
and nuclear (N) fractions. Protein was isolated from six pooled nuclear or cytoplasmic 
fractions and separated from oocyte proteins by electrophoresis on 12% discontinuous 
polyacrylamide gels, followed by autoradiography. 
B. The percentages of nuclear accumulation from the experiments described above were 
determined by densitometry of the autoradiograms. Each graphed data point reflects the 
mean of three to six replicate batches (D) of six pooled oocytes. Standard error of the 
means is indicated by the bars. (L5[20°C/-T3]: n=4; L5[20°CIT3]: n=3; TR~[20°C/-T3]: 
n=4; TR~[20°CIT3]: n=2; C122A[20°C/-T3]: n=4; C122A[20°CIT3]: n=2) (T3: thyroid 
hormone; -T3: minus thyroid hormone; DU.: nuclear injections) 
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2.3.5 Hormone does not affect localisation of EGFP-tagged TRa or C122A in cultured 
cells 
Addition of T3 to culture medium induced a nuclear shift in TRa, TR~, and C122A 
distribution in Xenopus oocytes (Section 2.3.4). As more nuclear retention sites appear to 
become available to hormone-bound receptors in oocytes, it was of interest to know whether 
this is the case in cultured mammalian cells. C122A, although DNA binding deficient, retains 
its honTIone binding ability (Section 1.1.4). Therefore, a shift in distribution from 100% 
cytoplasmic (Figure 2.4) might be predicted to occur with vadation in honnone 
concentrations. Results for the hormone incubation studies described in this section are 
summarised in Table 7. 
Cultured Nlli 3T3 cells were incubated in medium stdpped of T3, or supplemented 
with honnone at the following concentrations: 10-3 M; 10-6 M; 10-9 M. Synthesis of protein 
was arrested, by addition of cycloheximide, four hours before observation of receptor 
distribution. No alteration in EGFP-tagged C122A or TRa distribution was observed in 
response to the T3 treatments used (Figure 2.8, A and B). T3 incubations of EGFP transfected 
cells were perfonned, with no observable differences from control cells incubated in the 
absence of honTIone (Figure 2.8C). Transfection efficiencies are recorded in Table 7. 
2.3.6 v-ErbA binds hsp90 from rabbit reticulocyte lysate 
It has been proposed that complexing of NHRs with hsp90 renders the receptor unable 
to bind DNA, by sequestering the receptor in the cytoplasm (Dalman et al., 1990). In this 
way, hsp90 directly influences the localisation of the NHR in a honnone absent cellular 
environment, by preventing nuclear import of the receptor. Whilst v-ErbA associates with 
hsp90, TR does not form a heterocomplex with the heat shock protein (Dalman et al., 1989; 
1990). Therefore, it is important to determine whether the v-ErbA synthesised in vitro during 
the course of this study associates with hsp90 present in the reticulocyte lysate mixture. 
Figure 2.8. The effect of TJ incubation on TRa::EGFP, C122A::EGFP, and EGFP 
distribution in cultured mammalian cells. 
NIH 3T3 cells were transfected with TRa::EGFP (A), C122A::EGFP (B), or EGFP (C) and 
incubated as described in Figure 2.4. Transfection medium was replaced by complete medium 
after 24 hours incubation at 37°C and 5% CO2:95% air. Twenty four hours after incubation in 
complete medium, cells were washed with D-PBS. Cycloheximide (50 Jlglml) was added to 
the complete medium for thirty minutes. This medium was replaced with T 3 minus medium 
containing 50 Jlg/ml cycloheximide or medium supplemented with 10-3M, 10-6 M, or 10-9 M 
T3 for three hours incubation at 0-4°C. Cells were washed with D-PBS and visualised under a 
fluorescent microscope with a combination of bright-field and epifluorescence, as well as with 
epifluorescence only. 
(TRa: EGFP-tagged TRa; C122A: EGFP-tagged C122A; T3: thyroid hormone; -T3: minus 
thyroid hormone) 
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The rationale for this set of experiments was that if v-ErbA complexes with hsp90 
during synthesis, then the receptor would be effectively localised in an immobile complex in 
the cell cytoplasm after cytoplasmic microinjection into oocytes. Therefore, if v-ErbA were 
isolated by specific antibodies, any associated hsp90 would also co-precipitate from the rabbit 
reticulocyte lysate translation mixture. This hsp90 could then be detected in turn by a second 
hsp90-specific antibody. 
Monoclonal antibodies raised against v-ErbA or antibodies against hsp90 were used to 
immunoprecipitate [35S]-methionine-labelled v-ErbA from the translation mixture. When the 
immunoprecipitate was separated by PAGE, the coimmunoprecipitate (isolated by way of 
anti-hsp90) and immunoprecipitated v-ErbA (from anti-v-ErbA isolation) was visualised by 
autoradiography (Figure 2.9A) or silver staining (results not shown). 
Serial dilutions of anti-hsp90 or anti-v-ErbA are shown in Figure 2.9A. At all 
dilutions, v-ErbA was immunoprecipitated by antibody. However, hsp90 was not detectable 
by silver staining (not shown). 
When the separated proteins were transfelTed to membranes by western transfer, 
anti-hsp90 antibodies detected protein bands mnning at the expected molecular weight of 
90lcDa in the relevant lanes (Figure 2.9B). The second lane contains the anti-v-ErbA 
immunoprecipitate (from anti-v-ErbA dilution 1/3, Figure 2.9A), whereas the lane labelled 1/50 
is the same as that isolated by anti-hsp90 in Figure 2.9A. The immunoprecipitates were 
compared to a positive control lane of transcription/translation mixture (TNT) that contains 
rabbit reticulocyte lysate, in which hsp90 has been previously detected (Dalman et ai., 1990). 
These results show that the v-ErbA synthesised in vitro is already complexed with hsp90 prior 
to being introduced into Xenopus oocytes. 
Figure 2.9. Hsp90 associates with v-ErbA in rabbit reticulocyte lysate. 
A. Hsp90 and v-ErbA were immunoprecipitated from rabbit reticulocyte lysate with various 
concentrations of anti-v-ErbA monoclonal antibodies. The immunoprecipitates were 
separated by discontinuous SDS-PAGE and eSS]-methionine labelled v-ErbA was 
visualised on X-ray film. (TNT: 1 III of v-ErbA transcription coupled translation mix, 
positive control; No Ab: no antibody, negative control; -: empty lane; 1/3, 1110: dilutions 
of v-ErbA Ab; 1150, 11100, 1/200: dilutions of anti-hsp90 Ab; Ab: antibody). Replicate 
experiments were performed (n=3). 
B. Immunoprecipitates from above were transferred to PVDP membrane by western transfer 
techniques and hsp90 was detected on the blots by hsp90-specific antibodies. (TNT: 8 Ill; 
1/3: v-ErbA Ab immunoprecipitate from A.; 1/50: hsp90 Ab immunoprecipitates from A.; 
-: empty lane). (n=1) 
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2.3.7 Subnuclear distribution of wild type and EGFP fusion receptors 
EGFP-tagged receptor distribution was visualised in living cultured mammalian cells. 
However, the increased size (an extra 27 k Da) and possible artefactual affinities of the 
fusion proteins for cellular compartments may have influenced the nuclear distribution of the 
receptor. Therefore, it was important to determine whether the subnuclear distribution of wild 
type and tagged receptors differed and, in particular, whether they associated with the nuclear 
matrix. 
Distributions were compared by separation of proteins by PAGE, western transfer, 
and antibody detection by a well-established protocol (He et ai., 1990). The quantity of total 
cellular protein contained within each. of the biochemically-separated fractions was 
detennined prior to separation of samples by SDS-PAGE. As this value determined for each 
fraction varied, the percentage of TRa.::EGFP or C122A::EGFP is expressed relative to the 
total protein concentration of that fraction. Results of these studies are given in Table 8. 
The distributions of TRa. and TRa.::EGFP isolated by biochemical fractionation 
differed from that observed for TRa.::EGFP in living cells. Whereas no receptor was observed 
in the cytoplasms of living cells by fluorescent lnicroscopy, the CSK fraction (containing the 
phospholipids and soluble proteins) contained both forms of receptor (Figure 2.10, A and B). 
Although 46% of the total cell protein for TRa.-transfected cells was contained in the CSK 
fraction (see Section 2.2.11), only 7% of TRa. was detected in this fraction. Likewise, 50% of 
the total cell protein for TRa.::EGFP transfected cells contained only 10% of receptor. 
Interestingly, the majority of both receptors were detected in the RSB fraction (see Section 
2.2.11), which contains the cytoskeleton and polyribosomes. Fifty percent of TRa.: :EGFP was 
accounted for in 21 % of the total protein isolated, compared with 36% of TRa. in 8% of total 
protein. As expected from a previous study (Perlman et ai., 1982), a large amount of both 
TRa. and TRa.::EGFP was found associated with the digested chromatin and associated 
histones (DB), 21 % and 10% of 8% total protein, respectively. 
Figure 2.10. Distribution of TRa, TRa::EGFP, C122A, CI22A::EGFP, and EGFP in 
fractionated NIH 3T3 cells. 
NIH/3T3 cells were transfected with the EGFP fusion vectors. Forty eight hours 
post-transfection, cells were harvested and rinsed in ice-cold D-PBS. The NIH 3T3 cells were 
detached and collected by centrifugation, prior to separation of individual cell fractions in 
various buffers. Fractions were collected in CSK buffer (C: to remove phospholipids and 
soluble proteins whilst leaving the cytoskeleton intact), in RSB-Majik buffer (R: to collect the 
cytoskeleton and polyribosomes), in digestion buffer (D: to release the digested chromatin and 
associated histones), and in digestion buffer without additives (the isolated nuclear matrix 
intermediate filament (NM-IF, or N) pellet). The fractions were separated by PAGE on 12% 
discontinuous gels containing SDS and analysed after transfer to PVDF membranes. The 
membranes were probed with anti-TRa antibodies or anti-NuMA antibodies (in the case of 
untransfected cells). The results are displayed opposite: TRa (A); TRa::EGFP (B); Cl22A 
(C); CI22A::EGFP (D); and untransfected cells (E). (n=l) 
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Lastly, tagged and un tagged TRa was found associated with the nuclear 
matrix-intelmediate filament fraction (NM-IF). From 38% total protein, 36% of TRa was 
contained in this fraction, whereas 20% of TRa: :EGFP is contained in 21 % of protein. 
Although this experiment was pelformed only once, these results give an indication of 
receptor distribution within each cellular compartment. 
C122A distribution was also assessed (both tagged and wild type forms). The 100% 
cytoplasmic distribution of C122A::EGFP observed in living cells was reflected in the 
distributions of C122A and C122A::EGFP in fractionated cells (Figure 2.10, C and D). 90% 
of C122A (in 44% of total cellular protein) was associated with the CSK fraction. Only 5% 
of C122A was localised in the RSB fraction. Similarly, 95% of C122A (in 30% total protein) 
was found in the CSK fraction and 10% protein in the RSB fraction. No receptor molecules 
were detected associated with the chromatin and histones, nor with the NM-IF. 
NuMA is a very abundant nuclear matrix phosphoprotein in interphase and relocates 
to the spindle poles during mitosis (Harboth et al., 1999). NuMA was detected in the 
chromatin and NM-IF fractions isolated from untransfected cells (DB and NM), as shown in 
Figure 2.1 OE. This confirms the integrity of the fractionation procedure for the nuclear matrix. 
Further fractionation studies would need to be performed with a nuclear protein that is not 
associated with the nuclear matrix as an extra control. 
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Table 6 - Summary of receptor distribution studies in Xenopus oocytes. 
Receptor Site of Treatment % nuclear Student's 
injection protein t-test a 
TRa cytoplasm physiological conditions 39%±3% reference 
TRa cytoplasm addition of T 3 hormone 51%±3% p<O.OO1 
TRa cytoplasm chilled 40%± 1% NS 
TRa cytoplasm addition of T 3 Ichilled 48%±3% P<O.OO1 
TRa nucleus physiological conditions 62%±7% Reference 
TRa nucleus addition of T 3 hormone 85%±5% p<O.OO1 
TR~ cytoplasm physiological conditions 39%±3% reference 
TR~ cytoplasm addition of T 3 hormone 45%± 1% P=O.09 
TR~ nucleus physiological conditions 74%±3% reference 
C122A cytoplasm physiological conditions 41%±2% reference 
C122A cytoplasm addition of T 3 hormone 46%± 1% P=O.03 
C122A nucleus physiological conditions 72%±6% reference 
v-ErbA cytoplasm physiological conditions 21%± 7% reference 
v-ErbA cytoplasm addition of T 3 hormone 20%±2% NS 
v-ErbA cytoplasm chilled 25%±8% NS 
v-ErbA cytoplasm addition of T 3 Ichilled 20%±4% NS 
v-ErbA nucleus physiological conditions 87%±5% reference 
v-ErbA nucleus addition of T 3 hormone 83%±5% I\JS 
L5 cytoplasm physiological conditions 33%±4% reference 
L5 cytoplasm addition of T 3 hormone 25%±4% P=O.07 
L5 nucleus physiological conditions 68%±6% reference 
a Student's t-test values are expressed as the probability that the experimental treatments were 
significantly different at p<O.1. Treatments were compared with reference values obtained in 
oocytes incubated at physiological conditions, except in the case of combined T 310°C treatments 
where comparisons were made with O°C incubations. (NS: not significant). Sample sizes are given 
in Figures 2.2,2.3, 2.5, 2.6, and 2.7. 
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Table 7 - Summary of EGFP-tagged receptor distribution studies in NIH 3T3 cells. 
Receptor Sample Treatment Distribution of Transfection 
size (n) protein efficiency 
TRa 500 physiological conditions 100% nuclear 21"10± 6% 
TRa 500 T3 hormone minus 100% nuclear 20%±6% 
TRa 500 addition of T 3 hormone (10·3M) 100% nuclear 25% ± 14% 
TRa 500 addition of T 3 hormone (10·6M) 100% nuclear 18"10±8"10 
TRa 500 addition of T 3 hormone (10·9M) 100% nuclear 20%± 10% 
C122A 297 physiological conditions 100% cytoplasmic 11% ± 5% 
C122A 280 T 3 hormone minus 100% cytoplasmic 12"10±5"10 
C122A 234 addition of T 3 hormone (1 0·3M) 100% cytoplasmic 12"10± 7% 
EGFP 500 physiological conditions 100% diffused 71%±13% 
through entire cell 
EGFP 500 T 3 hormone minus 100% diffused 68%± 13% 
through entire cell 
EGFP 500 addition of T 3 hormone (10·3M) 100% diffused 66% ± 13% 
through entire cell 
Table 8 - Distribution of receptors in cell fractions. 
Nuclear TRa b TRa::EGFP b C122A D C122A::EGFP D 
fractions a 
CSK 7% 10% 95% 90% (6119) (7119) (13 119) (1O l1g) 
total protein 46% 50% 44% 30% 
RSB 36% 50% 5% 10% 
(1 I1g) (3119) (3119) (12119) 
total protein 8% 21% 10% 36% 
DB 21% 20% 0% 0% 
(1 I1g) (1 I1g) (7119) (7119) 
total protein 8% 8% 25% 22% 
NM-IF 36% 20% 0% 0% 
(5119) (3119) (6119) (4119) 
total protein 38% 21% 21% 12% 
a CSK: Cytoskeletal buffer (soluble proteins and phospholipids); RSB: RSB Majik buffer (cytoskeleton 
and polyribosomes); DB: Digestion buffer (chromatin and histones); NM-IF: Nuclear 
Matrix-Intermediate Filaments 
b The percentage of receptor localised in each fraction is compared to the amount of total protein in 
each sample. Micrograms protein loaded per lane for each sample is displayed in brackets. 
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2.4 Discussion 
The distributions of TRa, TR~, C122A, and v-ErbA in Xenopus oocytes, reported in 
this chapter, differ significantly from those previously reported in cultured cells or those 
observed in Nlli 3T3 cells during the course of this study. Microinjected TR is distributed 
between the nuclear and cytoplasmic compartments in Xenopus oocytes contrary to studies in 
other cell types which show that TR is constitutively nuclear (Perlman et al., 1982; Puymirat 
et ai., 1989; Macchia et al., 1992; Lee and Mahdavi, 1993). In living Nlli 3T3 cells, 
EGFP-tagged TR was also shown to be localised to the nucleus, whereas C122A was 
observed only in the cytoplasmic compartment. The possible effects of cellular context are 
discussed in Section 2.4.1. A reduction in the reported percentage of v-ErbA distributed to the 
nucleus (Bigler and Eisenman, 1988; Boucher et al., 1988) was also observed in Xenopus 
oocytes. Heat shock protein 90 was shown to associate with v-ErbA, which would account for 
the sequestering of v-ErbA in the oocyte cytoplasm (Section 2.4.5). 
DNA binding was shown not to be essential for nuclear retention of TR, as 
DNA-binding mutant C122A was localised to the oocyte nucleus to the same extent as TRa 
or TR~. This suggests that TR may associate with other nuclear binding sites apart from TREs 
(Section 2.4.2). In addition to associating with the chromatin and histone fraction, TR was 
seen to associate with the nuclear matrix fraction of biochemically fractionated 3T3 cells. 
C122A was not found in either of the nuclear fractions, confirming the observations made in 
hving cells. Incubation of microinjected oocytes in T3 resulted in a shift of TRa, TR~, and 
C122A, but not v-ErbA, to the nuclear compartment. No equivalent shift of EGFP-tagged 
TRa or C122A was observed in Nlli 3T3 cells. The implications of these observations are 
discussed in Section 2.4.3. 
2.4.1 Localisation of receptor is dependent on cell type 
The subcellular distributions of TRa and C122A vary greatly between Xenopus 
oocytes and cultured Nlli 3T3 cells. Whilst both TRa and C122A have approximately 40% 
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of receptor localised to the nuclei of oocytes, in Nlli 3T3 cells TRa is constitutively nuclear 
and C122A is excluded from the nuclei. 
The presence of cytoplasmically injected TRa in Xenopus oocytes was not shown to 
be due to a saturation effect. No difference in TRa distribution was observed for three 
concentrations of microinjected protein (50, 100, or 200 picograms per 50 nanolitre injection). 
Cytoplasmically introduced TRa reached a steady state at approximately five hours after 
microinjection and this steady state was monitored throughout a twelve hour period. In 
addition, when the same amount of protein was introduced to the nuclear compartment, a 
greater proportion was retained in the nucleus. This observation suggests that if 
cytoplasmically introduced receptor had entered the nucleus to a greater extent than that 
observed, a greater proportion of receptor would have been retained in the nucleus. As this is 
not the case, it suggests that nuclear retention sites are available for further binding and that 
nuclear accumulation was not saturated. Therefore, the difference in TRa distribution 
between cell types may be attributed to the cellular context; that is, the presence or absence of 
factors associated with transport mechanisms or anchoring proteins, as well as accessibility to 
these factors. 
A further way of testing for saturation of nuclear binding sites in Xenopus oocytes 
would be to introduce extra binding sites into the cell nucleus and then assay for a shift in TR 
distribution. A range of TREs incorporated into vectors is available for introduction by 
micro injection. A shift in receptor distribution could be assayed for by the standard protocols 
described in Section 2.2.4. In an attempt to investigate this aspect and in conjunction with 
nuclear retention site studies, additional sites were provided by way of nuclear preinjection of 
a synthetic TRE linked to a mouse mammary tumour virus (~TV) LTR-CAT fusion gene 
(TREp: Nelson et aI., 1993) during the course of the investigations described in this thesis. 
However, although cycloheximide was added to the incubation medium to prevent synthesis 
of proteins from unincorporated C5S]-methionine, present in the [35S]_TRa sample, 
expression of CAT produced enough background to obscure the e5S]-TRa band on the 
autoradiograms. No TRE constructs, excluding CAT fusions, were available in the laboratory 
for testing, thus these analyses were not pursued further. 
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Several explanations for the observed variation in TR distribution are proposed. 
Firstly, cytoplasmic factors responsible for TR import may be absent in oocytes, or present at 
reduced levels. Secondly, retention sites in the nuclei of Nll1 3T3 cells may be more abundant 
than those available in Xenopus oocytes (discussed in Section 2.4.2). Alternatively, T3 binding 
may not be necessary for nuclear import of TR in cultured cells, whilst it may be necessary 
for release from an associated cytoplasmic factor in oocytes. The effects of honnone binding 
on nuclear localisation will be discussed in Section 2.4.3. It has been observed that several 
proteins redistribute between the nuclear and cytoplasmic compmtments at precise stages in 
embryonic development (reviewed in Nigg, 1990). Moreover, transport rates are faster and 
the functional sizes of NPCs are significantly larger in proliferating cells than in quiescent 
cells (Feldherr and Akin, 1994). These observations support the idea that differences in 
cellular context may be implicated in receptor distribution, particularly when comparing 
oocytes with somatic cells. 
Members of the NHR supelfamily have been shown to associate with complexes 
containing hsp90 and associated factors. GR, AR, and MR are sequestered in the cytoplasm 
by hsp90 and upon honnone binding are released from this association prior to transport to 
the nucleus (reviewed in Feldherr and Akin, 1994; reviewed in Brasch and Ochs, 1995; 
Dittmar et al., 1996). TRa has not been isolated complexed with hsp90; however, it is 
possible that TRa may form an association with another type of cytoplasmic anchor. 
Cytoplasmic anchors regulate nucleocytoplasmic transport, and therefore cell signalling, by 
two general mechanisms: anchoring and release of the protein, or masking and unmasking the 
NLS. For example, endoplasmic reticulum membranes and cytoplasmic membranous 
organelles are directly involved in anchoring sterol-regulatory element binding proteins and 
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inactive phospholdnase A (PKA) holoenzyme (Wang et aI., 1994; Nigg, 1990; respectively). 
Conversely, IKB masks the NLS of NFKElRel, inhibiting import (Baeuerle and Henkel, 
1994). Phosphorylation and proteolysis of IKE inactivates the cytoplasmic anchor, allowing 
NFKE to enter the nucleus and bind DNA. 
The presence of a cytoplasmic anchor may be supported in part by the results of 
expeliments carTied out by Dr A. Allison on my behalf in her new laboratory (College of 
William and Mary, Williamsburg, VA, USA). It was observed during the course of this study 
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that TRa molecules in the cytoplasmic and nuclear fractions, extracted from micro injected 
oocytes, migrated differently during gel electrophoresis. Nuclear TRa migrates with a slower 
mobility than cytoplasmic TRa (Figure 2.2). However, when the nuclear fraction is treated by 
a dephosphorylation reagent (calf intestinal alkaline phosphatase), mobility of TRa is 
identical to that of cytoplasmic TRa (L. A. Allison; personal communication). To summarise, 
these pilot studies indicate that nuclear TRa is phosphorylated. This suggests that release 
from an anchor protein requires phosphorylation at one or a combination of the four possible 
phosphorylation sites detected during a search for protein motifs carried out through 
PROSITE (http://expasy.hcuge.ch/sprotJprosite.html). 
The percentage of v-ErbA present in the nucleus of oocytes determined during the 
course of this study is less than the 30-40% reported in the literature for cultured cells nuclei 
(Privalsky 1991; 1992). This variation may be due to hsp90 binding, and will be discussed in 
Section 2.4.5. 
The difference observed in TRa distribution between cell types could be attributed to 
the use of EGFP-tagged receptors in Nlli 3T3 cells rather than due to differences in cell type. 
Addition of the 238 amino acid EGFP tag to TR and C122A for the cultured cell studies 
accounts for a sizeable increase in receptor size (of 27 IcDa). In order to test whether import 
was affected by the EGFP fusion, control experiments would need to be pel formed with 
untagged receptor molecules that could be subsequently detected with specific antibodies, 
prior to detection by fluoroscein-Iabelled secondary antibodies and analysis by fluorescence 
microscopy. Although these studies were attempted, non-specific background masked any TR 
specific detection, and time constraints did not allow optimisation. Alternatively, EGFP 
constructs could be utilised in Xenopus oocytes. However, due to the pigmentation of the cell 
and auto-fluorescence of the yolk pigments, it would be necessary to detect receptor 
localisation by manual dissection of oocytes and subsequent immunoblotting. Interestingly, 
addition of a tag 3 IcDa larger than GFP, GST, to TR produces a fusion protein that has been 
shown to be similarly distributed to TR in Dr L. A. Allison's laboratory (College of William 
and Mary; personal communication). 
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Addition of a GFP tag may alter other properties of TRa or C122A, apart from size. 
In particular, DNA binding, hormone binding, and transactivation of gene expression need to 
be assessed, in order to determine whether altered distribution or transport characteristics 
could be attributable to factors other than size of receptor molecules. Data obtained in Dr L. 
A. Allison's laboratory (College of William and Mary) by electrophoretic mobility shift 
assays (EMSA) show that EGFP-tagged TRa binds a TRE, although there is no hormone 
binding data at present (personal communication). 
The substantially increased receptor size raises the likelihood that nuclear import is 
affected by the increased molecular weight (discussed in Section 2.4.4). In addition, whilst 
isolating the NM-IF to investigate whether TRa and C122A associate with nuclear matrix, it 
was observed that a fraction of both TRa and C122A, with and without GFP tags, was 
isolated with the soluble proteins of the cytoplasm, the polyribosomes, and the cytoskeleton. 
Therefore it is possible that a population of receptor is present in the cytoplasm of cultured 
cells that is not visible by fluorescence microscopy, or that it represents newly synthesised 
protein just released from the ribosomes. Alternatively, the fractionation procedure may not 
have produced very clean fractions. Verification of receptor localisation with confocal 
microscopy and laser imaging would be appropriate, as a three dimensional image through the 
cell is obtained at a greater resolution than is possible with 35 mm photography through a 
fluorescent microscope. 
2.4.2 Localisation of TR is not solely dependent upon DNA binding in Xenopus oocytes 
Nuclear accumulation of proteins can be separated roughly into two general classes 
(reviewed in Nigg, 1990), although these are not mutually exclusive. The first contains those 
proteins that are localised to the nucleus by a signal-directed mechanism and targeted to sites 
of action. Proteins in the second class enter the cell nucleus by passive diffusion and are 
retained in the nucleus by associations with nuclear proteins or complexes, through selective 
binding. Due to the constitutive DNA localisation of TR reported in somatic cells (Perlman et 
aI., 1982; Kumara-Siri et al., 1986; Horowitz et al., 1989; Puymirat et al., 1989; Macchia et 
al., 1992; Lee and Mahdavi, 1993), the mechanism of nuclear accumulation of TR has not 
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been previously investigated. Therefore, nuclear accumulation of TR in Xenopus oocytes 
could be due to signal-directed import and association with DNA or it may be due to passive 
diffusion and retention by association with nuclear factors or specific retention sites. In 
Xenopus oocytes, no significant difference is observed between the distributions of wild type 
TR isoforms and DNA-binding mutant C122A. This suggests that nuclear accumulation may 
be due, in part, to retention by association of TR with binding sites, other than DNA, in the 
cell nucleus. In light of these observations for TR, it is interesting to note that nuclear 
localisation and tight binding of GR to nuclei is affected by DNA binding (Sackey et al., 
1996). Other sites for nuclear retention could include components of the nuclear matrix 
(discussed in Section 2.4.4), as has been reported for other members of the NHR superfamily 
(described in Section 2.1.3). 
C122A is excluded from the nucleus whereas TRa is intranuclear in cultured 
NllI 3T3 cells. If nuclear import of TRa is by a facilitated mechanism in NllI 3T3 cells, then 
disruption of an NLS in the DBD, by the mutation at position 122, might prevent import. 
However it seems unlikely that such a disruption would occur, although it cannot be 
eliminated, as the only NLS identified in wild type TRa to date is found further towards the 
carboxyl terminal (Dang and Lee, 1989; Lee and Mahdavi, 1993), as is the case for TR~ (Zhu 
et al., 1998). The localisation of C122A to Xenopus oocyte nuclei and its exclusion from Nlli 
3T3 nuclei indicates again that cellular context is important in receptor distribution. Different 
cellular contexts have been shown to be associated with varying GR and MR distributions. 
Immunocytochemical studies showed that, independent of ligand binding, MR was nuclear in 
rabbit kidney cells (Farman et aI, 1991), and that unliganded GR was nuclear in chinese 
hamster ovary (CHO) cells (Sanchez et al., 1990). In contrast, unliganded GR and MR 
remained cytoplasmic in rat neurons (Fuxe et al., 1985; Wikstrom et al., 1987; Rossini and 
Malaguti, 1994; Almer et al., 1995) and over-expressing Sf9 insect cells and mouse 
macrophages (Robertson et al., 1993). There are several possible reasons for this variation. 
Firstly, unspecified cytoplasmic factors responsible for C122A transport may be absent in 
NllI 3T3 cells. This possibility seems unlikely as C122A is a synthetic mutant, varying in 
only one amino acid residue, and it would be expected that transpOli occurs through the saine 
factors as those responsible for wild type TR~ transport. Secondly, the binding specificity of 
these transport factors may vary between cell types; such that, whilst C is recognised 
76 
and transport is aided in oocytes, the factors in cultured mammalian cells may not recognise 
the mutated TR~ receptor. Thirdly, anchoring factors that associate with C122A may be 
present in Xenopus oocytes and to a greater degree in NIH 3T3 cells. However, if this is the 
sole reason for the 100% cytoplasmic localisation of C122A in NIH 3T3 cells, then it is 
unlikely that T 3 would playa role in anchor release as suggested in oocytes, due to a lack of 
observable effect when NIH 3T3 cells were incubated in 10-3 M hormone (discussed further 
in Section 2.4.3). 
Further aspects of the cellular environment to consider are the nuclear retention sites, 
not including DNA, as C122A does not bind DNA. Yamamoto and Albelts proposed a 
two-site DNA model for NHR action (reviewed in Nigg, 1990). It was proposed that NHRs 
associate with a large number of low affinity sites in the nucleus, and a smaller number of 
high affinity sites. In addition, specific binding to these higher affinity sites would be masked 
by the large number of low affinity sites. This model could be applied to TR, suggesting that, 
while DNA binding is observed, TR may also associate with a number of other sites with 
varying degrees of affinity. Modulation of the receptor by hormone binding may in turn 
increase the number of sites for potential binding, or may result in a rearrangement of TR 
distribution amongst these sites due to altered affinities (refer Section 2.4.3). The 
confOlmation of nuclear binding sites or the accessibility of these sites may also be more 
available in oocytes, allowing a closer association of receptor with these retention sites. These 
sites may be present in a less accessible conformation in cultured mammalian cells, if they are 
in fact present. If nuclear localisation is dependent upon binding to retention sites, then lack of 
association with sub nuclear compartments could conceivably lead to egress of C122A from 
the nucleus. However, it appears unlikely that C122A reaches the nuclear compartment in 
NIH 3T3 cells in any great concentration as no receptor was detected in the nuclear fractions 
during the isolation ofNM-IFs (refer Section 2.4.4). 
In order to test whether C122A is not retained in the nucleus, or whether it is simply 
not imported in cultured NIH 3T3 ceIls, specialised microinjection equipment for use with 
cultured cell lines would need to be utilised. C122A could be introduced to the nuclei of 
NIH 3T3 and other suitable cell lines by microinjection. Distribution of receptor could be 
detelmined with the use of EGFP tags or through antibody detection as discussed in the 
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previous section. Export of receptor from the cell nucleus would be identified, supporting the 
proposal that there are insufficient, if any, binding sites available rather than a lack of specific 
transport factors. 
Lastly, factors may be present in the oocyte that aid in association of receptor 
molecules with retention sites. Presumably, these factors would be absent or present in 
reduced levels in Nlli 3T3 cells, or would be unable to recognise the mutated C122A whilst 
retaining the ability to recognise TRa. 
2.4.3 Influence ofT3 hormone binding on receptor localisation 
The incubation of Xenopus oocytes in T3 resulted in a significant shift of TRa, TR~, 
and C122A to the nuclear compartment in both nuclear and cytoplasmically injected oocytes. 
However, v-ErbA distribution remained unaffected by addition of hOlmone. This observation 
was expected as mutations in the v-ErbA HBD render it unable to bind T3 at physiological 
levels. 
The shift of TRa, TR~, and C122A induced by T3 suggests several possibilities for 
the role T3 plays in receptor distribution. Firstly, it seems likely that hOlmone binding allows 
receptor molecules to associate with additional nuclear binding sites. The increased affinity 
for these sites may be due to the alteration in receptor conformation induced by the hormone 
binding (Toney et al., 1993), making the sites more accessible and therefore allowing a closer 
association of receptor with these retention sites. In support of this idea, it was recently 
reported that T3 induced an enhanced rate of translocation of EGFP-tagged TR~ to the nuclei 
of CV1 cells (Zhu et al., 1998). Mutation of the Lys-Arg residues (184-185) of this TR~-GFP 
chimera to Ala-Ala blocked this hOlmone induction. An alternative role for hOlmone could be 
in the release of TR from a cytoplasmic anchoring protein, as is the case for GR, AR, and MR 
(Yang and DeFranco, 1994). 
Distribution of TRa::EGFP and C122A::EGFP is not influenced by addition of 
hormone to cultured Nlli 3T3 cells. Therefore, whilst T3 binding may not be necessary for 
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nuclear import of TR in cultured cells, it appears to play a role in nuclear import of TRa, 
TRP, and C] 22A in Xenopus oocytes. Further analysis of TRa and C 122A receptors in 
cultured cells with confocal microscopy might indicate any fine alterations in distdbution 
within the cellular compartment (nuclear or cytoplasmic, respectively) of hormone-treated 
cells. Alternatively, indirect analysis of fixed cells with antibodies could be pelionned 
although this would be less sensitive. Thirdly, as discussed in the previous section, anchoring 
factors that associate with C122A may be present in Xenopus oocytes and to a greater degree 
in NIH 3T3 cells. 
2.4.4 Sub nuclear distribution of receptors in cultured mammalian cells 
A nuclear accumulation model has been proposed, based on binding of proteins to 
'quasifunctional binding sites', allowing gene regulation at the level of organisation of the cell 
nucleus (reviewed in Bonner, 1978). This model proposed that the measured binding of a 
protein in a cell nucleus may not be its ultimate functional binding, but rather reflects binding 
to low affinity sites prior to association with control sites. Alternative sites for nuclear 
retention, apart from DNA binding sites, could include components of the nuclear matrix, as 
has been reported for other members of the NHR superfamily. Association of ER and GR 
with the nuclear matrix has been detected (Alexander et aI., 1987; van Steensel et al., 1995). 
Receptors that bound T3 were isolated from the nuclear matrix of cultured GC cells by 
photoaffinity labelling of receptors by [125I]_T3 (Kumara-Siri et aI., 1986). In the 
investigations described in this thesis, subpopulations of both TRa and TRa::EGFP were 
isolated from the NM-IF fractions of TRa and TRa::EGFP transfected cells. Therefore, these 
results support an association of TRa with the nuclear matrix of NIH 3T3 cells. 
No cytoplasmic population of EGFP-tagged receptor was observed in living cells 
although TRa molecules (wild type and EGFP-tagged) were distdbuted throughout 
fi'actionated transfected cells when analysed by immunoblotting. Up to 60% of receptor was 
observed associated with the cytoskeleton, polyribosomes and soluble cytoplasmic proteins. 
However, it must be remembered that the biochemical fractionation experiment was 
performed only once and did not have internal controls for all the fractionation steps. No 
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cycloheximide was added to the growth medium to mTest protein synthesis prior to 
fractionation of the cells, as in the case of living cell studies. Therefore, newly synthesised 
protein would be present within the cytoplasmic fractions that had not yet been localised. 
FUliher, as western analysis is more quantitative than observation of living cells by 
fluorescent microscopy, it is feasible that a small diffuse cytoplasmic pool of receptor in 
living cells might remain undetected. Indeed, suppOli for the existence of a cytoplasmic fOlTn 
of receptor was provided recently when a TR~-GFP chimera was shown to be present in both 
the nuclear and cytoplasmic compmiments by confocal microscopy (Zhu et al., 1998). 
Similar concentrations of TRa and TRa: :EGFP were present in the nuclear fractions 
of biochemically fractionated cells when compared with the amount of total protein contained 
within each fraction. Although replicates of this experiment were not performed, these initial 
studies suggest that it is unlikely that localisation of TRa to the nuclei of Nlli 3T3 cells is 
affected by the increased moleculm' size of the EGFP-tagged receptor. 
The distributions of un tagged and EGFP-tagged C122A detected by antibody were the 
same and their distribution was consistent with that of C122A::EGFP in living cells (Section 
2.3.3). Receptor was only isolated from the cytoplasmic fractions of the cells, as was the case 
for EGFP-tagged C122A in living cells (Section 2.4.2). No C122A was associated with the 
chromatin, histones, or the NM-IF fraction. This finding suggests a role for DNA binding in 
receptor localisation. However, it must be cautioned that disruption of the DBD may also 
cause disruption of other regions necessary for correct cellular localisation (discussed further 
in Section 3.4.1 with respect to NLSs). 
2.4.5 v-ErbA associates with hsp90 
Rabbit reticulocyte lysate has been used for the coupled in vitro 
transcription/translation of a variety of proteins (Murdoch and Allison, 1996; Nagl et al., 
1997). This reticulocyte lysate also contains a multiprotein system that complexes NHRs with 
endogenous hsp90 (Dittmar et al., 1996). As discussed in Section 2.1.4, association with 
hsp90 renders the NHR unable to bind DNA. Due to this association, the NHR HBD is 
80 
transformed to an open hormone-binding conformation. Only after hormone binding and 
transformation of the NHR to an open DNA binding conformation, may the receptor be 
released from the cytoplasmic anchoring complex. It has been proposed that association of 
NHR with hsp90, rendering receptor unable to bind DNA, directly affects the cellular 
localisation of the receptor in a hormone-free environment (Dalman et al., 1990). Whilst 
v-ErbA has been shown to associate with hsp90, TR has not (Section 2.1.4). 
A difference between the distributions of TR (including both isoforms and the TR~ 
mutant, C122A) and v-ErbA is observed in Xenopus oocytes (discussed in Section 2.4.1). 
Whilst approximately 40% of TR is found in the nuclei of Xenopus oocytes, only 20% of 
v-ErbA is localised to the nucleus. As rabbit reticulocyte lysate, in which receptors were 
translated in vitro, contains hsp90 (Dittmar et al., 1996), the ability of v-ErbA to complex 
with hsp90 may account for the difference in distribution between TR and v-ErbA in the 
oocyte system. As v-ErbA can complex with predominantly cytoplasmic hsp90, the receptor 
could be anchored in immobile complexes in the cytoplasmic compartment and would 
therefore not be free to enter the nucleus through the NPCs until dissociation of hsp90 from 
receptor occurred. 
Association of v-ErbA with hsp90 in the in vitro translation mixture was confirmed. 
Although the presence of this complex was verified, it was not determined whether hsp90 was 
responsible for anchoring v-ErbA in the oocyte cytoplasm. In order to pursue this line of 
reasoning, an expression vector for v-ErbA would need to be introduced into the oocyte 
nucleus for the endogenous production of receptor as opposed to the introduction of 
exogenous protein formed in the presence of hsp90. Isolation of the receptor from oocyte 
homogenates and analysis according to the protocol described in Section 2.2.6 for the 
translation mixture, would allow the effects of hsp90 present in rabbit reticulocyte lysate to be 
assessed. Although the presence of hsp90 in Xenopus oocytes has been suggested (Uzawa et 
a!., 1995; Heikkila et a!., 1997), the concentration of a pool of hsp90 is unlikely to be 
consistent with that contained within the reticulocyte lysate mixture. Therefore, variation in 
endogenous-produced receptor localisation from that of introduced receptor might be 
indicative of hsp90 interactions and subsequent cytoplasmic retention. 
81 
Chapter 3 
Nucleocytoplasmic Transport of the 
Thyroid Hormone Receptor and Variants 
3.1 Introduction 
TR and its variants are not constitutively localised to the nuclei of Xenopus oocytes, as 
presented in Chapter Two. This novel finding suggests that nuclear localisation of receptor 
may not be due entirely to DNA bindIng (supp0l1ed by the nuclear accumulation of 
DNA-binding mutant C122A), and therefore, a comparison of the mechanisms of transport, 
into and out of the oocyte nucleus, of TR and variants was necessary. Differences in 
nUcleocytoplasmic transport mechanisms could lead to variation in receptor availability for 
nuclear retention or export. A lack in resolution obtained through standard 
immunocytochemical staining techniques may mean that fine-tuned regulation of TR nuclear 
localisation has been missed in cultured mammalian cells. Therefore, oocytes provide a good 
system in which to manipulate the factors involved in trafficking of the receptor due to the 
difference, from the accepted dogma, in distribution, and the possibility of studying both 
imp0l1 and export in quantitative telIDS. 
This chapter addresses whether TR and variants are imp0l1ed into or exported 
from the nuclei of Xenopus oocytes by a facilitated mechanism or by passive diffusion. Whilst 
TRa, TR~, and C122A fall within the upper size limits for passive diffusion through the NPC 
(46.8 lilla, 52 lilla, and 52 lilla, respectively), v-ErbA (with the viral gag protein fusion) 
exceeds the limit (75 kDa). Comparison of the nucleocytoplasmic transport of DNA-binding 
mutant C122A with that of wild-type receptor was petiormed to assess whether the integrity 
of DBDs alters the mechanism of transport. Results obtained in oocytes are compared with 
those obtained by tagging TRa and C122A with GFP in cultured Nlli 3T3 mammalian cells. 
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3.1.1 Nucleocytoplasmic transport 
Modification of the classical model for steroid hormone action has occurred due to 
elucidation of a diversity of mechanisms regulating nucleocytoplasmic transport of different 
members of the NHR superfamily that are in opposition to the model. It was proposed in the 
classical model of steroid hormone action that cytoplasmic pools of receptor were 
translocated to the nucleus after honnone binding, and that liganded receptor is associated 
with HREs prior to activation or repression of gene transcription (reviewed in Nigg, 1990). 
However, localisation of receptors does not appear to be a static, unidirectional process, but 
instead seems to reflect shuttling of receptor molecules between the nucleus and cytoplasm. 
This dynamic situation, or nUcleocytoplasmic shuttling, involves the transport of receptor 
molecules between the nuclear and cytoplasmic compartments. Identification of the 
mechanisms that control receptor shuttling has been the focus of several studies to date 
(presented in Table 9). 
3.1.2 Nucleocytoplasmic transport of nuclear hormone receptors 
The receptor for progesterone has been shown to shuttle between the nuclear and 
cytoplasmic compartments (Guiochon-Mantel et al., 1991). Initially it was observed that 
cytoplasmic and nuclear PR monomers interacted (Guiochon-Mantel et al., 1989). This 
observation was supported by experimentation with a series of deletion mutants and 
interspecies heterokaryon formation (Guiochon-Mantel et al., 1991; 1994). Whilst import of 
PR requires energy, export is energy independent. However, PR export is not by diffusion, but 
like import it is NLS-directed (Guiochon-Mantel et al., 1994). 
Import of GR is via a facilitated mechanism (Yang and DeFranco, 1994). This process 
is energy and temperature dependent and takes place after hormone binding. In addition, 
export occurs upon hOlIDone dissociation. Nucleocytoplasmic shuttling of GR has also been 
demonstrated in heterokaryon experiments similar to those calTied out for PR (Madan and 
DeFranco, 1993). Nucleocytoplasmic transport of AR and MR also appear to take place by a 
similar process to GR, with similar requirements (Yang and DeFranco, 1994). Although VDR 
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is predominantly nuclear, a portion of receptor is found in the cytoplasm, suggesting 
nucleocytoplasmic shuttling occurs (Bidwell et al., 1994; Barsony et al., 1997). 
Table 9 - Transport of nuclear hormone receptors. 
NHR Experimental Requirements Observations References 
GR Heterokaryons Hormone binding Shuttling Madan and DeFranco, 
1993 
In vitro and in vivo Hormone binding Import Yang and DeFranco, 1994 
(dissociation from hsp90) ATP/temperature 
dependent 
In vitro and in vivo Dissociation of Export (release from Yang and DeFranco, 1994 
(dissociation from hsp90) hormone chromatin) 
In vitro export in Dissociation of Chromatin release to Yang et al., 1997 
permeabilized cells hormone low affinity nuclear 
ATP independent compartment (export 
staging area) 
AR In vitro and in vivo Hormone binding Import Yang and DeFranco, 1994 
(dissociation from hsp90) ATP/temperature 
dependent 
In vitro and in vivo Dissociation of Export (release from Yang and DeFranco, 1994 
(dissociation from hsp90) hormone chromatin) 
MR In vitro and in vivo Hormone binding Import Yang and DeFranco, 1994 
(dissociation from hsp90) ATPltemperature 
dependent 
In vitro and in vivo Dissociation of Export (release from Yang and DeFranco, 1994 
(dissociation from hsp90) hormone chromatin) 
ER Anti-oestrogen Hormone binding Shuttling Dauvois et a/., 1993 
PR Deletion mutants Not defined Shuttling of PR Guiochon-Mantel et al., 
(qualitative only) monomers 1989 
Deletion mutants and ATP Energy independent Export ofPR Guiochon-Mantel et al., 
depletion 1991 
PR Heterokaryons Energy independent Shuttling (identified Guiochon-Mantel et al., 
export but energy after 12-18 hours) 1991 
dependent import 
NLS mutants NLS required Shuttling Guiochon-Mantel et a/., 
~-galactosidase fusions (import and export) 1994 
Energy dependent 
(import only) 
Although TR is widely accepted as being constitutively nuclear in cultured 
mammalian cells (Perlman et al., 1982; Kumara-Siri et al., 1986; Horowitz et al., 1989; 
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Puymirat et al., 1989; Macchia et al., 1992; Lee and Mahdavi, 1993), a significant amount of 
chicken TR is found in the cytoplasm when transiently expressed at high levels in a rat cell 
line (Horowitz et al., 1989). This suggests that localisation of receptor may be dependent on 
the availability of saturable receptor sites in the nucleus. Further, the results presented in 
Section 2.3.2 of this thesis clearly demonstrate that approximately 60% of 
cytoplasmically-introduced receptor molecules exist cytoplasmically in Xenopus oocytes, and 
that this is not simply due to a saturation effect. Therefore, a case is made to examine the 
nucleocytoplasmic transport mechanisms involved in nuclear localisation of TR. 
3.1.3 Differentiating facilitated transport from diffusion 
Protein transpOlt cannot be categorised into facilitated or passive processes simply 
upon size. Several molecules that are smaller than the 40-60 kDa size limit for diffusion are 
actively transported. For example, histone HI (21 kDa) nuclear import was shown to be 
inhibited by chilling, energy depletion, WGA, and addition of non-hydrolysable GTP 
analogues in digitonin permeabilised cell assays (Breeuwer and Goldfarb, 1990; Kurz et al., 
1997). Calmodulin (16.8 kDa) import is inhibited by WGA and chilling, but not energy 
depletion, when assayed by tissue culture cell microinjection and permeabilized cell import. 
This suggests that calmodulin import occurs by a facilitated diffusion process and not an 
active mechanism (Pruschy et al., 1994). Although histone HI import appears to take place 
through an active, receptor-mediated mechanism, no putative NLS has been identified. In the 
case of the 41 kDa catalytic subunit of cAMP-dependent protein kinase, the protein has lysine 
and arginine residues that could comprise an NLS. However, Harootunian and colleagues 
(1993) concluded that diffusion was sufficient to explain most aspects of the subunit's 
transport. 
Interestingly, as noted earlier in this section, WGA and chilling, but not energy 
depletion inhibit nuclear import of calmodulin; thus, facilitated pathways may be fmther 
distinguished through a requirement for energy. When a combination of these three assays is 
used, passive diffusion can be characterised as being distinct from facilitated and active 
transport mechanisms. 
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As described in Section 1.2.3, facilitated transport occurs via a two step process: 
docking of cargo protein, complexed with transport factors (such as importin c:xJ~ or 
transportin), at the NPC followed by translocation through the NPC. Inhibition of docking and 
translocation can be applied to determine the general mechanism for protein transport; that is, 
to discriminate between passive diffusion and signal-directed facilitated processes. The 
requirements for protein transport, and methods of inhibition are discussed in the following 
sections (Sections 3.1.4 to 3.1.7). In addition to assays assessing energy requirement, 
temperature dependence, and WGA inhibition by binding to the nucleoporins of the NPC, 
competition assays with ribosomal protein L5 and histone HI were also used to assess 
alterations in transpOlt kinetics. 
3.1.4 Energy requirements for transport 
Controlled protein transport (facilitated transport) through the NPC may occur by an 
energy dependent process as discussed in Chapter One (Section 1.2.2). Therefore, a 
requirement for energy can be used to distinguish facilitated transport from passive diffusion 
(Newmeyer and Forbes, 1988; Richardson et al., 1988; Akey and Goldfarb, 1989). The two 
stages of transport can be separated by depletion of energy, or by chilling of the transport 
system to 4°C (Newmeyer and Forbes, 1988; Richardson et al., 1988). Transport is arrested at 
the docldng stage and may be continued by addition of energy or reversion to a physiological 
temperature. 
Although it appears that the requirement for ATP is indirect, and rather that GTP 
hydrolysis mediated by GTPase Ran and accessory proteins is necessary (as discussed in 
Section 1.2.3), depletion of ATP (which also depletes GTP) has been used to distinguish 
between passive and facilitated mechanisms. ATP can be depleted by the addition of 
hydrolysing agents to test whether transport occurs after A TP depletion. Such agents have 
been used to hydrolyse ATP and thereby characterise energy requirements during transport of 
proteins and ribonucleoprotein particles in several systems, including Xenopus oocytes 
(Bataille et al., 1990) and cells in tissue culture. There is a stringent requirement for energy 
during the transport of libosomal subunits (Bataille et ai., 1990), mRNA (Dargemont and 
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Kiihn, 1992), and viral RNPs (Kemler et al., 1994), histone HI import in PtK1 cells 
(Breeuwer and Goldfarb, 1990; Kurz et al., 1997), nucleocytoplasmic transport of GR, AR 
and MR (Yang and DeFranco, 1994), and import of PR (Guiochon-Mantel et al., 1994). In 
addition to the use of hydrolysing agents, the matrix protein of vesicular stomatitis virus 
(VSV M protein), introduced into oocytes, was shown to inhibit Ran GTPase-dependent 
transport of small nuclear RNPs (Her et al., 1997). 
3.1.5 Temperature dependence 
A further criterion for establishing the mechanism of transport is to assess temperature 
dependence of the import or export process. At low temperatures, oDe to 4°e, facilitated and 
active transport are inhibited whilst pa~sive diffusion continues, although reduced to 
approximately 90% of the normal rate (Breeuwer and Goldfarb, 1990; Kambach and Mattaj, 
1992). Lowering the incubation temperature of the cellular environment during transport 
decreases the rates of enzyme-mediated processes. 
Experimentally, chilling has been shown to inhibit facilitated nuclear import of a 
variety of karyophilic proteins (reviewed in Wagner et al., 1990; Murdoch and Allison, 1996), 
including nucleoplasmin in tissue culture cells (Richardson et al., 1988), histone HI 
(Breeuwer and Goldfarb. 1990; Kurz et al., 1997), and calmodulin (Pruschy et al., 1994). 
Nuclear export of ribosomal subunits (Bataille et al., 1990), signal recognition particle RNA 
(He et al., 1994), and U snRNAs (Jalmolowski et al., 1994) al'e also temperature dependent 
processes. As discussed in Section 3.1.2, nucleocytoplasmic transport of some members of 
the NHR superfamily is inhibited by low temperature incubations. In contrast, small proteins 
lacking NLSs diffuse through the nuclear pores regardless of temperature (Breeuwer and 
Goldfal'b. 1990). 
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3.1.6 Competition assays 
Another approach to block nucleocytoplasmic import is to use a competitive inhibitor 
of facilitated or active protein import. Experiments performed in situ suggest that whilst some 
U snRNPs may be imported by alternative pathways, the majority of karyophilic proteins are 
imported by a shared pathway and therefore interact with the same import receptor complexes 
(Michaud and Goldfarb, 1992; 1993). Therefore, as active and facilitated transport of proteins 
are saturable processes, they are sensitive to competition by other substrates that follow the 
same pathway, such as histone HI (Breeuwer and Goldfarb, 1990; Harootunian et al., 1993; 
Kurz et al., 1997). The nuclear import of rhodamine (rd)-nucleoplasmin was somewhat 
inhibited by excess histone HI (810 flM), and fluoroscein-labelled histone HI (24 flM) by an 
equivalent concentration (24 flM) of unlabelled histone HI (Breeuwer and Goldfarb, 1990). 
3.1. 7 Inhibition of transport by wheat germ agglutinin 
The cytosolic factors required for docking, discussed in Section 1.2.3, are distinct 
from those necessary for translocation (reviewed in Davis, 1995). The second stage of 
transport, or translocation, can be inhibited by a variety of agents; for example, addition of 
wheat genn agglutinin (WGA) or anti-FG nucleoporin repeat antibodies (nucleoporins 
containing highly repetitive repeats of the amino acids phenylalanine (F) and glycine (G): 
reviewed in Davis, 1995), Ran GTPase-inhibiting VSV M protein (Her et al., 1997), 
dominant-negative mutants of importin ~ that bind to the NPC but not to Ran (Kutay et al., 
1997), and non-hydrolysable analogues of GTP (Breeuwer and Goldfarb, 1990; Kurz et al., 
1997). 
WGA is a plant-derived lectin that was originally shown to inhibit the ATP-dependent 
release of ribonucleoproteins in isolated rat nuclei (Baglia and Maul, 1983) and has now been 
used extensively in transport studies. Lectins are substances that bind to N-acetylglucosamine 
residues (GlcNAc) on glycoproteins. Nucleoporins, which are essential components of the 
NPC, with respect to stmcture and function, are glycoproteins with GlcNAc joined by 
O-linkages to the polypeptide backbone (Holt et al., 1987). Various lectins have been tested 
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for their ability to bind to the NPC (Baglia and Maul, 1983; Finlay et al., 1987; Gerace, 
1992). Fluorescently labelled WGA and another lectin, concanavalin A (Con A) were shown 
to bind to the periphery of nuclei in a punctate staining pattern, consistent with the lectins 
binding to nuclear pores (Finlay et al., 1987; Yoneda et al., 1987). However, only WGA 
inhibited the nuclear import of nucleoplasmin. WGA has a high affinity for clusters of 
GlcNAc residues. Further to the studies with fluorescently-Iabelled WGA, it has been 
demonstrated through the use of gold-conjugated WGA (Akey and Goldfarb, 1989; Pante and 
Aebi, 1994) and ferritin-labelled WGA (Finlay et al., 1987; Allen, 1990) that WGA binds to 
the central region of the NPC. In the latter study, WGA conjugated to ferritin was observed 
bound to fibrous material at the pore margins in cultured mammalian cells. 
Subsequently, inhibition of nucleocytoplasmic transport by WGA has been shown to 
occur in vivo in both Xenopus oocytes (Dabauvalle et al., 1988) and in cultured cells (Yoneda 
et al., 1987; Wolff et al., 1988). Although WGA blocks the uptake of a variety of karyophilic 
proteins independent of their molecular weight, importantly, WGA-induced inhibition of 
nucleocytoplasmic transport has been shown to be specific for facilitated transport processes 
(Dabauvalle et al., 1988). WGA does not simply block the I\TPC, preventing all transport. 
Passive diffusion of small fluorescently labelled dextran molecules has been shown to 
proceed at the same rate through the NPC in the presence and absence of WGA (Y oneda et 
al., 1987; Dabauvalle et al., 1988; Wolff et al., 1988). Transport of a range of molecules in 
Xenopus oocytes has proved sensitive to WGA inhibition. These include import of the UI-U6 
snRNAs (Fischer et al., 1991; Michaud and Goldfarb, 1992), 5S RNA and ribosomal protein 
L5 (Allison et al., 1993; Murdoch and Allison, 1996), calmodulin (Pruschy et al., 1994), and 
histone HI (Kurz et al., 1997), and the export of ribosomal subunits (Bataille et al., 1990) and 
signal recognition particle RNA (He et al., 1994). 
3.1.8 Summary of results 
This chapter addresses the nucleocytoplasmic transport of thyroid hormone receptor 
isoforms, a and ~, as well as the viral oncogenic variant, v-ErbA, and the in vitro-generated 
DNA-binding mutant, C122A, in Xenopus oocytes. Import and export were assessed in 
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oocytes by microinjection of eSS]-methionine-labelled protein. The results presented in this 
chapter demonstrate unexpected and novel findings. 
Import of TR and variants was assessed by chilling, competition, WGA, and apyrase 
(ATP depletion) assays in oocytes, whilst chilling assays alone were performed for export. 
Imp0l1 of both TR isoforms and mutant C122A was shown to occur by a passive diffusion. 
However, import of ribosomal protein L5, a protein known to be facilitatively transported, 
was inhibited by chilling, energy depletion, lectin binding, and competition assays. In contrast 
to import, exp0l1 of TRa, TR~, and C122A was temperature dependent, indicating that efflux 
of these receptors was not by diffusion. In addition, import and export of v-ErbA (which is 
larger in size due to its fusion to viral gag protein), was inhibited by chilling, competition, 
WGA, and ATP depletion. 
Transport of EGFP-tagged receptors in transfected mammalian cells, was also tested. 
These receptors, whilst being larger than the unlabelled receptor molecules due to the fusion 
with GFP protein, were expressed in the mammalian cell system (as presented in Section 
2.3.3). TRa::EGFP remained nuclear during chilling and energy depletion assays, suggesting 
that import of receptor synthesised before commencement of these assays was not inhibited 
(or was not at a detectable level) and that export of receptor by passive diffusion was not 
occurring. C122A remains cytoplasmic, even under conditions of chilling and ATP depletion. 
Potential reasons for the difference in observations between these two systems is discussed, as 
well as the implications of the passive transp0l1 mechanism observed for TR in Xenopus 
oocytes. 
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3.2 Materials and Methods 
3.2.1 Plasmids 
The plasmids used in the determination of receptor distribution in Xenopus oocytes 
were also utilised for Xenopus nucleocytoplasmic transport studies. A description of these 
plasmids, pB S-rTRa 1 , pGEM-TR~l, pGEM-Cl22A, pGEM-v-erbA, and pSP6-LS, is 
contained in Section 2.2.1. 
The EGFP fusion plasrnids for TRa and C122A, as well as wild-type EGFP, 
described in Section 2.2.1 for the receptor distribution studies in transfected mammalian cells, 
were also used in these nUcleocytoplasmic transport studies. EGFP fusion plasrnids for TR~ 
and v-ErbA were not used in these transpOli studies, as they could not be generated, as 
discussed in Section 2.2.1. 
3.2.2 Characterisation of receptor transport in Xenopus oocytes 
In vitro synthesised proteins were prepared, by coupled transcription/translation in 
rabbit reticulocyte lysate (Promega) supplemented with [35S]-methionine (Life Technologies), 
for transport studies in Xenopus oocytes, as described in Section 2.2.2. Oocytes were 
surgically removed from female adult Xenopus laevis and prepared for experimentation as 
described in Section 2.2.3. Microinjections were performed as described in Section 2.2.3 and 
oocytes treated as described in the assays below. Treatments for experiments performed in 
Xenopus oocytes are summarised in Table 10. 
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3.2.3 Chilling assays in Xenopus oocytes 
To assess temperature dependence, oocytes pre-chilled on ice, at 0-4°C for 30 
minutes, were microinjected with in vitro synthesised protein. Oocytes were not maintained 
on ice during the injection process, and therefore the number of oocytes injected at one time 
was reduced to give a maximum time of three minutes away from chilled conditions. 
Post-injection, oocytes were incubated on ice at 0-4°C, for six hours. As controls to ensure 
that each batch of oocytes was metabolically active, injected oocytes were also incubated at 
18-20°C for the same period, or for six hours on ice followed by six hours at 18-20°C, in order 
to determine whether physiological temperatures could restore transport competency. After 
incubation, nuclei were dissected in ice-cold NIM and extracted protein was assayed for 
nuclear import, as described in Section 2.2.4. 
3.2.4 ATP depletion and WGA assays in Xenopus oocytes 
ATP depletion, WGA, and competition assays were only performed for import in 
Xenopus oocytes, due to deterioration in the supply of healthy Xenopus frogs and 
subsequently their oocytes. Relocation of the frogs to a vivarium containing mice and rats, as 
well as a change in the frequency and type of diet, was followed by susceptibility of the 
Xenopus to several fungal and nematode infections. Experimentation was not undertaken 
during treatment of infections, and limited replicate experiments were performed after the 
relocation. ATP depletion assays were performed according to existing laboratory protocols 
with some modification (Allison et ai., 1993; Murdoch and Allison, 1996). Oocytes were 
preinjected with apyrase (Grade VIII, Sigma Chemical Co.) 30 minutes prior to 
microinjection of in vitro synthesised proteins. Fifty nanolitres of 1 U/fll apyrase, dissolved in 
PBS, was delivered to give an intracellular concentration of 100 U/ml, which has been shown 
to deplete ATP in a previous study undertaken in this laboratory (Allison et ai., 1993). After 
six hours incubation at 18-20°C, oocytes were manually dissected and assayed as described in 
Section 2.2.4. 
Wheat germ agglutinin assays were also carried out according to established 
laboratory protocols, with the modification of buffers as described above (Allison et ai., 1993; 
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Murdoch and Allison, 1996). Fifty nanolitres ofWGA (lectin, from Triticum vulgaris; Sigma) 
dissolved in PBS, or PBS as a control, were injected to give a final intracellular concentration 
of SOO J-lg/ml, three hours prior to microinjection of protein. After introduction of protein and 
incubation for six hours at 18-20DC, oocytes were assayed for nuclear import. 
3.2.5 Histone HI and ribosomal protein L5 competition assays in Xenopus oocytes 
Two concentrations of histone HI (Boehringer Mannheim) were initially trialled for 
inhibition of protein LS facilitated impOli, based upon the concentration of 810 J-lM used by 
Breeuwer and Goldfarb (1990). Histone HI was microinjected into oocytes to give final 
intracellular concentrations of 7S0 J-lM and 900 J-lM (designated low histone HI, LHI or 
[low], and high histone HI, HHI or [high],-respectively). The effect of the introduced histone 
HI was assessed to determine whether the concentrations fell within an inhibitory range, by 
dissection of oocytes after six hours incubation at 18-20DC and analysis as detailed in Section 
2.2.4. Subsequently, these concentrations were used in the studies of TRa, TR~, C122A, and 
v-ErbA. 
Ribosomal LS was also used as a competitor in experiments similar to those 
perfOlmed with histone HI. Equal quantities of eSS]-methionine-labelled LS and unlabelled 
LS (1 ng of each per SO nl delivery) were introduced into each Xenopus oocyte. The 
concentration of unlabelled LS in the translation mix was determined by comparison with 
labelled LS. The two forms ofLS were separated by PAGE and visualised by Coomassie Blue 
staining, as unlabelled LS could not be detected by autoradiography. The gels were incubated 
in five volumes of stain (0.2S% Coomassie brilliant blue R-2S0; SO% methanol; 10% acetic 
acid) for four hours with shaking, at room temperature. After the removal of the stain, the gel 
was destained by successive incubations in destain solution (S% methanol; 7.S% acetic acid), 
prior to photography with a Nikon 3S mm camera. The subcellular distribution of 
microinjected, eSS]-labelled LS, with and without coinjection of unlabelled LS, was 
determined by analysis and autoradiography as described in Section 2.2.4. Subsequent 
coinjections of labelled LS were made with TRa, TR~, C122A, and v-ErbA, prior to analysis 
as described (Section 2.2.4). 
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Table 10· Transport inhibition treatments in Xenopus oocytes. 
Treatment Effect Incubation 
Wheat germ agglutinin Inhibits facilitated transport, Three hours preinjection, 
binds GlcNAc-NPC proteins six hours at 18-20°C 
Chilling Inhibits facilitated transport Six hours at 0-4°C 
Six hours at 0-4°C/18-20°C 
Apyrase Inhibits facilitated transport, Thirty minutes preinjection, 
ATP depletion six hours at 18-20°C 
Histone H1 (H1) Competitor for general facilitated Coinjection, 
protein import pathway six hours at 18-20°C 
3.2.6 Chilling and ATP depletion assays in cultured mammalian cells 
NIH 3T3 cell cultures were maintained and prepared for experimentation as described 
in Section 2.2.7. Transfections were pelformed with the EGFP fusion vectors, EGFP: :TRa 
and EGFP::C122A as well as wild type EGFP, as described in Section 2.2.8. The incubation 
medium was removed 24-48 hours post-transfection and cells were washed in D-PBS. The 
medium was replaced with medium containing SO J-Lg/rnl cycloheximide for 30 minutes to 
prevent protein synthesis. This was necessary to ensure that any cytoplasmic protein observed 
was not freshly synthesised, and had therefore had insufficient time to be localised. A further 
replacement was made with cycloheximide-containing medium, as detailed in Table 11, and 
cells were incubated at 37°C/S% CO2:9S% air, or O°C as shown, for the time indicated prior to 
visualisation. Glucose minus DMEM, with a non-hydrolysable analogue of glucose, 
2-deoxyglucose (Sigma), and a metabolic inhibitor, oligomycin (types A, B, and C; Sigma), 
were used in energy depletion experiments. Cells were observed under bright field, 
fluorescence, and a combination of both conditions with a Leitz Orthoplan fluorescence 
microscope (as described in Section 2.2.9). 
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Table 11· Transport assays in cultured NIHl3T3 cells. 
Assay Culture medium Treatment I Incubation 
ATP depletion DMEM (pyruvate/glucose 6 mM 2-deoxyglucose Four hours 
minus) 50 I-1M oligomycin 
ATP control complete DMEM 37°C Four hours 
Chilling complete DMEM OAoC Three hours 
Chilling control complete DMEM 37°C Three hours 
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3.3 Results 
The following results are presented separately according to the cell type in which the 
experiments were pelformed. Sections 3.3.1 to 3.3.5 describe the results of transport studies 
carried out in microinjected Xenopus oocytes. The results of low temperature incubations on 
import and export ofTRa (46.8 kDa), TR~ (52 kDa), C122A (52 kDa), and v-ErbA (75 kDa) 
are presented in Sections 3.3.1 and 3.3.2 (and jointly displayed in Figures 3.1 to 3.5). Results 
for the competition assays with ribosomal protein L5 and histone HI are given in Sections 
3.3.4 and 3.3.3 (and jointly displayed in Figures 3.6 to 3.10), whilst ATP depletion and WGA 
inhibition assays are presented in Section 3.3.5. Data obtained from the transfection of NIH 
3T3 cells with EGFP-tagged TRa and C122A are displayed in Sections 3.3.6 and 3.3.7. The 
former describes the results for low temperature incubations and the latter contains the results 
for ATP depletion studies in NIH 3T3 cells. Results for nucleocytoplasmic transport studies 
for Xenopus oocytes and cultured NIH 3T3 cells are summarised in Table 13 and Table 14, 
respectively. These tables also contain the probability values for t-tests carried out between 
data sets. 
3.3.1 Import ofTRa; TRj3, and C122A in Xenopus oocytes is temperature independent 
Facilitated transport is inhibited in chilled cells whilst passive diffusion is not 
(described in Section 3.1.5). Therefore, to determine through which mechanisms nuclear 
import of TR and its variants occur, pre-chilled Xenopus oocytes were cytoplasmically 
injected with in vitro synthesised e5S]-methionine-labelled receptor molecules. A further 
incubation at OAoC was carried out for five to six hours post-injection to determine whether 
receptor transport was inhibited by low temperature incubations. As a control to assess the 
continuing viability of the cell environment, the chilled oocytes were returned to 
physiological temperatures after low temperature incubations to determine whether nuclear 
import was restored for the proteins affected by chilling. 
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Surprisingly, nuclear import of TRa did not appear to be inhibited by incubation of 
oocytes on ice at 0-4°C (Figure 3.1). Analysis by student's t-tests confirmed this finding 
(p>O.1). Import of TR~ and C122A was also not significantly inhibited (p>O.l) by chilling 
(Figures 3.2 and Figure 3.3). Although no significant inhibition of v-ErbA import by chilling 
was observed, great variability was observed between batches of oocytes (Figure 3.4). It was 
observed that the nuclear integrity of chilled oocytes microinjected with v-ErbA wa.'l not 
maintained to the extent of other oocytes. In addition, as such a low level of import was 
observed, it was difficult to assess significant differences between treatments. Ribosomal 
protein L5 was used as a control in these studies, as L5 has been shown to be imported to 
Xenopus nuclei by a facilitated process (Murdoch and Allison, 1996). Inhibition of ribosomal 
protein L5 nuclear import by chilling was observed as expected (Figure 3.5). Analysis by 
Student's t-tests suppOlted this inhibition effect (p<O.OOl). Competence of L5 import was 
restored when oocytes were further incuba~ed for six hours at 18-20°C (Figure 3.5 and Table 
13). 
3.3.2 Chilling inhibits TR a export in Xenopus oocytes 
Due to the size of Xenopus oocytes it is possible to microinject in vitro synthesised 
proteins directly into the nuclear compaItment, in order to investigate their nuclear export 
characteristics. As nuclear export of TR has not been demonstrated prior to the 
investigations contained in this thesis (Section 2.3.2), TRa and TR~, C122A, v-ErbA, and 
L5 were introduced into Xenopus oocytes and export was assessed. 
Approximately 62% of TRa was retained in the nuclear comprutment of Xenopus 
oocytes (Figure 3.1), indicating that export of a subpopulation of TR (38%) can occur. A 
proportion of TR~ and C122A was also exported, showing cytoplasmic distributions of 
26% and 28% respectively, as presented in Figures 3.2 and 3.3. However, v-ErbA was 
retained in the nucleus to a greater extent as shown in Figure 3.4. Approximately 23% of 
v-ErbA was localised to the cytoplasmic fractions of Xenopus oocytes. 
Figure 3.1. The effect of chilling on the nuclear import ofTR ain Xenopus oocytes. 
A. Approximately 100 picograms of in vitro synthesised [35SJ-methionine labelled TRa were 
introduced into each oocyte by microinjection. Oocytes were incubated at 18-20°C for 
five to six hours prior to manual dissection of the oocytes into cytopla",mic (C) and nuclear 
(N) fractions. As a control, oocytes were returned to physiological temperatures after low 
temperature incubations to determine whether nuclear import was restored for the proteins 
affected by chilling (O°C+20°C). Protein was isolated from six pooled nuclear or 
cytoplasmic fractions and separated from oocyte proteins by electrophoresis on 12% 
discontinuous polyacrylamide gels containing SDS, followed by autoradiography. (To: 
initial time point performed after microinjection). A representative autoradiogram is 
shown. 
B. The percentages of nuclear accumulation from the experiments described above were 
determined by densitometry of the autoradiograms. Each graphed data point reflects 
the mean of replicate batches (n) of six pooled oocytes. The bars indicate standard 
error of the means. (TRa[20°C]: n=8; TRa[O°C]: n=4; TRa[0°C+20°C): n=3; 
TRa[20°C/nu.]: n=8; TRa[OoGnu.]: n=4). (nu.: nuclear injections) 
A 
Cytoplasmic Nuclear 
CNCN CNC NCNCN 
B 
t:: 
(1) 
-0 
"-a. 
"Of/) 
(1)~ 
=(1) (1)-
.cO m~ 
_t:: 
~t:: o ._ 
Nuclear accumulation of TRa after low 
temperature incubation of oocytes 
100% 
80% 
60% 
40% 
20% 
0% 
Treatment 
200 e 
(nu.) 
oOe 
(nu.) 
97 
Figure 3.2. The effect of chilling on the nuclear import of TR/J in Xenopus oocytes. 
A. Oocytes were microinjected with eSS]-methionine labelled TRp. Five to six hours after 
incubation at 18-20°C, protein was isolated from oocytes cytoplasmic (C) and nuclear 
(N) fractions, and analysed as described in Figure 3.1. As a control, oocytes were 
returned to physiological temperatures after low temperature incubations (O°C+20°C) to 
determine whether nuclear import was restored for the proteins affected by chilling, 
prior to dissection. (To: initial time point performed after microinjection). A 
representative autoradiogram is shown. 
B. The percentages of nuclear accumulation from replicate experiments were determined 
by densitometry of the autoradiograms. Each graphed data point reflects the mean of 
replicate batches (n) of pooled oocytes. The bars indicate standard error of the means. 
(TRP[20°C]: n=4; TRP[O°C]: n=4; TRP[O°C+20°C]: n=3; TRP[20°C/nu.]: n=3; 
TRp[O°C/nu.]: n=3) (nu.: nuclear injections) 
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Figure 3.3. The effect of chilling on the nuclear import of C122A in Xenopus oocytes. 
A. Oocytes were microinjected with eSS]-methionine labelled C122A. Five to six hours 
after incubation at 18-20°C, protein was isolated from oocytes cytoplasmic (C) and 
nuclear (N) fractions, and analysed as described in Figure 3.1. As a control, oocytes 
were returned to physiological temperatures after low temperature incubations 
(O°C+20°C) to determine whether nuclear import was restored for the proteins affected by 
chilling, prior to dissection. (To: initial time point performed after microinjection). A 
representative autoradiogram is shown. 
B. The percentages of nuclear accumulation from replicate experiments were determined 
by densitometry of the autoradiograms. Each graphed data point reflects the mean of 
replicate batches (n) of pooled oocytes. The bars indicate standard error of the means. 
(C122A[20°C]: n=4; C122A[O°C]: n=4; C122A[O°C+20°C]: n=3; C122A[20°C/nu.]: 
n=3; C122A[O°C/nu.]: n=2) (nu.: nuclear injections) 
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Figure 3.4. The effect of chilling on the nuclear import of v-ErbA in Xenopus oocytes. 
A. Oocytes were microinjected with eSS]-methionine labelled v-ErbA Five to six hours after 
incubation at l8-20°C, protein was isolated from oocytes cytoplasmic (C) and nuclear (N) 
fractions, and analysed as described in Figure 3.1. As a control, oocytes were returned to 
physiological temperatures after low temperature incubations (O°C+20°C) to determine 
whether nuclear import was restored for the proteins affected by chilling, prior to 
dissection. (To: initial time point performed after microinjection). A representative 
autoradiogram is shown. 
B. The percentage of labelled protein in the oocyte nuclei from replicate experiments was 
quantified by densitometry of the autoradiograms produced in the experiments 
described in A Each graphed data point reflects the mean of replicate batches (n) of 
pooled oocytes. The bars indicate standard error of the means. (v-ErbA[20°C]: n=9; 
v-ErbA[O°C]: n=4; v-ErbA[20°C+O°C]: n=3; v-ErbA[20°C/nu.]: n=5; v-ErbA[O°C/nu.]: 
n=4) (nu.: nuclear injections) 
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Figure 3.5. The effect of chilling on the nuclear import of L5 in Xenopus oocytes. 
A. Oocytes were microinjected with eSS]-methionine labelled L5. Five to six hours after 
incubation at 18-20°C, protein was isolated from oocytes cytoplasmic (C) and nuclear (N) 
fractions, and analysed as described in Figure 3.1. As a control, oocytes were returned to 
physiological temperatures after low temperature incubations (O°C+20°C) to determine 
whether nuclear import was restored for the proteins affected by chilling, prior to 
dissection. (To: initial time point performed after microinjection). A representative 
autoradiogram is shown. 
B. The percentage of labelled protein in the oocyte nuclei from replicate experiments was 
quantified by densitometry of the autoradiograms produced in the experiments 
described in A. Each graphed data point reflects the mean of replicate batches (n) of 
pooled oocytes. The bars indicate standard error of the means. (L5[20°C]: n=4; 
L5[O°C]: n=5; L5[O°C+20°C]: ; L5[20°C/nu.]: n=4; L5[O°C/nu.]: n=3) (nu.: nuclear 
in jecti ons) 
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A subpopulation of ribosomal protein L5 (32%) was also exported from oocyte 
nuclei (Figure 3.5). It would be expected that a population of L5 would remain nuclear as 
L5 has been implicated in the nuclear import of 5S RNA (in a complex termed 5S RNP) 
and in nuclear retention of 5S RNA in the oocyte nucleoli (A1lison et ai., 1993; Murdoch 
and Allison, 1996; North and Allison, 1997). 
The mechanism of nuclear export of the receptors was assessed by low temperature 
incubations. Replicate results and statistical analysis are presented in Table 13. TRa, TR~, 
and C122A display similar export characteristics (Figures 3.1, 3.2, and 3.3). 86% of TRa 
is retained in the nucleus and 87% of both TR~ and C122A. Although export continues at 
low temperatures, the process is significantly inhibited in all cases (p<O.OO 1 p=O.03, and 
p=O.06, respectively). Therefore, nuclear export of TRa, TR~, and C122A is temperature 
dependent. Inhibition of v-ErbA export at low temperatures was not observed for all 
batches of oocytes. In fact an increased amount of receptor (82%) is exported. As reported 
in Section 3.3.1, integrity of the nuclear membrane appeared somewhat compromised in 
chilled oocytes injected with v-ErbA. This is not unexpected as v-ErbA has been observed 
to induce nuclear breakdown in Xenopus oocytes at physiological temperatures, although 
this took at least 24 hours to be initiated (Nagl et aI., 1997). Lastly, L5 export is 
temperature dependent (Figure 3.5) and is therefore inhibited by low temperature 
incubations (p<O.OOI). 
3.3.3 Histone Hl does not inhibit TRa, TR/3, or Cl22A import in Xenopus oocytes 
As an additional criterion for characterising import of TRa, TR~, C122A, and 
v-ErbA, competition assays with histone HI and ribosomal protein L5 were performed. 
Combined results for these competition assays are presented in Figures 3.6 to 3.10. The 
rationale for these competition experiments is that import kinetics of the introduced TR 
variants would be at a reduced level if histone HI or L5, acting as direct competitors of 
facilitated processes, were impOlted by the same mechanisms as TRa, TR~, C122A, or 
v-ErbA. This reduction is due to competition for shared transport factors; that is, facilitated 
transport is saturable. 
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An excess of histone HI has been used previously to investigate import of proteins 
(Breeuwer and Goldfarb, 1990). If TRa, TR~, C122A, or v-ErbA were imported by a 
facilitated or active mechanism, a decrease in observed nuclear localisation would be 
expected after incubation for six hours. 
In order to ascertain histone HI concentrations at which inhibition of facilitated 
transport occurred, excess histone HI was competed against ribosomal L5 (0.1 ng) at two 
intracellular concentrations of 750 ~M and 900 ~M. Both concentrations were shown to 
inhibit the nuclear import ofL5 (p<O.OOI), as demonstrated in Figure 3.6 (A and D) and Table 
13. 
TRa import was not inhibited (p>q.l) by coinjection with histone HI (Figure 3.7 A), 
at both low and high concentrations of histone Hl. The excess of histone Hl did not influence 
TR~ impOlt (Figure 3.8, A and C), nor did it affect import of C122A (Figure 3.9, A and C), at 
low (p>O.l) or high histone HI levels (p>O.l). Coinjection with the higher concentration of 
histone HI resulted in inhibition of v-ErbA import (p=0.05), supporting a facilitated or active 
mechanism of nuclear transport (Figure 3.10, A and C). 
3.3.4 Competition with ribosomal protein L5 does not affect TRo:, TRj3, or C122A 
import in Xenopus oocytes 
Import of L5 is via a facilitated process and would therefore be expected to have 
similar competition effects to histone HI. As is the case with the histone HI assays (Section 
3.3.3), coinjection of a protein with the same transport pathway requirements would lead to a 
reduction in the percentage of the respective proteins being localised to the Xenopus oocyte 
nucleus. 
Figure 3.6. The effect of competing proteins on the nuclear import of L5 in Xenopus 
oocytes. 
A. Oocytes were microinjected with 100 picograms of ('sS]-methionine labelled ribosomal 
protein L5 and histone HI (to an intracellular concentration of 750 ~M or 900 ~M). Five 
to six hours after incubation at 18-20°C, protein was isolated from oocytes cytoplasmic (C) 
and nuclear (N) fractions, and analysed as described in Figure 3.1. (LHI or [low]: low 
histone HI concentration of 750 ~M; HHI or [high]: high histone HI concentration of 
900 ~M. A representative autoradiogram is shown. 
B. Oocytes were microinjected with 100 picograms of eSS]-methionine labelled ribosomal 
protein L5 and 100 picograms of unlabelled protein L5 and analysed as described in A. 
C. Coomassie blue stained gel of translation products produced in vitro. The staining 
indicates that equimolar amounts of [3sS]-methionine-labelled and unlabelled ribosomal 
protein L5 were obtained. Equal volumes of protein were used from each sample to 
compete each other in the experiments described in B. 
D. The percentages of nuclear accumulation from replicate experiments were determined by 
densitometry of the autoradiograms. Each graphed data point reflects the mean of 
replicate batches (n) of pooled oocytes, as described in Figure 3.1. Standard error of the 
means is indicated by the bars. (L5[20°C]: n=4; L5[LHl]: n=3; L5[HHI]: n=3; L5+L5: 
n=2) 
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Figure 3.7. The effect of competing proteins on the nuclear import of TRa in Xenopus 
oocytes. 
A. Oocytes were microinjected with 100 picograms of eSS]-methionine labelled TRa and 
histone H I (to an intracellular concentration of 750 JlM or 900 JlM). Five to six hours after 
incubation at 18-20oC, protein was isolated from oocytes cytoplasmic (C) and nuclear (N) 
fractions, and analysed as described in Figure 3.1. (LHI or [low]: low histone HI 
concentration of 750 JlM; HHI or [high]: high histone HI concentration of 900 JlM). A 
representative autoradiogram is shown. 
B. Oocytes were microinjected with 100 picograms of eSS]-methionine labelled TRa and 100 
picograms of ('sS]-methionine labelled ribosomal protein L5 and analysed as described in 
A. 
C. The percentages of nuclear accumulation from replicate experiments were determined by 
densitometry of the autoradiograms. Each graphed data point reflects the mean of 
replicate batches (n) of pooled oocytes, as described in Figure 3.1. Standard error of the 
means is indicated by the bars. (TRa[200C]: n=8; TRa[LHI]: n=4; TRa[HH1]: n=6; 
TRa+L5: n=3; L5: n=4) 
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Figure 3.8. The effect of competing proteins on the nuclear import of TR/l in Xenopus 
oocytes. 
A. Oocytes were microinjected with 100 picograms of eSS]-methionine labelled TR~ and 
histone HI (to an intracellular concentration of 750 11M or 900 11M). Five to six hours after 
incubation at IS-20°C, protein was isolated from oocytes cytoplasmic (C) and nuclear (N) 
fractions, and analysed as described in Figure 3.1. (LHI or [low]: low histone HI 
concentration of 750 11M; HHI or [high]: high histone HI concentration of 900 JlM) 
B. Oocytes were microinjected with 100 picograms of eSS]-methionine labelled TR~ and 100 
picograms of CSS]-methionine labelled ribosomal protein L5 and analysed as described in 
A. 
C. The percentages of nuclear accumulation from replicate experiments were determined by 
densitometry of the autoradiograms. Each graphed data point reflects the mean of 
replicate batches (0) of pooled oocytes, as described in Figure 3.1. Standard error of the 
means is indicated by the bars. (TR~[20°C]: n=4; TR~[LHI]: n=2; TR~[HHl]: n=2; 
TR~+L5:n=3;L5:n=4) 
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Figure 3.9. The effect of competing proteins on the nuclear import of C122A in Xenopus 
oocytes. 
A. Oocytes were microinjected with 100 picograms of CSS]-methionine labelled C 122A and 
histone HI (to an intracellular concentration of 750 IJ.M or 900 IJ.M). Five to six hours 
after incubation at I8-20oC, protein was isolated from oocytes cytoplasmic (C) and nuclear 
(N) fractions, and analysed as described in Figure 3.1. (LHI or [low]: low histone HI 
concentration of 750 IJ.M; HHI or [high]: high histone H I concentration of 900 IJ.M) 
B. Oocytes were microinjected with 100 picograms of C5S]-methionine labelled CI22A and 
100 picograms of CSS]-methionine labelled ribosomal protein L5 and analysed as 
described in A. 
C. The percentages of nuclear accumulation from replicate experiments were determined by 
densitometry of the autoradiograms. Each graphed data point reflects the mean of 
replicate batches (n) of pooled oocytes, as described in Figure 3.1. Standard error of the 
means is indicated by the bars. (C122A[20°C]: n=4; CI22A[LHl]: n=3; C122A[HHI]: 
n=3; CI22A+L5: n=3; L5: n=4) 
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Figure 3.10. The effect of competing proteins on the nuclear import ofv-ErbA in Xenopus 
oocytes. 
A. Oocytes were microinjected with 100 picograms of CSS]-methionine labelled v-ErbA and 
histone HI (to an intracellular concentration of 750 JlM or 900 JlM). Five to six hours after 
incubation at 18-20°C, protein was isolated from oocytes cytoplasmic (C) and nuclear (N) 
fractions, and analysed as described in Figure 3.1. (LHI or [low]: low histone HI 
concentration of 750 JlM; HHI or [high]: high histone HI concentration of 900 JlM) 
B. Oocytes were microi~Jected with 100 picograms of eSS]-methionine labelled v-ErbA and 
100 picograms of [, sS]-methionine labelled ribosomal protein L5 and analysed as 
described in A. 
C. The percentages of nuclear accumulation from replicate experiments were determined by 
densitometry of the autoradiograms. Each graphed data point reflects the mean of 
replicate batches (n) of pooled oocytes, as described in Figure 3.1. Standard error of the 
means is indicated by the bars. (v-ErbA[20°C]: n=9; v-ErbA[LHl]: n=3; v-ErbA[HHI]: 
n=3; v-ErbA+L5: n=3; L5: n=4) 
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Competition assays with L5 and individual NHRs, either TRa, TR~, C122A, or 
v-ErbA, were peliOlmed. Data obtained from replicate experiments are displayed in Table 13. 
An inhibitory concentration of ribosomal L5 was detelmined by competing equimolar 
amounts of eSS]-methionine-labelled L5 and unlabelled L5 (Figure 3.6C). Nuclear import of 
labelled L5 was inhibited (p<O.OOI) by equimolar amounts of unlabelled L5 as is 
demonstrated clearly in Figure 3.6 (B and D). 
Coinjection with L5 did not lead to an alteration in the ratio of nuclear to cytoplasmic 
distributed protein in the case of TRa (Figure 3.7B). The distributions of TR~ and C122A 
were also not observed to have been affected by coinjection of L5 (Figures 3.8B and 3.9B). 
These findings were confirmed by Student's t -tests (p>O.l; as assessed from the replicate 
experiments displayed in Figures 3.7C, 3.8C, and 3.9C). The lack of competition observed 
with L5 by TRa, TR~,. and C 122A suggests that independent mechanisms of transport are in 
operation for L5 as opposed to these NHRs. The import of v-ErbA was inhibited by 
coinjection with ribosomal protein L5 (p=0.02), with a reduction of nuclear localised protein 
from 21 % to 9% (Figure 3.10, B and C). The observations made in these ribosomal protein 
L5 coinjection studies support the observations made in the histone HI assays. 
3.3.5 WGA and apyrase do not inhibit TR import in Xenopus oocytes 
The two stages of transport can be separated by depletion of energy, or by chilling of 
the transport system to 4°C (Richardson et aI., 1988; Newmeyer and Forbes, 1988). ATP can 
be depleted by the addition of hydrolysing agents to test whether transport occurs after ATP 
depletion. Whereas ATP hydrolysis arrests transport at the docking stage, the second stage of 
transport, or translocation, can be inhibited by a variety of different agents; for example, 
addition of WGA (reviewed in Davis, 1995). WGA-induced inhibition of nucleocytoplasmic 
transport has been shown to be specific for facilitated transport processes (Dabauvalle et al., 
1988). 
Figure 3.11. The effect of ATP depletion on the nuclear import of TR ~ v-ErbA, and LS in 
Xenopus oocytes. 
A. The effect of ATP depletion on the nuclear import of TRa, v-ErbA, and LS was assessed 
by injection of oocytes with apyrase (to an intracellular concentration of 100 D/ml). After 
incubation for 30 minutes at IS-20°C, CSS]-methionine labelled protein was injected into 
the cytoplasm, prior to incubation at IS-20°C for a further five to six hours. Nuclear 
import was assessed as described in Figure 3.1. (C: cytoplasmic fractions; N: nuclear 
fractions; Apy: Apyrase). 
B. The percentages of nuclear accumulation from replicate experiments were determined by 
densitometry of the autoradiograms. Each graphed data point reflects the mean of 
replicate batches (n) of pooled oocytes. Standard error of the means is indicated by the 
bars. (TRa[20°C]: n=S; TRa[Apy]: n=2; v-ErbA[20°C]: n=9; v-ErbA[Apy]: n=3; 
LS[20°C]: n=4; LS[Apy): n=2) 
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Figure 3.12. The effect of WGA on the nuclear import of TR a; v-ErbA, and LS in 
Xenopus oocytes. 
A. Oocytes were preinjected with WGA, at an intracellular concentration of 0.5 mg/ml, three 
hours prior to injection with eSS]-labelled TRa, v-ErbA, or C122A. Five to six hours 
post-injection, oocytes were processed and analysed, as described in Figure 3.1. (C: 
cytoplasmic fractions; N: nuclear fractions; WGA: wheat germ agglutinin). 
B. The percentages of nuclear accumulation from replicate experiments were determined by 
densitometry of the autoradiograms. Each graphed data point reflects the mean of 
replicate samples (n) of pooled oocytes. Standard error of the means is indicated by the 
bars. (TRa[20°C]: n=8; TRa[WGA]: n=3; v-ErbA[20°C]: n=9; v-ErbA[WGA]: n=3; 
L5[20°C]: n::;4; L5[WGA]: n=2) 
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Injections of apyrase and WGA are harsh treatments that may affect the integrity of 
the oocytes (personal observation). Treated oocytes are susceptible to disruption of the cell 
membranes and nuclear membranes during handling. In addition, the consistency of the 
cytoplasmic compartment may become either 'paste-like' or 'crumbly' in appearance, after 
microinjection and subsequent incubation. Therefore, all oocytes were carefully selected for 
use in these studies, and those with unstable membranes were discarded. Consequently, fewer 
oocytes could be obtained and in cases where less than two batches were processed, results 
are not presented (specifically for TR~ and C122A). Actual sample numbers are indicated in 
the legends of Figures 3.11 and 3.12. 
Ribosomal protein L5 import was inhibited by both apyrase (p<O.OOl) and WGA 
(p<O.OOl), as expected for a protein transported through a facilitated process (Figures 3.11 
and 3.12, respectively). WGA inhibition reduced L5 import from 33% to 5%, with a similar 
reduction to 4% observed for energy depletion assays. A passive diffusion mechanism of TRa 
impOli is supported by the results presented in Figures 3.11 and 3.12 (A and B). Import was 
not shown to be significantly inhibited by either ATP depletion (p>O.l) or WGA preinjection 
(p>O.l). Import of v-ErbA was also not shown to be inhibited by ATP depletion (15% 
nuclear; p>O.l) and WGA (13% nuclear; p>O.l), as shown in Figures 3.11 and 3.12 (A and 
B). Although two batches of v-ErbA-injected oocytes, for each treatment, were inhibited by 
ATP depletion and WGA preinjection (from the same two frogs for both treatments), a third 
batch was not. 
3.3.6 Chilling does not affect EGFP-tagged TRa or C122A nuclear localisation in 
cultured NIH 3T3 cells. 
Transport mechanisms for TR have not been characterised previously as, in the past, it 
has been generally accepted that the receptor popUlation is constitutively nuclear (Perlman et 
a!., 1982; Puymirat et al., 1989; Macchia et a!., 1992; Lee and Mahdavi, 1993). 
Experimentally, chilling has been shown to inhibit facilitated nuclear import of karyophilic 
proteins (Section 3.1.5). Lowering the incubation temperature of the cellular environment 
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during transport decreases the rates of enzyme-mediated processes. Pre-treatment of cultured 
cells with cycloheximide prevents de novo protein synthesis. Therefore, EGFP-tagged 
receptor molecules would have sufficient time to be localised to the correct cellular 
compartment. Possible outcomes for low temperature incubations and ATP depletion studies, 
classified by transport mechanisms, are displayed in Table 12. The data obtained from tbese 
investigations are summarised in Table 14. 
Table 12 - Predicted outcomes for low temperature incubations and ATP depletion 
studies 
Receptor Import mechanism Export mechanism Expected localisation 
TRa::EGFP Passive diffusion Passive diffusion Nuclear (no change from 
physiological conditions) 
Passive diffusion Facilitated transport Nuclear (no change from 
physiological conditions) 
Facilitated transpOli Passive diffusion Cytoplasmic plus residual 
nuclear subpopulation 
Facilitated transport Facilitated transport Nuclear (no change from 
physiological conditions) 
C] 22A: :EGFP Passive diffusion Passive diffusion Cytoplasmic (no change from 
physiological conditions) 
Passive diffusion Facilitated transport Cytoplasmic (perhaps some 
nuclear) 
Facilitated transpOlt Passive diffusion Cytoplasmic (no change from 
physiological conditions) 
Facilitated transport Facilitated transport Cytoplasmic (no change from 
I physiological conditions) 
TRa and C122A tagged with EGFP were transfected into cultured cells that were 
exposed to low temperatures 48 hours post-transfection. Transfection efficiencies are recorded 
in Table 14. Neither TRa::EGFP nor CI22A::EGFP were observed to significantly alter their 
distributions at OAoC from those observed in control incubations (Figure 3.13 compared with 
2.4), suggesting that any inhibition of TR import was not detectable and that export of 
receptor by passive diffusion had not OCCUlTed. 
Figure 3.13. The effect of chilling on TRa::EGFP and C122A::EGFP localisation in 
transfected mammalian cells. 
Plasmid constructs containing TRa or C122A fused to EGFP were transfected into NIH 
3T3 cells, cultured to 50% confluence. Transfection medium was replaced by complete 
medium after 24 hours incubation at 37°C and 5% CO2:95% air. After a further 24 hour 
incubation, cells were washed with D-PBS, and incubated in medium containing 50 [lg/ml 
cycloheximide for thirty minutes, followed by three hours incubation at 0-4°C. Living cells 
were rinsed with D-PBS prior to visualisation with a fluorescent microscope, under a 
combination of bright-field and epifluorescence, as well as with epifluorescence only (as 
shown). Control transfections with EGFP were performed. 
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3.3.7 ATP depletion does not affect EGFP-tagged TRaand C122A nuclear 
localisation in cultured NIH 3T3 cells 
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A requirement for energy can be used to distinguish facilitated transport from passive 
diffusion (Newmeyer and Forbes, 1988; Richardson et al., 1988; Akey and Goldfarb, 1989). 
Although the requirement is not direct, ATP can be depleted by the addition of hydrolysing 
agents to test whether transport occurs after ATP depletion (Section 3.1.4). A combination of 
2-deoxyglucose and oligomycin in glucose minus DMEM were used to provide an ATP 
depleted medium for incubation of transfected cells. Possible outcomes for these experiments 
are summarised in Table 12. 
The distributions observed during low temperature incubations were mirrored by the 
results of energy depletion experiments in cultured NllI 3T3 cells (Figure 3.14 and Table 14). 
No significant shift in cellular distribution was observed for TRa::EGFP nor for 
C122A::EGFP, with the same implications as suggested for low temperature incubations in 
the previous section (3.3.6), that is, either import of receptor was not inhibited or any 
inhibition occurring was not at a detectable level. 
Figure 3.14. The effect of ATP depletion on TRa::EGFP and C122A::EGFP localisation 
in transfected mammalian cells. 
Cultured NIH 3T3 cells were transfected and incubated, as described in Figure 3.13 Twenty 
four hours after the culture medium replaced the transfection medium, cells were washed with 
D-PBS. Cel1s were incubated in medium containing 50 Jlg/ml cycloheximide for thirty 
minutes, followed by four hours incubation in cycloheximide-containing medium 
supplemented with 6 mM 2-deoxyglucose and 50 JlM oligomycin. Cells were washed with D-
PBS and viewed with a fluorescent microscope. Transfected cells are shown with a 
combination of bright-field and epifluorescence, as well as with epifluorescence only. 
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Table 13 ~ Summary of nucleocytoplasmic transport studies in Xenopus oocytes. 
Receptor Direction of Treatment % nuclear Student's 
transport protein t-test a 
TRa import Physiological conditions 39%±5% reference 
TRa import Chilling 40% ± 1% NS 
TRa import 0°C+20°C 40% ±8% NS 
TRa import WGA 32%± 14% NS 
TRa import Apyrase 36%±3% NS 
TRa import Competition/low histone H1 41%±2% NS 
TRa import Competition/high histone H1 40%±4% NS 
TRa import Competition/L5 40%±3% NS 
TRa export Physiological conditions 62%±7% reference 
TRa export Chilling 86% ± 9% p<0.001 
TRP import Physiological conditions 39% ± 3% reference 
TRP import Chilling 38%±7% NS 
TRP import 0°C+20°C 37%±5% NS 
TRP import Competition/low histone H1 43%±6% NS 
TRP import Competition/high histone H1 42%±6% NS 
TRP import Competition/L5 41% ±2% NS 
TRP export Physiological conditions 74% ± 3% reference 
TRP export Chilling 87%±6% p:::::0.03 
i 
C122A import Physiological conditions 41%±2% reference 
C122A import Chilling 40%±5% NS 
C122A import O°C+20°C 41%±9% NS 
C122A import Competition/low histone H1 38%±5% NS 
C122A import Competition/high histone H1 37%±7% NS 
C122A import Competition/L5 38%±5% NS 
C122A export Physiological conditions 72% ±6% reference 
C122A export Chilling 87%±6% p=0.06 
v-ErbA import Physiological conditions 21% ±7% reference 
v-ErbA import Chilling 25%±8% I\JS 
v-ErbA import 0°C+20°C 22%±2% NS 
v-ErbA import WGA 13% ±7% NS 
v-ErbA import Apyrase 15% ± 10% NS 
v-ErbA import Competition/low histone H1 22%±3% NS 
v-ErbA import Competition/high histone H1 11% ± 3% p:::::O.05 
v-ErbA import Competition/L5 9%±2% p=O.02 
118 
v-ErbA export , Physiological conditions 87%±5% reference 
v-ErbA export Chilling 82%±2% NS 
L5 import Physiological conditions 33%±4% reference 
L5 import Chilling 18%±2% p<0.001 
L5 import 0°C+20°C 29%±4% NS 
L5 import WGA 5%±4% p<0.001 
L5 import Apyrase 4%±1% p<0.001 
L5 import i Competition/low histone H1 21%±2% p<0.001 
L5 import Competition/high histone H1 16% ±2% p<0.001 
L5 import Competition/L5 8%±1% p<0.001 
L5 export Physiological conditions 68%±7% reference 
L5 export Chilling 95%±5% p<0.001 
a Student's t-test values are expressed as the probability that the experimental treatments were 
significantly different at p<O.1. Treatments were compared with the appropriate values obtained in 
oocytes incubated at physiological conditions. (NS: not significant) 
Table 14 - Summary of nucleocytoplasmic transport studies in NIH 31'3 cells. 
Receptor Sample Treatment Distribution of Transfection 
size (n) protein efficiency 
TRa::EGFP 500 physiological 100% nuclear 21% ±6% 
conditions 
TRa::EGFP 384 0°C-4°C 99.48% nuclear 14%±7% 
TRa::EGFP 500 ATP minus 99.25% nuclear 13%±7% 
C122A::EGFP 297 physiological 100% cytoplasmic 11%± 5% 
conditions 
C122A::EGFP 254 0°C-4°C 100% cytoplasmic 8%±5% 
C122A::EGFP 261 ATP minus 100% cytoplasmic 9%±3% 
EGFP 500 physiological 100% (diffused 71% ± 13% 
conditions through entire cell) 
EGFP 500 0°C-4°C 100% (diffused 66% ± 16% 
through entire cell) 
EGFP 500 ATP minus 100% (diffused 64% ± 16% 
throuqh entire cell) 
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3.4 Discussion 
The results presented in this chapter demonstrate that the nuclear impOlt of TRa., 
TR~, and DNA-binding mutant Cl22A through the NPC in Xenopus oocytes occurs via 
passive diffusion (Section 3.4.1). Import is temperature-independent, is not sensitive to ATP 
depletion or WGA, and is not competed by histone HI or ribosomal protein L5. However, 
nuclear import of v-ErbA is via a facilitated mechanism. In contrast, efflux of TRa., TR~, and 
CI22A molecules from the nuclear compartment is temperature dependent (Section 3.4.3). 
In Chapter Two, it was demonstrated that DNA binding was not a requirement for 
nuclear retention of TR. It also appears that a loss of integrity in the DNA binding domain 
does not influence the transport mechanisms operating in Xenopus oocytes (Section 3.4.1). 
In addition, low temperature incubations and ATP depletion assays were performed in 
TRa.::EGFP and C122A::EGFP transfected NllI 3T3 cells, to begin to characterise transport 
mechanisms and to determine whether nucleocytoplasmic shuttling of receptor occurs. No 
change in receptor localisation was observed. The implications of this observation are 
discussed in Section 3.4.4. 
3.4.1 Nuclear import of TR ~ TRfJ, and C122A in Xenopus oocytes occurs by a passive 
process 
The mechanism of nuclear import of a protein can be characterised by a range of 
assays, including low temperature incubations, energy depletion, WGA inhibition, and 
competition assays. Categorisation of protein transport into facilitated or passive processes 
cannot be made simply upon size as several proteins that are smaller than the limit for 
diffusion are transported by a facilitated mechanism; such as calmodulin (Pruschy et al., 
1994) and histone HI (Breeuwer and Goldfarb, 1990; Kurz et al., 1997). TRa., TR~, and 
C 122A fall within the upper size limits for diffusion through the NPC (46.8 kDa, 52 lilla, and 
52 lilla, respectively), whilst v-ErbA exceeds the limit (75 kDa). 
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As TR has been reported to be constitutively localised to the nuclei of cultured 
somatic cells (Perlman et al., 1982; Kumara-Siri et al., 1986; Horowitz et al., 1989; Puymirat 
et al., 1989; Macchia et aI., 1992; Lee and Mahdavi, 1993), nucleocytoplasmic transport 
mechanisms had not been previously investigated. Since nuclear localisation of TRa, TR~, 
and C122A is not constitutive in Xenopus oocytes (approximately 40% is nuclear), as 
determined by the investigations presented in this thesis, these oocytes provide a unique 
model cell system for defining these transport mechanisms. An array of assays was performed 
to determine the mechanisms of transport for TRa, TR~, DNA-binding mutant C122A, and 
oncoprotein v-ErbA. 
Import of the TR isoforms and C 122A in Xenopus oocytes occurred to the same 
extent for all three receptors in a temperature independent manner, consistent with passive 
diffusion. This finding provides further evidence that nuclear accumulation of TR is due to 
nuclear retention of receptor molecules by specific binding to nuclear retention sites (refer 
Section 2.4.2). In support of a passive import mechanism, nuclear import of the receptors was 
not inhibited by competition with facilitated import of histone HI or L5. Active and facilitated 
transport of proteins are saturable processes and as such, they are sensitive to competition by 
other substrates that follow the same pathway; for example, histone HI (Breeuwer and 
Goldfarb, 1990; Harootunian et aI., 1993; Kurz et al., 1997). Further, the effects of energy 
depletion and WGA inhibition on TRa and v-ErbA import were assessed in Xenopus oocytes. 
WGA blocks the uptake of a variety of karyophilic proteins independent of their molecular 
weight and inhibition of transport has been shown to be specific for facilitated transport 
processes (Dabauvalle et al., 1988). Facilitated transport can be described more completely as 
an energy dependent process in most cases, without which transp011 is arrested at the docking 
stage (Newmeyer and Forbes, 1988; Richardson et al., 1988; Akey and Goldfarb, 1989). 
Neither apyrase nor WGA treatments inhibited TRa import to the extent that L5 was 
inhibited. This finding might suggest that two import pathways exist for TRa in Xenopus 
oocytes, and that whilst passive diffusion of TRa is not inhibited, secondary import by a 
facilitated mechanism is inhibited. In addition, a high degree of variability between oocyte 
batches biased the statistical t-tests performed. This bias could be countered by an increase in 
replicate number, although flUther experiments could not be peliormed in the time frame of 
this thesis. Therefore, whilst it appears that most nuclear proteins, including proteins of a size 
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suitable for diffusion (upper limit 40 to 60 kDa), are transported by a facilitated mechanism 
requiring the interaction with transport complexes, the influx of TRa, TRP, and C122A into 
the Xenopus oocyte occurs by passive diffusion and not by a facilitated mechanism. 
In contrast to the results observed for TR import, the mechanism of v-ErbA import in 
Xenopus oocytes is not passive diffusion. Although, v-ErbA import was not significantly 
inhibited in comparison to L5 by low temperature incubations, WGA, or ATP depletion, 
import was significantly affected by coinjection with L5 and high levels of histone HI. 
Oocytes injected with v-ErbA were more likely to display deterioration of the nuclear 
membrane after incubation at low temperatures. A loss of membrane integrity, previously 
described to be induced by v-ErbA (Nagl et aI., 1997), would lead to 'leakiness' of the 
nuclear compartment, although this occurred over a longer time frame. In addition, it must be 
re-emphasised that the statistical t-tests performed to compare treatments are influenced by 
high variability between samples and low replicate numbers of samples. 
A potential difficulty in assessing v-ErbA import was identified during the course of 
this study. As discussed in Section 2.4.5, the majority of cytoplasmically microinjected 
v-ErbA may have been sequestered in the cytoplasmic compartment in association with 
hsp90, in a form that was not competent for nuclear import. 
3.4.2 Role of the 1'R NLS in nuclear localisation 
Small proteins lacking an NLS diffuse through the central channel of the NPC 
regardless of temperature (Breeuwer and Goldfarb, 1990). In light of the passive mechanism 
observed for nuclear import of TRa, TRP, and C122A, it is important to note that NLSs have 
been identified for TR. Dang and Lee (1989) identified an NLS in the DBD of chicken TR, 
and similarly an NLS was identified in the hinge regions of both rat TRal (Lee and Mahdavi, 
1993) and human TRPI (Zhu et al., 1998). Therefore, it would seem that these NLSs would 
be redundant with a simple passive import process. However, it must be pointed out that 
presence of an NLS may not necessitate import via a facilitated mechanism. Although the 
41 kDa catalytic subunit of cAMP-dependent protein kinase has lysine and arginine residues 
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that could comprise an NLS, it was concluded that diffusion was sufficient to explain most 
aspects of the subunit's transport (Harootunian et at., 1993). It is possible that subtle 
regulation of TR function could occur by import of a small population of receptor by a 
facilitated mechanism, which might show more rapid kinetics in comparison to the relatively 
slow process of passive diffusion. Signal-mediated impOlt could ensure targeting of TR 
molecules to specific association sites with the oocyte nucleus, rather than delivery en masse 
of the majority of nuclear receptor by undirected passive diffusion. Also to be considered is 
the manner in which the NLSs were isolated. Due to the close proximity of the NLSs to the 
DBD of the receptor (Dang and Lee, 1989; Lee and Mahdavi, 1993; Zhu et al., 1998), 
isolation of this function may be due to disruption of another function, perhaps even mutation 
of an NES (Laskey and Dingwall, 1993; Schmidt-Zachmann et al., 1993). However, in the 
case of PR, a specific NES (distinct from an NLS) may not be required for PR export, and 
export may be mediated through an NLS (Guiochon-Mantel et aI., 1994). Evidence for a 
signal-mediated mechanism of transport is provided by the temperature dependence of TRa, 
TRP, and C122A export. It remains to be determined whether export is mediated by the NLS, 
or by a specific NES. 
3.4.3 Export of TR isofonns, C122A, and v-ErbA is temperature dependent in Xenopus 
oocytes. 
Localisation of TR, v-ErbA, and C122A has been demonstrated not to be 
constitutively nuclear in oocytes (Section 2.3.2). As a result of this observation, TR and 
variants were introduced into oocyte nuclei to determine whether receptor was localised in the 
nucleus or whether nuclear export occurred. Nuclear export of several NHRs has been shown 
to occur; including, GR, AR, and MR (Yang and DeFranco, 1994), PR (Guiochon-Mantel., 
1991), and ER (Dauvois et aI., 1993). 
The presence of TR export in oocytes, in combination with passive diffusion of 
receptor into the nucleus, is indicative of nUcleocytoplasmic shuttling. Nucleocytoplasmic 
shuttling has been demonstrated in the NHR superfamily. Liganded PR and GR shuttling 
between nuclei of heterokaryon fusions was identified (Guiochon-Mantel et al., 1991; Madan 
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and DeFranco, 1993; respectively). Heterokaryon experiments performed with the 
TRa::EGFP clone used in the study described in this thesis, carried out in Dr L. A. Allison's 
laboratory (College of William and Mary), have suggested shuttling of receptor (personal 
communication). It has been proposed that nucleocytoplasmic shuttling of proteins could be 
implicated in two types of protein regulation (Nigg, 1990; Nigg, 1997). Firstly, shuttling 
proteins may act as carrier molecules for nuclear import or export of other proteins or RNA. 
For example, it has been proposed that the yeast protein Glelp acts as an essential mRNA 
export factor (Murphy and Wente, 1996). Secondly, cytoplasmic regulation of nuclear 
activities may be regulated by transient exposure of the shuttling protein to the cytoplasmic 
compartment. This cytoplasmic exposure would allow modification of the receptor (by 
phosphorylation or other means) resulting in altered affinities for specific nuclear protein 
interactions. IKE inhibits nuclear localisation of NFKElRel transcription factors through 
interactions formed in the cytoplasmic compartment (Baeuerle and Henkel, 1994). 
Inactivation of IKE leads to nuclear imp011 of the NFKElRel transcription factors. IKE appears 
to contain an NBS and it has been suggesting that shuttling of the inhibitor may playa role in 
terminating NFKB signal transduction through a negative feedback mechanism (Fritz and 
Green, 1996). The significance of nucleocytoplasmic shuttling for TR seems most likely to be 
involved with cytoplasmic regulation. Indeed, as detailed in Section 2.4.1, phosphorylation of 
nuclear receptor, but not cytoplasmic TR, has been observed (L. A. Allison, personal 
communication). Regulation of shuttling TR in the cytoplasmic compartment would therefore 
provide a means to transfer information from this compartment to the nucleus. 
3.4.4 No effect of chilling or ATP depletion on localisation ofEGFP-tagged TRaor 
C122A is observed in cultured cells 
Low temperature incubations and energy (ATP) depletion have been demonstrated to 
inhibit the facilitated nuclear transport of a variety of proteins, including histone HI import in 
PtKI cells (Breeuwer and Goldfarb, 1990; Kurz et al., 1997); nucleocytoplasmic transport of 
GR, AR and MR (Yang and DeFranco, 1994); import of PR (Guiochon-Mantel et al., 1994) 
and nucleoplasmin in tissue culture cells (Richardson et al., 1988). 
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No difference in distribution of either TRa::EGFP or CI22A::EGFP was observed in 
chilled versus wanll cells, or in energy-depleted versus control cells. The lack of observable 
difference could be accounted for a variety of reasons. Firstly, TRa: :EGFP may diffuse into 
the nuclei of NIH 3T3 cells and then be retained, therefore chilling and ATP depletion would 
not inhibit the process. This seems unlikely as the EGFP-tagged protein would exceed the 
upper size limit for diffusion, and at 73.8 kDa is similar in size to v-ErbA. However, if this is 
the case, and if nucleocytoplasmic shuttling of TRa occurs, this implies that export of 
receptor is temperature and energy dependent, enabling TRa: :EGFP to accumulate in the 
nucleus in association with binding sites. Secondly, impOli of TRa::EGFP may occur by a 
rapid facilitated mechanism, meaning that the 30 minute incubation period in cycloheximide 
would be sufficient for import of all receptor to occur prior to chilling. Any 
nucleocytoplasmic shuttling would be constrained as previously described. Alternatively, low 
levels of receptor present in the cytoplasmic compartment (retained or exported) might be 
undetectable by fluorescent microscopy. Therefore, the findings made for the low temperature 
incubations and energy depletion assays do not allow distinctions to made between, firstly, 
active versus passive import, and, secondly, inhibition of shuttling as opposed to absence of 
nuclear export. In order to assess the two events, import and export or shuttling, it would be 
necessary to establish whether export or shuttling occurs. Assessment of TRa expori could be 
pelfonned in heterokaryon fusion cells in experiments similar to those performed for PR 
(Guiochon-Mantel et al., 1989; Guiochon-Mantel et al., 1991) and GR (Madan and 
DeFranco, 1993). Experimentation is currently in progress in Dr L. A. Allison's laboratory 
(College of William and Mary). Export and import could also be assessed by the introduction 
of TRa::EGFP into one cell nucleus by microinjection and examination of the movement of 
receptor to the other nucleus. As a control for these experiments, a protein that is exported 
under chilled and energy-depleted conditions should be included. The inhibitory action of 
cycloheximide on de novo protein synthesis could also be assessed by introduction of a CAT 
expression vector and subsequent assay for synthesised protein by enzyme linked 
immunosorbant assay (ELISA). 
In contrast to the nuclear distribution of TRa::EGFP, EGFP-tagged C122A is 
cytoplasmically distributed. In light of the absence of receptor detected in the nuclear 
compaliment of both living cells (Section 2.3.3) and fractionated cells (Section 2.3.7), it 
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seems unlikely that import occurs. Therefore, it would be interesting to introduce C 122A by 
microinjection into the nuclei of Nlli 3T3 cells to observe whether the DNA-binding mutant 
is retained in the nucleus or exported to the cytoplasm, especially as C 122A is exported in 
Xenopus oocytes (Section 3.3.2). It has been previously observed that when non-nuclear 
proteins are microinjected into the nucleus they are unable to be exported (Dingwall et ai., 
1982; Lanford et ai., 1986; Mandell and Feldherr, 1990; Guiochon-Mantel et ai., 1991). 
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Chapter 4 
Conclusion 
The study presented in this thesis examines the distribution and nUcleocytoplasmic 
transport of the a- and ~-isoforms of TR, a DNA-binding mutant of TR~ (C122A), and the 
AEV-derived oncoprotein v-ErbA which no longer binds T3. Results presented in Chapter 
Two demonstrate that distributions of TR and its variants, introduced into Xenopus oocytes, 
vary from those described in the literature for mammalian and avian cens. These observations 
were specific for the oocyte cell context. Incubation of oocytes in T3 induced a significant 
shift of TRa, TR~, and C122A to the oocyte nucleus indicating that, either, nuclear binding 
sites had become more accessible, or, that additional sites had become accessible. In contrast, 
TRa: :EGFP was localised to the nuclei of cultured NllI 3T3 celJs and incubation in the 
absence or presence of T3 induced no changes in distribution. Examination of the nuclear 
transport of receptors revealed that TRa, TR~, and C122A entered the oocyte nucleus by 
passive diffusion, whilst export occurred by a temperature dependent mechanism. There was 
some suggestion that nuclear import of a small subpopulation of TR might occur by a 
facilitated mechanism. Export of TR has not been described in the literature, and observation 
of TR expOlt in oocytes suggests that nucleocytoplasmic shuttling of TR may occur. Integrity 
of the TR DBD was not essential for correct localisation or transport of receptor, as 
characterised by use of DNA-binding mutant C122A. 
The results contained in Chapters Two and Three provide insight into interactions of 
TR and variants with the cellular transport machinery and nuclear retention sites in the 
nuclear matrix. Potential regulatory mechanisms for TR action have also been discussed in 
these two chapters. Therefore, Chapter Four is designed to place the implications of TR 
localisation and transpOlt mechanisms in the context of regulation of TR activity, and with 
other members of the NHR superfamily. 
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4.1 Comparison of TR with other members of the NHR superfamily 
As a member of the NHR supedamily, TR shares a common structure with 
other NHRs (Figure 1.1). Function is structurally related and, therefore, it is expected that 
receptors in the supedamily will have features in common. 
The NHR supedamily displays a range of distributions within the cellular 
compartments. The classical model proposed that NHRs were cytoplasmic in the absence of 
ligand binding and were imported after binding in order to associate directly with DNA, 
activating or repressing genes by way of response elements (reviewed in Nigg, 1990). This 
model was being revised by 1986 as the presence of nuclear pools of unliganded receptor 
were described for ER and PR (King and Greene, 1984; Perrot-Appian at et ai., 1985). 
Structural integrity of the DBD is an important determinant for the nuclear localisation 
and tight nuclear binding of GR (Sackey et ai., 1996). The study presented in this thesis 
demonstrates that maintenance of DNA binding is not the sole determinant for nuclear 
localisation and import of TR, as nuclear import of C122A (a DNA-binding mutant) proceeds 
at the rate and to the degree observed for wild type receptor in oocytes but not in cultured 
NllI 3T3 cells. 
Association of NHRs with nuclear sites separate from DNA has also been described, 
with ER and GR localising to the nuclear matrix (Alexander et ai., 1987; van Steensel et ai., 
1995), VDR localising to discrete nuclear foci (Barsony et ai., 1997), and GR and MR 
concentrating in approximately 1000 clusters within the nucleus (van Steensel et ai., 1996). 
Additionally, it was demonstrated that the distributions of several NHRs were dynamic rather 
than static in the absence of ligand; that is, receptors shuttled between the nuclear and 
cytoplasmic compartments (reviewed in Guiochon-Mantel et ai., 1996). Figure 4.1 
summarises what is currently known about the trafficking of NHRs. 
Synthesis of 
receptor 
(VDR, RAR, 
or RXR) 
Addition of 
Hormone 
CYTOPLASM 
I. 
Synthesis of 
receptor 
(PR or ER) 
••• 
Synthesis of 
receptor 
N (GR,AR,Or MR) Association 0 
with Hsp90 ~ 
~ Dissociation ~ of Hsp90 
• 0 e 
______.f--NPC ______ I ________ I ~ 
NUCLEUS 
Addition of 
Hormone 
Receptor binds 
to HRE 
1 
• Nuclear Hormone Receptor 
o Masking of NLS 
Hormone 
Dissociation 
of Hormone 
.. --"'------+--+ • \ 
Low affinity binding site 
or "export staging area" 
128 
Figure 4.1 - Localisation of nuclear hormone receptors. The trafficking of various NHRs 
and alternative pathways for receptor localisation between the cytoplasmic and nuclear 
comparlments are displayed. This figure is collated from previously reported studies 
discussed in the introductory sections contained in this thesis (Chapter 3). 
129 
Some members of the NHR superfamily have been shown to complex with hsp90 in 
the cytoplasmic compartment (FeldhelT and Akin, 1994; reviewed in Brasch and Ochs, 1995; 
Dittmar et al., 1996), which effectively anchors the receptor and prevents nuclear import. In 
telms of hsp90 association, TR is similar to VDR, RAR, and RXR, as they all remain 
from complex formation. However, unliganded TR is reported to be constitutively nuclear in 
cultured cells (for example, NllI 3T3 cells, as demonstrated in this study) and has been shown 
in this study to be distributed between the cytoplasmic and nuclear compartments in Xenopus 
oocytes. In this way, the constitutively nuclear distributions observed in cultured cells 
(Perlman et al., 1982; Kumara-Siri et al., 1986; Horowitz et al., 1989; Puyrnirat et al., 1989; 
Macchia et ai., 1992; Lee and Mahdavi, 1993) and in NllI 3T3 cells (in this study) are more 
similar to those observed for PR (Perrot-AppIan at et al., 1985) or ER (King and Greene, 
1984) than for VDR (Barsony et al., 1997), MR (Lombes et al., 1990; Robertson et al., 1993; 
Lombes et ai., 1994; Fejes-T6th et ai., 1998), GR (Fuxe et al., 1985; Wikstrom et al., 1987; 
Rossini and Malaguti, 1994; Akner et al., 1995), or AR (Simental et al., 1991; Jenster et al., 
1993). 
Perhaps the most surprising observation made dUling this study is that TR appears to 
passively diffuse into the nuclei of Xenopus oocytes, regardless of the presence of an NLS 
(Dang and Lee, 1989; Lee and Mahdavi, 1993; Zhu et al., 1998), although there is the 
potential that two alternative pathways exist. In contrast to TR, impOlt is an energy and 
temperature dependent, facilitated process for larger NHRs; such as, GR (94 kDa), AR 
(110 kDa), MR (107 kDa; Yang and DeFranco, 1994), and PR (90 kDa; Guiochon-Mantel et 
al., 1994). Export of TR in Xenopus oocytes is by a temperature dependent mechanism 
suggesting a facilitated mechanism, which is different from the energy independent 
mechanism of PR export (Guiochon-Mantel et al., 1991). 
Hormone association is necessary for nuclear import of AR, GR, and MR, whereas 
dissociation of hormone results in dissociation of the receptor molecules from chromatin and 
subsequent nuclear export (Yang and DeFranco, 1994). Whilst ligand binding is not 
obligatory for import of TR in Xenopus oocytes, localisation of receptor to the nucleus is 
enhanced in the presence of hormone. Nuclear localisation of EGFP-tagged TR~ is also 
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enhanced in the presence of T3, displaying a shift from 60% to 85% nuclear (Zhu et al., 
1998). However, as TR is constitutively localised to the nuclei of somatic cells (Perlman et 
al., 1982; Kumara-Siri et al., 1986; Horowitz et al., 1989; Puymirat et al., 1989; Macchia et 
al., 1992; Lee and Mahdavi, 1993), and observed in this study in NllI 3T3 cells, ligand 
binding is not an absolute requirement for nuclear import. Ligand binding is also not 
obligatory for nuclear localisation of PR (Perrot-AppIan at et al., 1985) and ER (King and 
Greene, 1984; Welshons et al., 1984; Welshons et al., 1985), although binding to target DNA 
is necessary. 
A population of TR introduced into Xenopus oocytes is mobile and able to be 
exported from the nucleus through the NPc. This suggests that TR has the ability to cycle 
through the nuclear and cytoplasmic compartments in oocytes in the manner that PR 
(Guiochon-Mantel et al., 1991) and GR (Madan and DeFranco, 1993) have been shown to 
shuttle in heterokaryon fusion cells. Evidence of EGFP-tagged TR shuttling has also been 
observed in heterokaryon fusion cells (L. A. Allison, personal communication), suggesting a 
more universal mechanism. 
4.2 Nuclear localisation of TR 
This section describes a model fOlmulated to account for the phenomena observed 
during the course of this study. Evidence for the interactions presented in this model is 
provided by the original investigations contained in this thesis placed in context with previous 
studies of TR. Figure 4.2 displays the possible interactions TR makes with cell components 
during its transport into, through, and out of the nuclear compartment. 
The fate of TR is determined by the cellular context in which the receptor is placed or 
synthesised, although a universal model for TR localisation is proposed in Figure 4.2. TR is 
impOlied into the nuclei of cultured cells and remains there. Alternatively, TR associates with 
anchoring complexes in the cytoplasmic compartment (for which a case may be made in 
Xenopus oocytes). TR molecules in excess of anchor complexes would remain free to diffuse 
into the nucleus. Dissociation of the anchoring complex may be due directly to hormone 
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binding or it might be due to a phosphorylation event induced by hormone binding. Evidence 
for receptor phosphorylation was detailed in Section 2.4.1. Liganded TR diffuses into the 
nuclear compmtment, or in the case of cultured cells, receptor binds ligand in the nucleus or 
during its passage through the cytoplasm. Alternatively, in oocytes, unliganded TR may be 
imported and be more likely to be retained if it binds T 3 in the nucleus. 
Alternative associations can be formed between TR and the nuclear architecture. 
Three fates are described for TR. Firstly, TR binds TREs in the cell genome. Unliganded TR 
is also found in association with TREs in cultured cells. Secondly, TR associates with 
retention sites within the nucleus, such as the nuclear matrix, or with low affinity binding 
sites. The nuclear matrix is associated with actively transcribed genes and their transcription 
factors (Zeng et al., 1997). Therefore, TR might trans-activate gene expression while 
associated with the nuclear matrix, which has positioned TR in close proximity to the 
chromatin allowing TRE binding by TR to occur (not shown in Figure 4.2). Lastly, shuttling 
of TR occurs with the efflux of receptor via a facilitated mechanism. Dissociation of hormone 
within the nuclear compartment is likely to result in a remTangement of receptor associations, 
and may therefore induce shuttling of TR. This rearrangement may also be a movement of TR 
to quasifunctional sites or low affinity retention sites. 
Several requirements must be met for the interactions proposed in this model to occur. 
DNA binding appem's to be essential for nuclear localisation of receptor (EGFP-tagged) in 
NIH 3T3 cells but not necessarily in Xenopus oocytes. Association of TR with TREs is 
dependent on integrity of the DBD which is, however, not necessary for interactions with 
alternative sites in oocytes. The size of TR is also a determining factor in receptor transport as 
the viral fusion protein, v-ErbA, is too large to passively diffuse through the NPC. In addition, 
hsp90 complexes with v-ErbA, but not TR, acting as a cytoplasmic anchor. 
Synthesis of TR 
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Figure 4.2. Model for interactions of TR with cellular components. See text for 
explanation (Section 4.2). Homodimers of TR are shown to bind TREs, however, 
heterodimers with RXR and RAR are also formed. 
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4.3 Regulatory Dlechanisms of TR activity 
A number of mechanisms have been proposed during the course of this study to 
account for regulation of TR activity. It seems likely that TR is regulated at a number of levels 
within the cell, in addition to regulation while bound to TREs. Perhaps the most 'global' 
mechanism is provided by the distribution of TR; that is, compartmentalisation of TR restricts 
access of these receptor molecules to activation sites, such as DNA and nuclear matrix, and 
factors involved in repression and activation at these sites. This compartmentalisation has 
been observed for several proteins as well as specifically for other members of the NHR 
supelfamily. For example, several proteins have been observed to redistribute between the 
cytoplasmic and nuclear compartments in embryonic cells at particular developmental stages 
(reviewed in Nigg, 1990); and unliganded GR, AR, and MR appear restricted to the 
cytoplasm, due to complex formation with hsp90, until release by ligand binding, whereupon 
they localise to the cell nucleus (Yang and DeFranco, 1994). 
Association with cytoplasmic anchoring factors is an aspect of this type of 
compartmental regulation. Regulation of nucleocytoplasmic transport by anchoring factors 
falls into two categories. Firstly, the cytoplasmic factor may act as a physical anchor. An 
example of this is the anchoring of sterol-regulatory element binding proteins and PKA 
holoenzyme by the ER and cytoplasmic membranous organelles (Wang et al., 1994; Nigg, 
1990; respectively). Secondly, the cytoplasmic anchor may mask the NLSs until modification 
of the anchor occurs, exposing the NLS. For example, Ild3 masks the NLS of NFld3lRel, 
inhibiting import (Baeuerle and Henkel, 1994). Ild3 anchoring is inactivated by 
phosphorylation and proteolysis. As mentioned in the previous paragraph, several NHRs are 
physically anchored by the formation of complexes with hsp90. Although TR has not been 
shown to complex with hsp90 (Dalman et al., 1991), it is possible that another anchoring 
factor is present in Xenopus oocytes, which would account for the presence of a large 
cytoplasmic population of TR in oocytes as opposed to somatic cells. Nuclear populations of 
TR, extracted from Xenopus oocytes by Dr L. A. Allison in pilot studies, are phosphorylated, 
unlike their cytoplasmic counterparts (personal communication). This observation could 
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indirectly support the presence of an anchoring protein, indicating that release of TR is 
dependent upon either the phosphorylation and modulation of TR itself or the 
phosphorylation of an NLS sequence. An alternative scenario is that TR shuttles through the 
nuclear and cytoplasmic compartments passively and is not retained or anchored in either 
compmiment. This seems unlikely as TR export in oocytes has been shown to occur via a 
facilitated mechanism. 
An extra level of regulation could be provided by nucleocytoplasmic transport. 
Regulation could be provided by the mechanism of transport or by the NPC itself. It has been 
shown that transport rates in proliferating cells m"e faster and the functional sizes of NPCs are 
significantly larger than in quiescent cells (Feldherr and Akin, 1994). Also, variability in the 
number of NPCs present in the nuclem" membrane depends on the physiological state of the 
cell. Amphibian oocytes (such as Xenopus oocytes) have been estimated to have a density of 
over 60 pores per square micrometre, whilst most higher eucaryotes have a sparser density at 
10 to 20 pores per square micrometre (reviewed in Nigg, 1990). Therefore, different 
mechanisms for TR transpOli might be in operation in different cell systems, dependent on the 
number of NPCs available. For exmnple, in Nlli 3T3 cells NPCs are sparser than in Xenopus 
oocytes and this might necessitate a facilitated mechanism to direct import. 
The availability of nuclem" binding or retention sites may also effect nuclear import. 
As discussed in Section 1.2.2, passive diffusion and facilitated diffusion occur down the 
chemical concentration gradient. Therefore, a protein imported by this mechanism may only 
continue to diffuse whilst there is a lower concentration of free protein in the nuclear binding. 
Protein that associates with nuclem" binding sites, such as chromatin or nuclear matrix, is 
effectively removed from this concentration gradient. The significance of this is that once all 
of the binding sites in the nuclear compmiment are taken, an equal concentration of free TR in 
both the nuclear and cytoplasmic compm"tments will be reached, providing a fmiher level of 
regulation. Saturation of binding sites in the Xenopus oocytes was not observed (with 50 to 
200 picograms introduced per oocyte) during the course of the investigations described in this 
thesis, although TR impOli occurred by a passive diffusion mechanism. 
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Further to the discussion of nuclear accumulation of TR, is the characterisation of 
nuclear binding sites in Xenopus oocytes and somatic cells. TR has been shown to be 
constitutively nuclear in somatic cells (Perlman et al., 1982; Kumara-Siri et al., 1986; 
Horowitz et al., 1989; Puymirat et al., 1989; Macchia et al., 1992; Lee and Mahdavi, 1993), 
and in particular to be associated with the DNA in GH1 cells (Perlman et al., 1982). Between 
30% and 50% of endogenous thyroid hormone-binding receptors in GC cells have also been 
shown to be associated with the nuclear matrix (Kumara-Siri et al., 1986). However, the 
importance of this data is not clear as labelled T 3 molecules were tracked, and not receptor 
molecules themselves. Association of EGFP-tagged TRa with nuclear matrix components 
was also observed in NllI 3T3 cells (as presented in Section 2.3.7). The nuclear matrix may 
serve as a framework on which target DNA sequences are brought in contact with 
transcriptional regulatory proteins. These regulatory proteins include co-repressors (N-CoR 
and SMRT) and co-activators (including, steroid receptor co-activator-1, SRC-1, and 
transcription intermediary factor 2, TIF2) , as well as regulators of these co-regulators 
(reviewed in Shibata et al., 1997). 
A significant shift in TR distribution (a and ~ isoforms) from the cytoplasmic to the 
nuclear compartments in Xenopus oocytes was induced by incubation in T3 . This shift was 
also observed for the DNA-binding mutant C122A, indicating that receptor does not just 
associate with DNA. These findings suggest that TR binds to at least two types of sites in cell 
nuclei (both in oocytes and somatic cells). TR binds to the TREs in DNA as well as to the 
nuclear matrix, although it was not determined whether TRE binding is necessary for nuclear 
matrix association. As discussed in Section 2.4.4, a two-site DNA model for NHR action has 
been proposed (reviewed in Nigg, 1990). The two types of sites for NHR nuclear 
accumulation would be a large number of low affinity sites or a lesser number of high affinity 
sites. All of these sites would not necessarily be functionally active binding sites, but rather 
may be retention sites or quasifunctional sites. Therefore, when applied to TR, DNA binding 
is observed and TR may also associate with a number of other sites with varying degrees of 
affinity. The increase in nuclear localisation of TR, induced by hormone, could reflect an 
increase the number of sites for potential binding, or may result in a rearrangement of TR 
distribution amongst these sites due to altered affinities. TR conformational changes have 
been shown to be induced by hormone binding (Toney et al., 1993) and it has been reported 
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that T3 induced an enhanced rate of translocation of EGFP-tagged TR~ to the nuclei of CV1 
cells (Zhu et al., 1998). 
4.4 Prospects and conclusions 
The data contained in this thesis suggest that TR localisation occurs by a process 
regulated at several levels. Regulation of TR function does not only occur at the 
transcriptional regulation level, but rather involves transport mechanisms that seem to be 
regulated by hormone binding and possibly by phosphorylation. The findings in Xenopus 
oocytes are novel and do not reflect the previously described constitutively nuclear state of 
TR in somatic cells. 
Thyroid hormone is involved in the growth and developmental processes in virtually 
every type of vertebrate tissue (reviewed in Chatterjee and Tata, 1992), and it is TR that 
regulates the transcription of the genes that mediate the effects of T3 on differentiation, 
development, and metabolism (Ribeiro et al., 1995). Therefore, mutations in TR could 
underlie T3-1inked diseases in humans (Nagaya and Jameson, 1993). Aberrant expression of 
TR has been implicated in a variety of endocrine and neoplastic diseases, such as small cell 
lung carcinoma, generalised thyroid hormone resistance, and colon carcinoma in humans, as 
well as hepatocellular carcinoma in mice (Dobrovic et al., 1988; Markowitz et ai., 1989; 
Damm, 1993; Barlow et al., 1994; Yen et al., 1994; Beug et al., 1996; Fraichard et al., 1997; 
Lin et al., 1997). Characterisation of TR nuclear localisation aids in defining the regulatory 
mechanisms in operation for this NHR. Knowledge of how proteins function, and are 
regulated, in the normal cell is important in assisting us to elucidate the changes that occur 
upon disruption of the normal environment. Only by understanding these changes can we 
better fOlIDulate treatments against the central defects of a transfonned celL 
The investigations presented in this thesis suggest a variety of directions for future 
studies of TR and its variants. Whilst the focus of this thesis has fallen on TR, transport of 
v-ErbA is an obvious direction for future research. The v-erbA oncogene is unique, but 
similar derivatives of TR might be involved in human cancers. Therefore, the viral oncogene 
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provides us with a tool for investigating disruption of nonnal cell function. The v-erbA gene 
is fused to the viral gene, gag, which accounts for the greatly increased receptor size. 
Separation of the two component sequences would enable assignment of transport and 
subcellular localisation characteristics to each of the two gene products. Interestingly, v-ErbA 
was localised to the nuclear membrane and cytoplasmic fibrils of NPCs in Xenopus oocytes 
suggesting a role in modulating nucleocytoplasmic transport (Nagl et al., 1997). 
The scope for further investigation of TR is broad and could encompass the 
interactions of TR with cytoplasmic anchors, elucidation of NLS and NES sequences and 
function, characterisation of alternative nuclear binding sites and their relative affinities, and 
the export and nucleocytoplasmic shuttling of receptor molecules. Confinnation of 
nucleocytoplasmic shuttling in mammalian cells would aid in the interpretation of results 
contained in this thesis, and therefore pilot studies in heterokaryon cells are being carried out 
in Dr L. A. Allison's laboratory (College of William and Mary). 
The field of investigation of NHR distribution and nucleocytoplasmic trafficking is 
very much influenced by the available techniques. One has only to examine the findings made 
in this field in the last decade to appreciate its rapid advancement. Perhaps most importantly, 
these advances emphasise the dynamic nature of biological systems and their ability to 
respond to a wide range of stimuli in a regulated manner. 
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Appendix I 
Protein sequence comparison of TR and variants 
hTR~l 
rTRa2 
gag-v-erbA3 
hTR~ 
rTRa 
gag-v-erbA 
hTR~ 
rTRa 
gag-v-erbA 
hTR~ 
rTRa 
gag-v-erbA 
hTR~* 
rTRa 
gag-v-erbA 
hTR~ 
rTRa 
gag-v-erbA 
hTR~ 
rTRa 
gag-v-erbA 
reeqvtseqakfwlglgggrvsppgpeciekpaterridkgeemg 
ettvqrdakmapekmatpktvgtscyqcgtatgcncvtasappppyvgsglypslagage 
mtengltawdkpkhepdrehdwklvgmseaelhrkshserrstlkneqssphliqttwts 
meqkpskveeg 
qgqggdtprgaegpraepghagqapgpaltdwarireelastgppvvampvviktegpaw 
sifhldhddvndqsvssaqtfqteekkekgyipsyldkdelevvegdkatgyhyreitee 
sdpeensarspdgkrkrkngqeplkssmsgyipsyldkdeqevvegdkatgyhyreitee 
tplepedtrwldgkhkrkssqelvkssmsgyipseldkdeqevvegdkatgyhyrei tee 
g~kgffrrtiqknlhpsysekyegkevidkvtrnqeqeerfkkeiyvgmatdlvIddskr 
gekgffrrtiqknlhptysekydseevidkitrnqeqlerfkkeiavgmamdlvIddskr 
geksffrrtiqknlhptysetydgeevidkitrnqeqlerfkkeisvgmamdlvIddskr 
vakrklieenrerrrkeemikslqhrpspsaeewelihvvteahrstnaqgshwkqrrkf 
Ipedigqapivnapeggkvdleafshftkiitpaitrvvdfakklpmfeelpeedqiill 
Ipddigqspivsmpdgdkvdleafseftkiitpaitrvvdfakklpmfselpeedqiill 
lledigqspmasmldgdkvdleafseftkiitpaitrvvdfaknlpmfselpeedqiill 
161 
hTR~ kgccmeimslraavrydpesetltlngemavirgqlkngglgvvsdaifdlgmslssfnl 
rTRa lraavrydpesdtltlsgemtvkrkqlkngglgvvsdai 
gag-v-erbA kgccmeimslraavrydpesetltlsgemavkreqlkngglgvvsdaifdlgkslsafnl 
hTR~ ddtevallqavllmssdrpglacveriekyqdsfllafehyinyrkhhvthfwpkllmkv 
rTRa ddtevallqavllmstdrsgllcvdkieksqeayllafehyvnhrkhniphfwpkllmkv 
gag-v-erbA ddtevallqavllmssdrtglicvdkiekcqesyllafehyinyrkhniphfwskllmkv 
hTR~ tdlrmigachasrflhmkvecptellpplflevfed 
rTRa tdlrmigachasrflhmkvecptelfpplflevfedqev 
1 
2 
3 
* 
adlrmigayhasrflhmkvecptelspqev 
hTR~ accession number 72119 
rTRa accession number 112393 
gag-v-erbA accession number 871521 
denotes the line in which a cysteine (Q) to alanine transition occurs in C122A 
Appendix II 
PEGFP::TRa construct 
EGFP 
(1-5900) 
peR primers: 
Left 
(function) 
Right 
(function) 
---Sac! 
(1360) 
TR 
(1360-2560) 
BarnHI 
(2560) 
CC GAGCTCG A ATGGAACAGAAGCC 
link S acI link insert 
GGT GGATCC TTA GACTTCCTGATCC 
vector BamHI stop insert 
162 
pEGFP 
(1-6000) 
peR primers: 
Left 
(function) 
Right 
(function) 
Appendix 
pEGFP::C122A construct 
BarnHI 
(2660) 
EcoR1 
(1360) 
CCC GAATTC G ATGACAGAAAATGGCC 
vector EcoRI link insert 
GGT GGATCC CTA ATCCTCGAACACTTCC 
vector BamHI stop insert 
163 
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Appendix IV 
This reprint from the Journal of Cellular Biochemistry contains results obtained 
during the initial oocyte investigations described in this thesis. My contributions to the 
paper included the microinjection and analysis of the oocytes in the experiment detailed in 
1. (C) and the microinjection of oocytes for the experiment detailed in Fig. (B). I 
also assisted Dr S. Nagl in the processing and analysis of these oocytes. 
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Abstract The growth-promoting properties of the retroviral v-erbA oncogene, a highly mutated version of the 
chicken thyroid hormone receptor (TR) a, have so far exclusively been linked to dominant repression of the 
antimitogenic roles of TR and retinoic acid receptors. Here we show that when expressed in Xenopus oocytes v-ErbA 
induced ultrastructural changes characteristic of early and intermediate events of meiotic maturation by activating gene 
transcription. v-ErbA-induced maturation events occurred without activation of the cAMP/maturation-promoting factor 
signal pathway and were arrested prior to meiotic spindle formation. The effects of v-ErbA were not mimicked by a 
dominant negative in vitro-generated mutant of human TR, suggesting that v-ErbA can contribute to cell cycle reentry by 
interference with regulatory pathways distinct from those involving TR. Interestingly, a portion of v-ErbA expressed in 
oocytes was present at the cytoplasmic fibrils of the nuclear pore complexes, suggesting that in addition to its intranuclear 
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The cooperative action ofv-erbA and its retro-
viral partner v-erbB, both carried by the avian 
erythroblastosis virus, induces acute erythro-
blastosis and fibrosarcomas in young chicks. 
The v-erbA product, a highly mutated version of 
the chicken thyroid hormone receptor (TR) a, 
dominantly represses the actions of normal TR 
and retinoic acid receptors (RARs) [reviewed in 
Privalsky, 1992]. In addition, two mutations in 
the DNA binding domain, together with muta-
tions in an N -terminal region, alter the range of 
DNA target sequences the v-erbA protein can 
bind to relative to TR [Chen et a1., 1993; Smit-
McBride and Privalsky, 1993; Subauste and 
Koenig, 1995]. While chicken embryo fibro-
blasts expressing only v-erbA do not display a 
fully transformed phenotype, they exhibit a 
greatly enhanced growth potential and a de-
creased requirement for growth factors [Gan-
drillon et a1., 19871. 
Contract grant sponsors: Cancer Society, Lottery Health 
Research, Health Research Council of New Zealand. 
*Correspondence to: Lizabeth A. Allison, Department of 
Zoology, University of Canterbury, Private Bag 4800, 
Christchurch 8001, New Zealand. 
E-mail: Lallison@zool.canterbury.ac.nz 
Received 2 June 1997; accepted 18 June 1997 
([) 1997 Wiley-Liss, Inc. 
The growth-promoting properties of v-ErbA 
have so far been linked to dominant repression 
of the antimitogenic roles of TR and RAR. This 
mode of action is indicated by the fact that 
v-erbA is able to stimulate proliferation by over-
coming growth inhibition by retinoic acid [Sharif 
and Privalsky, 1991]. In this context, v-erbA 
function is strongly correlated with its action as 
a dominant negative oncogene in abolishing 
AP-1 repression by RAR and TR [Desbois et a1., 
1991a,b; Zhang et aI., 1991]. Furthermore, in 
the presence of v-erbA, erythrocytic progenitor 
cells are insensitive to the induction of apopto-
sis and self-renewal inhibition by retinoic acid 
or thyroid hormone [Gandrillon et aI., 1994]. 
The question of whether the growth-promoting 
properties of v-ErbA can be exclusively attrib-
uted to dominant repression of TR and RAR or 
whether they also involve the activation of spe-
cific v-ErbA-responsive genes remains unan-
swered to date. Thus, we sought to determine 
whether it was possible to identify a direct role 
of v-ErbA in cell cycle induction at the level of 
gene transcription by employing meiotic matu-
ration assays. 
Meiotic maturation assays carried out in fully 
grown (stage VI) [Dumont, 19721 oocytes from 
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Xenopus laevis, the African clawed frog, have 
been used extensively for studies of oncogene 
involvement in the kinase signal cascades of 
the cell cycle [reviewed in Smith, 19891. Fully 
grown oocytes are arrested at the G2/M border 
and can be induced to enter M-phase by proges-
terone, insulin, and a range of introduced onco-
genic protein kinases. Within minutes ofproges-
terone exposure, a decrease in levels of cAMP 
occurs, mediated by inhibition of adenylate cy-
clase, which in turn downregulates protein ki-
nase A and protein kinase C activities [Smith, 
19891. The induction of Xenopus oocyte matura-
tion by progesterone does not require gene tran-
scription but is absolutely dependent on poly-
adenylation and translation of stored mRNA 
coding for the serine-threonine kinase Mos [Bal-
tus et aI., 1973; Sagata et aI., 1988; Yew et aI., 
1992; Sheets et aI., 19951. A network of phos-
phorylation cascades [Kosako et al., 1994a,b; 
reviewed in Mordret, 19931 culminate in the 
activation of maturation-promoting factor 
(MPF) and mitogen-activated protein kinase 
(MAPK). MPF contains the Xenopus homolog of 
the universal M-phase inducer p34cdc2 , a serine-
threonine kinase with histone HI phosphorylat-
ing activity, which is complexed with B-type 
cyclins [Maller, 1990]. MPF and MAPK trigger 
the events of maturation, including nuclear 
breakdown, chromosome condensation, and mei-
otic spindle formation [Smith, 1989; Bement 
and Capco, 1990). 
In fully grown (stage VI) oocytes, the chromo-
somal loops associated with high transcrip-
tional activity during earlier stages of oogen-
esis have retracted considerably, and the 
chromatin is quite condensed [Hausen and 
Riebesell, 19911. Thus, although microinjected 
gene templates are transcribed efficiently in 
stage VI oocytes [Nagl et al., 1995], it was an 
open question whether Xenopus homologs of 
potential target genes would be accessible to 
v-ErbA and the general transcription machin-
ery in stage VI oocytes. 
In the present study, we show that v-ErbA 
initiates ultrastructural changes characteristic 
of early and intermediate meiotic events, but 
meiosis was arrested prior to spindle forma-
tion. The initiation ofthis subset of maturation 
events by v-ErbArequired de novo gene expres-
sion and did not involve activation ofthe cAMPI 
MPF signal pathway. Events induced by v-
ErbA were not mimicked by a dominant 
negative in vitro-generated mutant of TR, sug-
gesting that the ultrastructural changes were 
not mediated by dominant repression of endog-
enous TR. Our study suggests that v-ErbA, 
acting as a transcriptional activator, can contrib-
ute to cell cycle reentry by interference with regu-
latory pathways distinct from those involving TR. 
MATERIALS AND METHODS 
Plasmids 
RS-v-erbA was a gift from R. Evans (Salk 
Institute for Biological Studies, La Jolla, CA). 
The expression vector contains the gag-v- erbA 
oncogene cDNA under the transcriptional con-
trol of the Rous sarcoma virus (RSV) long termi-
nal repeat (LTR) [Damm et aI., 1989; Thompson 
and Evans, 1989). The RSh-TRI3 C122>A ex-
pression plasmid was a gift of P. Romaniuk 
(University of Victoria, Victoria, BC, Canada). 
It contains an in vitro-generated mutant hu-
man TRI3 gene (alanine instead of cysteine at 
position 122) under control of the RSV LTR 
[Nelson et aI., 1993). pRSV-lacZ was obtained 
from M. Harkey (University of Washington, 
Seattle, WA) and contains the E. coli l3-galacto-
sidase gene under control of the RSV LTR [Gor-
man et aI., 19831. The pKCR2-cea plasmid was 
a gift of B. Venn strom (Karolinska Institute, 
Stockholm, Sweden) and contains the chicken 
c-erbA cDNA expressed from the SV-40 pro-
moter [Sap et aI., 19891. The pGEM-4Z vector 
was a gift ofM. Privalsky (University of Calif or-
nia, Davis, CA), and contains the gag-v-erbA 
cDNA under control of the SP6 RNA polymer-
ase promoter. 
Oocyte Microinjections 
A lobe of ovary was surgically removed from 
an adult female Xenopus laevis and processed 
as described [Allison et al., 1991, 1993). Micro-
injections were performed according to pub-
lished methods with modifications [Nagl et aI., 
19951. Defolliculated stage VI oocytes [Dumont, 
19721 were microinjected with 5 ng expression 
vector in a fixed volume of 20 nl TE (10 mM 
Tris-HCl, pH 8.0, 1 mM EDTA) into the nucleus 
by the "blind" injection method with the needle 
inserted in the center of the animal pole. Alter-
natively, v-erbA protein was synthesized from 
the pGEM-4Z template by in vitro coupled tran-
scription/translation in rabbit reticulocyte ly-
sate (Promega, Madison, wn, according to the 
manufacturer's specifications, using SP6 RNA 
polymerase. Fifty nanoliters v-erbA solution (ap-
proximately 100 pg v-ErbA in rabbit reticulo-
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cyte lysate) was microinjected into the oocyte 
cytoplasm. 
Incubation Treatments and Assessment 
of Germinal Vesicle Migration and Germinal 
Vesicle Breakdown 
Oocytes were incubated in 0-R2 medium [Al-
lison et al., 19911 only or in 0-R2 containing (1) 
10 JIg/ml progesterone (Sigma Chemical Co., St 
Louis, MO), (2) 20 JIM forskolin (Sigma) and 
2 mM isobutylmethylxanthine (IBMX) (Sigma); 
(3) 30 JIg/ml actinomycin D (actinomycin C1 ) 
(Boehringer Mannheim NZ Ltd., Auckland, New 
Zealand), or (4) 200 JIg/ml cycloheximide (BDH 
Chemicals NZ Ltd., Palmerston North, New 
Zealand). Twenty-four hours after nuclear mi-
croinjection with 5 ng RS-v-erbA or pRSV-lacZ 
or cytoplasmic injection of 50 nl of in vitro-
synthesized v-erbA protein, oocytes were scored 
for germinal vesicle migration (GVM) under a 
stereomicroscope, as indicated by pigment rear-
rangement at the apical pole that produces a 
whitish circular spot delineated by a dark ring 
of pigment [Smith, 1989; Bement and Capco, 
1990; Brachet et al., 1970]. Oocytes were as-
sessed for germinal vesicle breakdown (GVBD) 
by manual dissection after fixation in ice-cold 
1 % trichloroacetic acid (TCA) for 5 min. Oocytes 
were scored positive for GVBD when the nucleus 
could not be dissected intact due to nuclear 
instability. 
Differential Interference Contrast Microscopy 
Oocytes incubated in progesterone or microin-
jected with 5 ng RS-v-erbA, RSh-TR~ C122 > A, 
or pRSV-lacZ were fixed and embedded essen-
tially as described by Hausen and Riebesell 
[199ll. In brief, oocytes were fixed in Romeis 
fixative (25 ml saturated mercuric chloride, 20 
ml 5% TCA, 15 ml 37% formaldehyde) for 3 h. 
Subsequently, oocytes were dehydrated in an 
ethanol series of 50% (15 min), 70% (30 min), 
80% (15 min), 90% (15 min), 95% (15 min), and 
100% (3 X 10 min), infiltrated in 50% glycol 
methacrylate infiltration solution (Polaron, 
Auckland, New Zealand) in ethanol for 1 h, and 
then left in 100% infiltration solution over-
night. Oocytes were embedded in glycol methac-
rylate (Polaron) in gelatine capsules under ni-
trogen at 37QC for 5 h. Five micron sections 
were obtained with Ralph glass knives. In order 
to remove mercury precipitates, we treated the 
dry sections with an alcoholic iodine potassium 
iodide solution (2% iodine, 3% potassium iodide 
in 90% ethanol) for 2 min, washed them in 
0.25% sodium thiosulfate for 15 min, and thor-
oughly rinsed them in distilled water. The sec-
tions were stained utilizing an azofuchsinl 
aniline blue/orange G triple-staining method 
[Hausen and Riebesell, 19911. Three indepen-
dent batches of oocytes were used, and three to 
four oocytes per treatment per batch were ana-
lyzed using differential interference contrast 
microscopy. Oocyte sections were photographed 
using Agfa optima color film with a blue filter. 
Electron Microscopy for Ultrastructural Analysis 
In ultrastructural studies of Xenopus 00-
cytes, long fixation times and special fixation 
procedures are necessary. Unless indicated oth-
erwise, all procedures were carried out at 4QC. 
Oocytes were fixed in 2.5% glutaraldehyde and 
0.05% low molecular weight tannic acid in 0-R2 
overnight, washed in 0-R2 three times for 30 
min, and subsequently transferred to 2% OS04 
(in ddH20) for 3 h with one change. Oocytes 
were then washed in 0-R2 for 30 min and 
dehydrated in a graded ethanol series of 30% 
(30 min), 50% (30 min), 70% (overnight), 80% 
(20 min), 90% (20 min), 95% (15 min), and 100% 
(2 X 15 min). After the 70% ethanol step, all 
further procedures were carried out at room 
temperature. Oocytes were incubated in 100% 
acetone twice for 20 min and then gradually 
embedded in Spurr's resin in acetone: 30% resin 
(1 h), 50% resin (3 h), 70% resin (overnight), 
90% resin (8 h), and 100% resin (overnight). 
Oocytes were transferred into 100% resin in 
molds and cured at 70°C for 24 h. Ultrathin 
sections (50 nm) were stained with 5% uranyl 
acetate in 50% ethanol for 20 min, washed in 
ddH20, stained with lead citrate for 20 min, 
and put through a final washing step in ddH20. 
Three independent batches of oocytes were used, 
and three to four oocytes per treatment per 
batch were analyzed. 
Histone Hl Kinase Assay 
Adult female Xenopus laevis were injected 
with 0.5 ml gonadotropin (from pregnant mares' 
serum (Sigma); 200 U/ml in sterile ddH20) sub-
cutaneously into the dorsal lymph sac to im-
prove the synchrony of response to progester-
one in oocytes. After 4 days, a lobe of ovary was 
surgically removed from the animal and pro-
cessed as described above. Defolliculated stage 
VI oocytes were microinjected into the nucleus 
with 5 ng RS-v-erbA or pRSV-lacZ or incubated 
in 10 JIg/ml progesterone. At specified times, 
oocyte extracts were prepared by homogenizing 
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groups of ten oocytes in 20 pI extraction buffer 
(20 mM Tris, pH 7.5, 80 mM [3-glycerophos-
phate, 20 mM EGTA, 15 mM MgCb, 25 pg/ml 
aprotinin, 25 pg/mlleupeptin, 1 mM benz ami-
dine, 0.5 mM phenylmethylsulfonyl fluoride 
(PMSF), 5 mM Pefabloc (Boehringer Mann-
heim), and 1 mM DTT). The homogenate was 
centrifuged at 1O,000g for 10 min at 4°C to 
pellet yolk and pigment. Ten microliters of the 
supernatant were mixed and incubated for 20 
min at 25°C with 10 pI kinase buffer (30 mM 
Tris, pH 7.5, 30 mM MgCI2, 1 mCilml -y[32P] 
ATP (Amersham Life Sciences, Auckland, New 
Zealand), 3 mg/mi histone HI [Sigma]) [Kosako 
et al., 1994b]. The reaction was stopped by the 
addition of an equal volume of 2x SDS sample 
buffer (4% SDS, 20% glycerol, 120 mM Tris, pH 
6.8, 0.01% bromophenol blue) and boiling for 5 
min. Samples were resolved by 12% SDS-PAGE 
followed by autoradiography. 
Immunoprecipitation of Oocyte Fractions 
With an Anti-v-erbA Antibody 
Oocytes were microinjected with 5 ng RS-v-
erbA or pKCR2-cea into the nucleus and incu-
bated in a sterile microtitre plate (five oocytesl 
well) in 30 pI of O-R2 with 1 mCilml L_[35S] 
methionine (1,000 Cilmmol) (Amersham) at 
1SOC for 24 h. Nuclear fractions of 10 or 20 
pooled v-erbA-injected oocytes were prepared 
manually, after fixation in 1% ice-cold TCA for 5 
min [Allison et aL, 1993]. Net-2 (50 mM Tris, 
pH 7.4, 150 mM NaCI, 0.05% Nonidet P-40) 
samples were homogenized in 0.5 ml NET-2 
[Allison et aL, 1993] containing 0.1 mM PMSF. 
For preparation of nuclear membrane frac-
tions, nuclei were manually isolated in nuclear 
isolation medium (NIM) (83 mM KCI, 17 mM 
NaCI, 10 mM Tris, pH 7.2, 5 mM Pefabloc) 
lKrohne and Franke, 1983] in a small silicon-
ized petri dish using watchmaker's forceps. Nu-
clei were freed from adhering yolk by aspirat-
ing them into a pipette with an inner bore 
diameter of 0.7-0.8 mm and then washed once 
in fresh NIM and transferred into nuclear enve-
lope isolation medium (NEM) (83 mM KCI, 17 
mM NaCI, 10 mM MgCI2, 10 mM Tris, pH 7.2, 5 
mM Pefabloc). Within 30-60 s, the nuclear con-
tent forms an opaque and compact aggregate 
from which the nuclear membrane (envelope) 
detaches. The nuclear membranes were iso-
lated by aspirating nuclei into a pipette with an 
inner bore diameter of 0.3-0.4 mm, cleaned in 
fresh NEM by repeated aspiration into a small 
pipette, and transferred into a microfuge tube. 
Ten or 20 nuclear envelopes were pooled per 
sample and collected by centrifugation for 4 
min at 8,000g and resuspended by gentle aspi-
ration in 0.5 ml NET-2 containing 5 mM Pefabloc. 
For total soluble protein electrophoretic sepa-
rations, 20 pI 2 x SDS sample buffer and 1 mM 
dithiothreitol (DTT) were added to 20 pI cleared 
homogenate from nuclear and nuclear mem-
brane fractions, which were then resolved by 
12% SDS-polyacrylamide gel electrophoresis 
and stained with Bio-Rad Silver Stain CBio-Rad 
Laboratories Pty Ltd., Auckland, New Zealand). 
For immunoprecipitation assays, 30 pI of 
monoclonal antibody LA038 against v-erbA resi-
dues 58-75 (Quality Biotech, Camden, NJ)were 
bound to 20 pI preswollen protein G-Sepharose 
beads (Gamma Bind Plus Sepharose, Pharma-
cia LKB Biotechnology, Auckland, New Zea-
land) in 0.45 ml NET-2 for 2 h at room tempera-
ture with end-over-end rotation. After 
incubation, the resin was pelleted for 5 s in a 
microfuge and resuspended in 1 ml of NET-2, 
and the wash was repeated three times. Pooled 
nuclei or nuclear membrane samples in NET-2 
were added to each washed protein G-Sepha-
rose-antibody pellet and incubated at 4°C for 
1 h with end-over-end rotation. After incuba-
tion, the resin with bound antigen was pelle ted 
and washed four times with NET-2. 'l\venty 
microliters of2x SDS sample buffer was added 
to each pellet, the samples were heat-dena-
tured to release the antigen, and the resin was 
pelleted for 5 s in a microfuge. The supernatant 
(with 1 mM DTT added) was resolved by 12% 
SDS-PAGE followed by fluorography. 
Immunolabeling of Isolated Nuclear Membranes 
Oocytes were microinjected with 5 ng RS-v-
erbA into the nucleus and incubated in O-R2 for 
12-14 h. Nuclear membranes of 20 oocytes per 
sample were manually isolated as described 
above and fixed in 2% formaldehyde, freshly 
made from paraformaldehyde in phosphate buff-
ered saline (PBS) (137 mM NaCl, 1.3 mM 
Na2HP04, 2.5 mM NHzP04, pH 7.2), for 10 min 
at 4°C. Immunolabeling with colloidal gold, em-
ploying a biotin-streptavidin bridging tech-
nique, was carried out following published pro-
cedures [Cordes et aI., 1993) with modifications 
and according to the manufacturer's specifica-
tions (Amersham). Membranes were collected 
by centrifugation at 8,000g for 4 min and 
washed three times in PBS, pH 7.2, containing 
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50 mM NH4Cl. Membrane samples were then 
resuspended in 24 111 PBS, pH 7.2, with 6 111 
anti-v-erbA antibody LA038, and incubated for 
2 h at room temp. Subsequently, membranes 
were centrifuged at 8,000g for 4 min, washed 
three times in PBS, resuspended in 99 111 PBS, 
pH 7.2, containing 1111 biotinylated goat anti-
mouse Ig antibody (Amersham), and then incu-
bated for 2 h at room temperature. The samples 
A 
a b 
c d 
Fig. 1. v-ErbA induced GVM and GVBD in Xenopus oocytes by 
activating de novo gene expression. A: v-ErbA induced GVM and 
concomitant pigment rearrangements similar in appearance to 
meiotic white spot formation. Stage VI IDumont, 1972] oocytes 
were injected with 5 ng lacZ expression plasmid (panel a), 
incubated in 10 f-lglml progesterone (panel b), or injected with 5 
ng v-erbA template (panels c,d), followed by examination of the 
pigment arrangement after 24 h. B: The mean frequency of GVM 
and GVBD in v-erbA·injected and progesterone-treated oocytes 
after 24 h. VI oocytes were injected with 5 ng v-erbA 
template (V) or 5 ng lacZ expression vector (C) and incubated in 
O-R2 alone or in 10 f-lglml progesterone (Pl. C: GVBD initiation 
by v-ErbA required de novo gene expression. The frequency of 
GVBD was assessed as follows: oocytes were scored positive 
when the nucleus could not be dissected intact from uninjected 
controls or from oocytes injected with in vitro-synthesized v-ErbA 
(in rabbit reticulocyte lysate) after a 24 h incubation in O-R2 or 30 
f-lglml actinomycin D (Act. D). As an additional control, oocytes 
were injected with the rabbit reticulocyte lysate transcription! 
translation mixture (TNT) and scored for GVBD. The error bars 
indicate the SEMs of three independent experiments (30-40 00-
cytes/treatmentlexperiment). 
were then washed with PBS, pH 7.2, as de-
scribed above. Next, membranes were incu-
bated in 38111 PBS, pH 7.2, with 2111AuroProbe 
EM streptavidin 10 nm (Amersham) for 2 h at 
room temperature and washed in PBS as be-
fore. Membranes were fixed in 2.5% glutaralde-
hyde in PBS, pH 7.2, for 30 min at 4°C, washed 
three times in PBS, and treated with 2% aque-
ous OS04 for 30 min at 4°C, followed by several 
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washes in ddH20. Membrane samples were de-
hydrated in a graded ethanol series, incubated 
in 100% acetone twice for 20 min, and embed-
ded in Spurr's resin in acetone: 50% resin (1 h), 
90% resin (overnight), and 100% resin (1 h). 
Membranes were then immersed in fresh resin 
and cured at 70°C for 14 h. Ultrathin sections 
(50 nm) were stained with 2% uranyl acetate in 
50% ethanol for 10 min, washed in ddH20, 
stained with lead citrate for 5 min, and washed 
inddH20. 
RESULTS 
v-ErbA Induced GVM and GVBD in Xenopus 
Oocytes by Activating De Novo Gene Expression 
During meiosis, pigment granules in the ani-
mal hemisphere cortex of Xenopus oocytes are 
rearranged, producing a whitish circular spot 
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Fig. 2. The effects of expression of v-erbA in oocytes occurred 
independently of the cAMP/MPF pathway. A: v-erbA-injected 
(V), lacZ-injected (Cl, or progesterone-treated (P) oocytes were 
incubated in 20 flM forskolin/2 mM IBMX. After 24 h, the 
percentage of oocytes displaying GVM was assessed by inspec-
tion of whole oocytes, and the frequency of GVBD induction 
was scored by manual dissection of nuclei in 1 % TCA. Three 
independent experiments were performed (30-40 oocytes per 
treatment per experiment). The error bars indicate the SEMs. B: 
v-ErbA did not induce MPF histone Hl kinase activity. After 
[reviewed in Smith, 1989]. Pigment displace-
ment commences during early maturation and 
is thought to be initiated by structural changes 
in the oocyte cortex immediately upon meiotic 
induction [Bement and Capco, 1990]. The pro-
gressive migration of the nucleus (germinal 
vesicle migration), from near the center of the 
oocyte toward the animal pole, contributes to 
the rearrangement of pigment granules. Upon 
germinal vesicle breakdown and completion of 
maturation, a clearly delineated white spot rep-
resents the area where the meiotic spindle has 
formed [reviewed in Smith, 1989; Bement and 
Capco, 1990; Brachet et aI., 1970]. 
We first tested the ability ofv-ErbA to initiate 
maturation in Xenopus oocytes by comparing 
the rate of nuclear migration and breakdown in 
progesterone-treated and v-erbA-injected 00-
B 
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microinjection of 5 ng v-erbA or pRSV-lacZ template as a 
control (Cl (upper panel) or incubation in progesterone or O-R2 
as a control (C) (lower panel), oocytes were collected at the 
indicated times, and MPF kinase activity was using 
histone Hl as a substrate and -y[32P] ATP. Samples were resolved 
by 12%, 5DS-polyacrylamide gel electrophoresis followed 
autoradiography. MPF histone Hl kinase activity was in 
oocytes with (7) or without (-) a distinct white spot (GVM). A 
representative example of three independent experiments, us-
ing oocytes from different female Xenopus, is shown. 
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cytes obtained from the same females. We have 
shown previously that v-ErbA, synthesized from 
a microinjected gene template in Xenopus 00-
cytes, is functional and acts as a dominant 
repressor of TR [N agl et aL, 1995]. Microinjec-
tion of v-erbA expression plasmid into the 
nucleus of stage VI oocytes resulted in GVM 
and concomitant pigment displacement which, 
in most cases, was highly similar in appearance 
to GVM induced by progesterone after 24 h 
(Fig. lA; cf. panels b,c). Occasionally, pigment 
aggregation in the center of the whitish circular 
spot in v-erbA-injected oocytes was seen (Fig. 
lA, panel d). GVM occurred in 41% ofv-erbA-
injected oocytes, while the mean frequency of 
GVM in progesterone-stimulated oocytes was 
69% (Fig. 1B). Next, oocytes were assessed for 
GVBD and were scored positive when the 
nucleus could not be dissected intact due to 
nuclear instability 24 h after microinjection of 
v-erbA template or due to nuclear dissolution 
after a 24 h incubation in progesterone. Accord-
ing to this criterion, GVBD occurred at a mean 
frequency of 67% in v-erbA-injected oocytes 
compared to 94% in progesterone-treated 00-
cytes (Fig. IB). It has been noted previously 
that the pigment displacement associated with 
GVM is not always apparent during matura-
tion [Smith, 1989; Bement and Capco, 1990]. In 
the present study, GVBD could be observed in 
the absence of GVM both in progesterone-
treated and v-erbA-injected oocytes. 
It should be noted that progression through 
meiosis, induced by progesterone, occurred at a 
decelerated pace in all oocytes employed in this 
study [for comparison see Smith, 1989; Bement 
and Capco, 1990]. We attribute this fact to 
seasonal and dietary factors in Xenopus donor 
animals. Since this time course was consistent 
throughout the study, this did not interfere 
with the temporal comparison of progesterone-
and v-erbA-induced events. Progesterone-
treated oocytes, scored positive for GVBD, still 
retained remaining fragments of the germinal 
vesicle after 24 h. In contrast, when v-erbA-
injected oocytes were incubated in progester-
one, the complete disappearance of the nucleus 
was observed in all oocytes examined upon 
manual dissection after 24 h (data not shown). 
This shortened time course for the complete 
breakdown of the nucleus may suggest synergis-
tic action ofv-ErbAand progesterone in meiotic 
maturation. 
To test whether the partial release of G2 
arrest by v-ErbA required de novo gene expres-
sion, we scored the frequency of GVBD in 00-
cytes that had been injected with in vitro-
synthesized v-erbA protein into the cytoplasm 
or treated with progesterone and incubated in 
actinomycin D. Consistent with the reported 
lack of requirement for gene transcription dur-
ing progesterone-mediated meiotic induction 
[Baltus et al., 1973; Sagata et al., 1988; Yew et 
al., 1992; Sheets et al., 1995], actinomycin D 
did not affect the frequency of GVBD in proges-
terone-treated oocytes (data not shown). Since 
v-ErbA was not purified from the translation 
reaction mixture, it was possible that the rabbit 
reticulocyte lysate could supply factors that 
would effect GVBD. Thus, oocytes were injected 
with lysate mixture as a control. As shown in 
Figure lC, the lysate alone did not induce 
GVBD. Twenty-four hours after microinjection, 
the mean frequency of GVBD in oocytes in-
jected with v-ErbA and incubated in the ab-
sence of inhibitor was 61% in this series of 
experiments (Fig. 1C). In contrast, incubation 
of v-ErbA-injected oocytes in actinomycin D 
reduced the frequency of GVBD to 7.5% (Fig. 
lC), showing that the nuclear migration and 
nuclear instability induced by v-ErbA were de-
pendent on de novo gene expression. A require-
ment for translation of the newly transcribed 
message(s) was shown by reduction of GVBD 
frequency to the same level (Le., 7.5%), by cyclo-
heximide (data not shown). 
Induction of GVM and GVBD by v-ErbA 
Does Not Involve Activation of the 
cAMP/MPF Pathway 
Treatment of oocytes with forskolin, an ad-
enylate cyclase activator, or IBMX, an inhibitor 
of cAMP breakdown, blocks meiotic induction 
by progesterone [reviewed in Smith, 1989; Be-
ment and Capco, 1990]. Forskolin and IBMX 
did not significantly affect GVBD in v-erbA-
injected oocytes and decreased GVM only mod-
erately while completely inhibiting progester-
one-induced GVM and GVBD (Fig. 2A). MPF 
kinase activation, the definitive parameter of 
MPF -mediated oocyte maturation, can be mea-
sured in vitro by means of kinase activity of 
oocyte extracts using histone HI as a substrate 
[Langan et al., 1989]. We assayed HI histone 
kinase activity in v-erbA-injected and progester-
one-incubated oocytes in three independent ex-
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periments with oocytes obtained from different 
female Xenopus. The results of a representative 
experiment, using oocytes from the same fe-
male, are shown in Figure 2B. Marked v-erbA-
induced nuclear changes, consistent with the 
onset of maturation, were present 16 h after 
microinjection (see Figure 3). Therefore, HI 
histone kinase activity was assayed over an 
18 h period which included and extended be-
yond the window of potential MPF activation at 
the start of maturation. In extracts prepared from 
v-erbA-microinjected oocytes, HI kinase was 
not activated over this 18 h period when com-
pared with an extract from lacZ-injected con-
trols assayed after 2 h (Fig. 2B). The slightly 
elevated levels of HI histone kinase activity in 
samples assayed 4 hand 14 h after microinjec-
tion were interpreted as not significant, as they 
were not reproduced in repeat assays. More-
over, similar fluctuations in HI histone kinase 
activity were also observed in extracts of lacZ-
injected controls assayed over time (data not 
shown). Compared with a control extract from 
oocytes cultured in O-R2, extracts from oocytes 
incubated in progesterone exhibited high levels 
of histone HI kinase activity after 2 h (2 h, 
GVM - ), approximately 6 h prior to the appear-
ance of the white spot (8 h, GVM + ) (Fig. 2B). 
Both in the presence and absence of GVM, 
strong HI histone kinase activity was present 
in extracts from progesterone-incubated 00-
cytes over the entire time interval assayed, 
except for the extract from oocytes lacking a 
meiotic spot after a 10 h incubation (10 h, 
GVM -). In summary, these experiments 
showed that induction of nuclear migration and 
nuclear instability in the presence of v-ErbA 
did not involve the activation of the cAMP-
regulated CDC2IMPF pathway. 
v-ErbA Initiated Changes in the Nucleus and 
Cortex Characteristic of Early and Intermediate 
Meiotic Events 
Many studies have relied solely on inspection 
of whole oocytes and dissection of nuclei to 
assay for GVM and GVBD, respectively. How-
ever, this approach does not allow the distinc-
tion of complete maturation from arrested meio-
sis which is also accompanied by nuclear 
migration and destabilization IBaltus et aL, 
1973; Steinert et aI., 1974}. To enable us to 
discriminate between these two outcomes in 
v-erbA-injected oocytes, we performed a de-
tailed analysis of semithin sections from 
v-erbA-injected oocytes exhibiting nuclear in-
stability by differential interference contrast 
microscopy. As shown in Figure 3A, extensive 
invaginations of the basal nuclear membrane 
and lamina were visible in v-erbA-expressing 
oocytes 16 h after microinjection. At 36 h, the 
invaginations appeared as sealed off lacunae of 
cytoplasm separated by stretches of nuclear 
membrane, and a yolk-free area was visible in 
the cytoplasm below (Fig. 3B). The appearance 
ofv-erbA-injected oocytes 36 h after microinjec-
tion was highly similar to the appearance of 
progesterone-treated oocytes after 16 h (Fig. 
3D). The dynamic rearrangements of the 
nuclear membrane in v-erbA-injected oocytes 
eventually resulted in membrane rupture at 
the apical (animal) pole after 42 h (Fig. 3C), and 
meiotic spindle formation did not occur. In con-
trast, in progesterone-induced maturation the 
rupture of the nucleus always occurs in the 
vegetal half [Baltus et aI., 1973; Bement and 
Capco, 1990; Hausen and Riebesell, 1991]. Fur-
ther, in progesterone-treated oocytes meiotic 
spindle formation was observed after 26 h (data 
not shown). Apical membrane rupture was not 
observed in lacZ-injected controls, demonstrat-
ing that rupture in v-erbA-injected oocytes was 
not due to damage during the process of micro-
injection (Fig. 3E). Nuclear membrane rupture 
at the apex has previously been shown to be 
independent of the site of oocyte microinjection 
and is associated with arrested meiotic matura-
tion [Baltus et aL, 1973; Steinert et aL, 1974]. 
The progressive ultrastructural changes tak-
ing place in the nucleus and the cytoplasm 
during maturation have been well character-
ized [Bement and Capco, 1990] and can serve as 
markers for temporal subsets of meiotic trans-
formations. As shown in Figure 4A, the vegetal 
half of the nucleus in lacZ-injected controls was 
extensively folded, forming narrow cytoplasmic 
channels and larger invaginations extending 
into the nucleoplasm. Annulate lamellae (AL) 
were often seen in the cytoplasm, in close prox-
imity to the nuclear membrane. LacZ-injected 
oocytes were identical in appearance to unin-
jected oocytes (data not shown). In contrast, in 
v-erbA-injected oocytes, the structure of the 
nuclear membrane was drastically altered. v-
ErbA induced the formation of long stretches of 
adjoined double membranes and the transfor-
mation of AL into cisternae (Fig. 4B-E). Seen in 
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Fig. 3. Semithin sections of nuclei of v-erbA-expressing 00-
cytes showed structural changes indicative of meiotic induc-
tion, but meiosis was arrested prior to spindle formation. 
A: Invaginations of the basal nuclear membrane and lamina in 
v-erbA-expressing oocytes 16 h after microinjection. B: Progres-
sive v-ErbA-mediated structural changes along the circumfer-
ence of the nuclear membrane and yolk-free zone below the 
cross-section, the two double membranes ap-
peared tightly adjoined to each other, except for 
small islands of enclosed cytoplasmic material 
(Fig. 4D,E). A striking feature of this mem-
brane rearrangement was the alignment of 
nuclear pore complexes (NPCs) across the joined 
membranes (Fig. 4F). Furthermore, clustering 
ofNPCs, with adjacent portions of nuclear mem-
brane depleted of NPCs, was seen in the basal 
regions of the nuclear envelope (Fig. 4G,H). 
Concomitant with the altered nuclear mem-
brane architecture, multiple layers of cisternae 
devoid ofNPCs developed (Fig. 41). In addition, 
the nucleoli showed signs of meiotic transforma-
tion (Fig. 4J); that is, the granular and fibrillar 
parts had become clearly segregated. The re-
basal nuclear membrane 36 h after microinjection. C: Rupture 
of the apical nuclear membrane (NM) in v-erbA-expressing 
oocytes 42 h after microinjection. D: Invaginations of the basal 
nuclear membrane and lamina and yolk-free space in progester-
one-induced oocytes after 16 h. E: Absence of nuclear mem-
brane invaginations in lacZ-injected control oocytes 36 h after 
microinjection. Scale bars = 100 fJM. 
arrangements of the basal nuclear membrane, 
NPC clustering, AL transformation into cister-
nae, and segregation ofthe granular and fibril-
lar components of nucleoli represent the initia-
tion of events leading to the disassembly of the 
nuclear membrane and NPCs during meiosis 
[Bement and Capco, 1990; Brachet et aI., 1970; 
Steinert et aI., 1974; Kessel and Subtelny, 1981]. 
The cortex of oocytes expressing v-erbA exhib-
ited a subset of meiotic changes but did not 
develop the characteristics belonging to the late 
stage of maturation (Fig. 5A-C). Microvilli, al-
though less numerous and shortened compared 
to untreated controls (data not shown), were 
present 36 h after microinjection ofv-erbA tem-
plate (Fig. 5A,C), whereas they were lacking 
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Fig. 4. Ultrastructural meiotic changes in thin sections of 
nuclei of v-erbA-expressing oocytes, A: The basal nuclear 
membrane (NM) of control oocytes injected with 5 ng lacZ 
template was highly folded and formed narrow channels of 
cytoplasm (eYTj and lobes extending into the nucleus (N). 
Annulate lamellae CAL) are visible close to the nuclear mem-
brane (en face view), M, mitochondrion, B-): Thin sections of 
v-erbA-expressing oocytes. B,C: Extensive regions of nuclear 
membrane were tightly adjOined to each other 36 h after 
microinjection (adjoined membranes, AM). AL had become 
transformed into cisternae (e). eYT, cytoplasm; ,\I, nucleus. D,E: 
Long stretches of adjoined membranes (arrows) with aligned 
after 16 h in oocytes undergoing progesterone-
induced maturation (Fig. 5D). Pigment gran-
ules were clustered at a distance from the 
plasma membrane in both v-erbA-expressing 
(Fig. 5B) and progesterone-induced oocytes (Fig. 
5E), resulting in formation of a whitish circular 
NPCs (arrowheads) separated off islands of cytoplasm (CI) con-
taining mitochondria and other cytoplasmic material. N, nucleus. 
F: NPCs (arrowheads) were aligned across the adjoined mem-
brane'S (short arrows) by electron-dense material (long arrow). 
AM, adjoined membranes. G,H: NPCs in the basal nuclear 
membrane were clustered (large arrowheads), with adjacent 
regions being depleted of \lPCs (small arrowheads), 36 h after 
microinjection. I: AL were transformed into cisternae (Cl devoid 
of i\lPCS. ,''.01, mitochondrion. J: The nucleoli (Nul were segre-
gated into distinct fibrillar and granular regions. CYT, cyto-
plasm; N, nucleus. A-E,J: Scale bars = 1 jJm. H: Scale bar = 500 
nm. F,G,I: Scale bar 200 nm. 
spot. In contrast, the majority of cortical gran-
ules in v-erbA-expressing oocytes remained lo-
calized adjacent to the plasma membrane in 
the area of displaced pigment (Fig. 5B) but 
were retracted into the interior in progesterone-
treated oocytes (Fig. 5E,F). This finding is con-
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Fig. 5. The cortex of v-erbA-expressing oocytes showed a 
subset of meiotic transformations in thin and semithin sections. 
A: In the cortex of v-erbA-expressing oocytes, microvilli (MV) 
and yolk-free corridors (asterisk) were visible 36 h after microin-
Cortical granules (CG) were localized immediately 
the plasma membrane. EM, extracellular matrix; P, pig-
ment granules; Y, yolk platelet. 8: Pigment granules were re-
tracted and clustered in the cytoplasm, while cortical granules 
(arrowhead) were present adjacent to the apical plasma mem-
brane, in the area of the displaced pigment 36 h after microinjec-
tion of v-erbA (semithin section). C: The microvilli of v-erbA-
expressing oocytes were partially retracted and of low density. 
The cortical endoplasmic reticulum (arrowheads) had not formed 
an extensive network and did not encircle the cortical granules. 
CG, cortical granules; M, mitochondrion; MV, microvilli; P, 
pigment granules; Y, yolk platelet. 0: Progesterone-induced 
maturation resulted in the complete retraction of microvilli after 
16 h; yolk-free corridors were disrupted, and mitochondria (M) 
were randomly dispersed throughout the cortex. CG, cortical 
sistent with the observation that the rapid de-
crease in cAMP level triggered by progesterone 
correlates with the movement of cortical gran-
ules away from the plasma membrane, suggest-
granules; P, pigment granules; Y, yolk platelet. E: Progesterone 
induction caused the retraction of cortical granules and the 
clustering of pigment granules in the cytoplasm (semithin sec-
tion). F: Retraction of almost all cortical granules (CG), pigment 
granules (P), and other vesicles resulted in an area of clear 
cytoplasm in the meiotic white spot (.',,1S) of progesterone-
induced oocytes after 16 h. Y, yolk platelet. G: Cortex of a 
lacZ-injected control oocyte 36 h after microinjection. CG, 
cortical granules; EM, extracellular matrix; MV, microvilli; P, 
pigment granules; Y, yolk platelets. H: Continuous pigment 
layer adjacent to the plasma membrane in a lacZ-injected 
oocyte 36 h after microinjection (semithin section). I: Numerous 
extended microvilli (MV) in a lacZ-injected oocyte 36 h after 
microinjection. The cortical endoplasmic reticulum (arrow-
heads) was comparable to that of v-erbA-injected oocytes. CG, 
cortical granules; p, pigment granules. A: Scale bar 2 ~m. 
B,E,H: Scale bars = 1 00 ~m. D,F,G: Scale bars 1 ~m. C,I: 
Scale bars 500 nm. 
ing that cortical granule position is controlled 
by the level of intracellular cAMP [Bement and 
Capco, 1990]. Since v-ErbA-induced changes 
occur without a decrease in cAMP, the cortical 
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granules would be expected to remain at the 
plasma membrane. In oocytes microinjected 
with the lacZ plasmid, microvilli were more 
numerous and further extended (Fig. 5G,I) than 
in v-erbA-injected oocytes (Fig. 5A,C). The layer 
of pigment granules was continuous in lacZ-
injected oocytes and located directly adjacent to 
the plasma membrane (Fig. 5H), differing mark-
edly from the clustered pigment arrangement 
in v-erbA-injected oocytes (Fig. 5B). The struc-
ture of the cortical endoplasmic reticulum in 
lacZ-injected controls (Fig. 51) was comparable 
to that of the cortical endoplasmic reticulum in 
v-erbA-expressing oocytes (Fig. 5C). Finally, 
features characteristic of late meiotic matura-
tion-for example, disruption of the yolk-free 
corridors and development of an extensive corti-
cal endoplasmic reticulum-were not seen in 
v-erbA-expressing oocytes (Fig. 5A,C). A sum-
mary of the comparison of ultrastructural 
changes induced by progesterone and v-ErbA is 
presented in Table I. 
v-ErbA Did Not Act as a Dominant Antagonist 
of Endogenous TR 
Some of the growth-promoting properties of 
v-ErbA in mammalian cells are mediated by 
dominant repression of TR and RAR [Sharif 
and Privalsky, 1991; Desbois et al., 1991a,b; 
Zhang et al., 1991; Gandrillon et al., 1994]. 
Stage VI Xenopus oocytes contain low levels of 
TRa and TRI3 protein [Eliceiri and Brown, 1994] 
but lack thyroid hormone [Nagl et al., 1995]. 
Conceivably, unliganded TR might contribute 
to the G2 arrest by repressing certain M-phase-
inducing genes. Therefore, we wished to assess 
whether dominant negative inactivation of un-
liganded TR by v-ErbA was responsible for the 
induction of early meiotic events. We have 
shown elsewhere that the action of endogenous 
oocyte TR can be blocked by a dominant nega-
tive in vitro-generated mutant of human TRI3 
(TR C122 > A) [Nagl et al., 1995]. When v-
ErbA was replaced by the mutant TR C122 > A, 
the morphology of the basal nuclear membrane 
in TR C122 > A-injected oocytes was identical 
to that of untreated G2-arrested oocytes (Fig. 
6). This finding suggests that v-ErbA-induced 
ultrastructural changes, characteristic of early 
and intermediate maturation events, were not 
initiated byv-ErbAacting as a dominant antago-
nist of endogenous TR. 
TABLE I. Induction of Early and Intermediate 
Meiotic Events by v-ErbA in Xenopus Oocytes 
Meiotic eventa 
Early 
AL transformation 
Basal membrane changes 
Cortical granule retraction 
Intermediate 
Nuclear migration 
Pigment rearrangement 
NPC repositioning 
Nucleolar dissolution 
Microvilli retraction 
GVBD 
Chromosome condensation 
Late 
Yolk-free corridor disruption 
ALabsent 
Cortical ER development 
Microvilli retraction com-
pleted 
Meiotic spindle 
v-ErbAb 
+ 
initiated 
initiated 
initiated 
apical breakdown 
UMeiotie events were timed [Bement and Capeo, 1990] and 
identified as described [Bement and Capeo, 1990; Hausen 
and Riebesell, 1991; Brachet et al., 1970; Steinert et al., 
1974; Kessel and Subtelny, 1981; Kessel, 1992]. 
bThe presence (+) or absence (-) of events indicative of 
different stages of progesterone-induced maturation, in v-erbA-
expressing oocytes is shown (see Figs. 4, 5). 
v-ErbA Was Detectable at Nuclear Pore 
Complexes 
In immunoprecipitation assays, v-ErbA, syn-
thesized in oocytes, is almost exclusively recov-
ered from manually isolated nuclei, while ap-
proximately 10% of v-ErbA partitions to the 
cytoplasmic fraction (data not shown). In oocyte 
fractionation assays, a protein with a molecular 
weight of approximately 75 kD was detectable 
in total soluble protein fractions from isolated 
nuclei 8 h after microinjection of the gene tem-
plate (Fig. 7A, panel a). This protein corre-
sponds in size to the full-length gag-v-erbA 
fusion protein encoded by the RS-v-erbA expres-
sion template [Privalsky, 1992]. Mter 24 h, accu-
mulation of the 75 kD protein in nuclear frac-
tions was further increased, and, surprisingly, 
the protein was also detectable in total soluble 
protein fractions from isolated nuclear mem-
branes (Fig. 7 A, panel b). To confirm the iden-
tity of the 75 kD protein, we carried out immu-
noprecipitation assays on both fractions using a 
monoclonal antibody with dual specificity for 
both v-erbA and chicken c-erbA [Freake et aL, 
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Fig. 6. A dominant negative mutant of TR did not mimic the action of v-ErbA. Semithin section showing the basal 
nuclear membrane of a TR C122 > A-injected oocyte 36 h after microinjection. Scale bar = 20 iJm. 
1988]. As shown in Figure 7A, panel c, the 75 
kD protein was immunoprecipitated from the 
nuclear membrane and nuclear fractions. In 
contrast, deliberate overexposure of the fluoro-
graph showed that wild-type chicken c-ErbA, 
expressed from injected c-erbA templates, was 
exclusively immunoprecipitated from the 
nuclear fraction (Fig. 7A, panel d). 
To identify the precise location ofv-ErbA, we 
performed immunogold labeling of manually 
isolated nuclear membranes (Fig. 7B). Nuclear 
membranes, isolated from v-erbA-expressing 
oocytes, were exclusively decorated with gold 
particles at the cytoplasmic face of NPCs (Fig. 
7B, panels a-c), and, more specifically, the v-
erbA product was localized to the fibrils emanat-
ing from the cytoplasmic annuli (Fig. 7B, pan-
els d,e). A possible reason for the relatively low 
labeling density, which contrasted with the 
strong signal obtained by immunoprecipita-
tion, is that the primary antibody was raised 
against a synthetic peptide of v-erbA (residues 
58-75) within the DNA binding domain. Since 
the DNA binding domain is separated from the 
v/c-erbA nuclear localization sequence (NLS) by 
only 12 amino acid residues [LaCasse and Lefe-
bvre, 1995], antibody accessibility might have 
been reduced due to steric hindrance caused by 
interactions between the NLS and a NPC com-
ponent(s). Control nuclear membranes from un-
injected oocytes did not exhibit immunogold 
labeling with the anti-erbA antibody (data not 
shown), indicating that the observed binding of 
the gold probes to the cytoplasmic fibrils was 
specific for the v-ErbA antigen. 
DISCUSSION 
Our study shows that v-ErbA induces ultra-
structural changes in Xenopus oocytes charac-
teristic of early and intermediate events of meio-
sis. This subset of meiotic events was induced 
by v-ErbA independently of the cAMP-regu-
lated CDC2IMPF pathway and required gene 
transcription. Importantly, a dominant nega-
tive mutant of TR did not induce ultrastruc-
tural changes in oocytes, suggesting that this 
effect ofv-ErbA was not mediated by inactivat-
ing endogenous TR. This finding implies the 
existence of a pathway for the partial release of 
the G2 arrest in oocytes which can be triggered 
by the expression of an as yet unidentified 
v-ErbA-inducible gene(s). The identification of 
this gene(s) can be expected to provide further 
insights into the mechanisms through which 
v-ErbApromotes cell growth. 
The rearrangements of the basal nuclear 
membrane, NPC clustering, annulate lamellae 
transformation into cisternae, and segregation 
of the granular and fibrillar components of 
nucleoli, which were all observed in v-erbA-
expressing oocytes, represent the initiation of 
events leading to the disassembly ofthe nuclear 
membrane and NPCs during meiosis [Bement 
and Capco, 1990; Brachet et al., 1970; Steinert 
et al., 1974; Kessel and Subtelny, 1981]. How-
ever, the reorganization of the nuclear mem-
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Fig. 7. v-ErbA was detectable at nuclear pores. A: Low amounts 
of v-ErbA were present in nuclear membrane fractions. Panel a: 
Total soluble protein fractions were prepared from ten manually 
isolated nuclei (N) or nuclear membranes (NM) 0 or 8 h after 
microinjection of 5 ng v-erbA expression template and resolved 
12% SDS-PAGE and silver staining. The arrowhead indicates 
a protein of approximately 75 kD, corresponding in size to the 
full-length gag-v-erbA fusion protein. Molecular weights (D) are 
indicated by dashes: 8:;,200, 55,600, 39,200, 26,600, 20,100, 
and 14,300. Panel b: Total soluble protein fractions from ten 
nuclei or ten nuclear membranes 24 h after microinjection. 
Symbols are as described in panel a. Panel t: The 75 kD 
gag-v-erbA protein was immunoprecipitated from nuclear mem-
brane and nuclear fractions using anti-v/c-erbA antibodies. 
Oocytes microinjected with 5 ng v-erbA expression vector were 
cultured in O-R2 medium with 1 mCi/ml L_llsSI methionine for 
24 h, and nuclear membranes and nuclei were manually iso-
lated. Nuclear membrane (NM) and nuclear (N) fractions of ten 
v-erbA-injected oocytes were incubated with protein G-
Sepharose-antibody complexes in an immunoprecipitation as-
say. Labeled polypeptides were recovered and separated by 
B 
a , 
b 
d 
~".,,:,: .. , .' . .... ; .. 
e 
... ~ 
c 
.;:,.rs~ 
12,){, SDS-PAGE followed by lIuorography. Panel d: c-ErbA was 
exclusively immunoprecipitated from the nuclear fraction. Im-
munoprecipitation of c-erbA protein from the nuclear (N) and 
nuclear membrane (:'JM) fractions of 20 oocytes injected with 5 
ng c-erbA expression vector was carried out as described in 
panel c. B: Immunogold EM detection of v-ErbA at ,'JPCs. 
Manually isolated nuclear membranes from v-erbA-injected 
oocytes were immunolabeled with 10 nm colloidal gold using a 
v-erbA-specific monoclonal antibody in a biotin-streptavidin 
bridging technique prior to embedding and thin sectioning. 
Panel a: An en face view of the cytoplasmic side of the nuclear 
envelope. Arrowheads indicate examples of colloidal 
labeled NPCs clearly revealed by this plane of sectioning. 
Panels b,t: Selected examples of transversely sectioned NPCs 
labeled by the anti-v-erbA antibody. Panels d,e: Representative 
examples of tangentially sectioned nuclear envelopes. The v-
erbA-specific antibody exclusively labeled the cytoplasmic fibrils 
of NPCs. The cytoplasmic side of all cross-sectioned nuclear 
envelopes faces the top of the figure. The cytoplasmic side of the 
nuclear envelope often forms blebs (panel e). a: Scale bar 200 
nm. b: Scale bar = 100 nm. c-e: Scale bar = 50 nm, 
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brane in v-erbA-injected oocytes did not pro-
ceed past this intermediate stage, and 
eventually the nuclear membrane ruptured at 
the apical pole. CDC2IMPF, either directly or 
through activation of other protein kinases, 
induces disassembly of the nuclear lamina fila-
ments and NPCs and the vesicularization ofthe 
nuclear membrane [reviewed in Smith, 1989; 
Bement and Capco, 1990], and chromosome 
condensation and meiotic spindle formation are 
mediated by the reorganization of micro tubules 
by CDC2IMPF and MAPK [Smith, 1989; Be-
ment and Capco, 1990]. The failure of these 
progressive events to occur in v-erbA-express-
ing oocytes was correlated with the fact that 
CDC2IMPF was not activated and that v-ErbA-
mediated nuclear changes were not inhibited 
by taxoL This suggests that the nuclear changes 
did not involve rearrangements of the microtu-
bular network and, by implication, occurred 
independently of an MPFIMAPK requirement. 
There was a striking match between the v-
erbA-induced events and oocyte pseudomatura-
tion [Smith, 1989; Baltus et aL, 1973; Steinert 
et aL, 1974]. In pseudomaturation, a distinctive 
subset of structural changes is induced in the 
absence ofMPF activation and de novo synthe-
sis of c-mos protein [Drury and Schorderet-
Slatkine, 1975; Wasserman and Masui, 1975; 
Kobayashi et aL, 1991]-in particular, adjoined 
nuclear membranes, mottling of the pigment 
layer, and condensation of the fibrillar core of 
the nucleoli [Baltus et aL, 1973; Steinert et aL, 
1974]. Moreover, spindle formation is never ob-
served in pseudo maturation, and eventually 
apical rupture of the nuclear membrane occurs 
[Brachet et aL, 1970; Steinert et aL, 1974; Drury 
and Schorderet-Slatkine, 1975]. In oocytes, M-
phase induction by v-ErbA, like pseudomatura-
tion, is ultimately a destructive process. The 
reason for this most likely lies in the absence of 
additional signals from activated protein ki-
nases, essential for the completion of matura-
tion. Once the G:IM restriction point is passed, 
the maturing oocyte is committed to undergo 
events leading to GVBD and lacks the ability to 
reverse the meiotic pathway. Consequently, the 
initiated structural transformations eventually 
lead to the disintegration of the oocyte. This 
situation is wholly different from the context in 
which v-ErbA functions in somatic cells. So-
matic cells constantly receive a wide range of 
extracellular signals conveyed by growth fac-
tors, which activate mitogenic kinases. Abnor-
mal activation of a gene(s), encoding a putative 
cell cycle inducer, by v-ErbA can be expected to 
act in a complementary manner to these events 
and to enhance certain mitogenic signals. As a 
result, v-ErbA apparently does not cause 
nuclear dissolution in somatic cells but confers 
a reduced requirement for growth factors and 
an enhanced growth potential [Gandrillon et 
aL,1987]. 
In summary, the partial release of G2 arrest 
by v-ErbA appears to allow meiotic ultrastruc-
tural transformation up to a point where signal 
transmission by activated MPF and the subse-
quent phosphorylation cascade become essen-
tial for M-phase progression. In somatic cells, 
v-ErbA cooperates with oncogenic tyrosine ki-
nases, such as v-erbB, v-src, or v-sea, to achieve 
a fully transformed phenotype [Frykberg et aL, 
1983; Kahn et aL, 1986; Schroeder et aL, 1992]. 
The effects of v-ErbA in initiating the partial 
release from G2 arrest in oocytes may be seen as 
corresponding to the strictly cooperative role of 
the v-erbA oncogene in cellular transformation. 
A portion ofv-ErbA expressed in oocytes was 
present at the nuclear membrane at the cyto-
plasmic face of the NPCs near the cytoplasmic 
annuli. Specifically, colloidal gold-labeled v-
ErbA was detected at the cytoplasmic fibrils of 
the NPCs, possibly at fibril components, which 
have been shown to be involved in NLS-medi-
ated ligand docking [Forbes, 1992; Gorlich et 
aI., 1994]. That components of the nuclear im-
port machinery may interfere with cell cycle 
regulation is demonstrated by the effects of a 
mutation in the S. cerevisiae NLS receptor, 
Srp1, that targets proteins to the NPC [Loeb et 
aI., 1995]. A conditional srpl mutant arrests 
cells at the G:IM border and was suggested to 
act by blocking the import of a critical cell cycle 
regulator. Similarly, Pendulin (or OH031), a 
Drosophila tumor suppressor gene product with 
sequence homology to Srp1, exhibits cell-cycle-
dependent nuclear localization and is required 
for normal cell proliferation [Kiissel and Frasch, 
1995; Torok et al., 1995]. In addition, other 
recent studies showed that the fibrils emanat-
ing from the cytoplasmic face of NPCs contain 
the proteins CAN/nup214 [Kraemer et aI., 1994] 
and TPRlnup265 [Byrd et al., 1994], which have 
both been associated with oncogenesis in hu-
mans when fused to other genes. Thus, onco-
genes may be capable of inducing oncogenesis 
by altering the functions of NPCs. Potential 
effects ofv-ErbA at NPCs would be expected to 
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play an early inductive role, as the association 
ofv-ErbA with NPCs occurs well in advance of 
meiotic events. While the significance of the 
localization of v-ErbA at NPCs remains to be 
determined, it is interesting to consider the 
possibility that in addition to its intranuclear 
function in gene activation v-ErbAmight modu-
late nucleocytoplasmic transport of a key cell 
cycle regulator(s). 
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